Request for Consultants: Provision of Technical Oversight for the Implementation of Workstream on Building Local Capacity to Produce Quality ACT: 

Enhancing Local Manufacturing and Supply Chain Management for Health

Commodities and Supplies in Nigeria

1. Background

Nigeria faces a significant burden from both communicable and non-communicable diseases, which strains the healthcare system and hinders economic development. Despite ongoing efforts to address these challenges, the country remains heavily reliant on imports for essential health commodities. This dependency leads to high costs, supply chain vulnerabilities, and inconsistent availability of critical healthcare products. Strengthening local capacity and optimizing supply chain management is essential to improving the accessibility, affordability, and sustainability of healthcare products. This is key to advancing public health.

Market shaping strategies have proven successful in other health sectors by leveraging economies of scale, improving quality control, and enhancing distribution efficiency. Adopting this model for manufacturing and distributing essential health commodities could reduce costs, improve product consistency, and ensure more reliable supply chains. However, transitioning from an import-dependent system to one with a robust local production capacity and an efficient pooled procurement system is a complex process. It requires a comprehensive, multi-faceted approach that addresses manufacturing capabilities, quality assurance mechanisms, supply chain optimization, workforce capacity building, and supportive policy frameworks.

https://googleads.g.doubleclick.net/pagead/ads?gdpr=0&us_privacy=1—&gpp_sid=-1&client=ca-pub-2321249943983804&output=html&h=280&adk=3292208330&adf=3651786664&pi=t.aa~a.1381849204~i.13~rp.4&w=728&abgtt=6&fwrn=4&fwrnh=100&lmt=1745427050&num_ads=1&rafmt=1&armr=3&sem=mc&pwprc=6515900736&ad_type=text_image&format=728×280&url=https%3A%2F%2Fngojobsite.com%2Finvitation-to-bid-provision-of-technical-oversight-for-the-implementation-of-workstream-on-building-local-capacity-to-produce-quality-act-at-health-systems-consult-limited-hscl%2F&fwr=0&pra=3&rh=182&rw=727&rpe=1&resp_fmts=3&wgl=1&fa=27&uach=WyJXaW5kb3dzIiwiMTUuMC4wIiwieDg2IiwiIiwiMTM1LjAuNzA0OS44NSIsbnVsbCwwLG51bGwsIjY0IixbWyJHb29nbGUgQ2hyb21lIiwiMTM1LjAuNzA0OS44NSJdLFsiTm90LUEuQnJhbmQiLCI4LjAuMC4wIl0sWyJDaHJvbWl1bSIsIjEzNS4wLjcwNDkuODUiXV0sMF0.&dt=1745426256758&bpp=4&bdt=1842&idt=4&shv=r20250421&mjsv=m202504170101&ptt=9&saldr=aa&abxe=1&cookie=ID%3Dd402398dbe8029b3%3AT%3D1730191189%3ART%3D1745426888%3AS%3DALNI_Mbqv4ZjCA2FyHoBsYRqGiGVSR4f2A&gpic=UID%3D00000f5f5123b4f7%3AT%3D1730191189%3ART%3D1745426888%3AS%3DALNI_MaUeBuU5kMVXlTiiGykJasfdDE9vw&eo_id_str=ID%3D3685604803237a2e%3AT%3D1730191189%3ART%3D1745426888%3AS%3DAA-AfjZ2X441EOy64ZtttSEJoFR_&prev_fmts=0x0%2C750x280%2C1497x702&nras=3&correlator=8747092532096&frm=20&pv=1&u_tz=60&u_his=1&u_h=768&u_w=1366&u_ah=720&u_aw=1366&u_cd=24&u_sd=0.9&dmc=8&adx=190&ady=1181&biw=1497&bih=702&scr_x=0&scr_y=0&eid=95358862%2C95358864%2C95354562%2C95355310%2C95357877%2C95357716&oid=2&pvsid=3942448291295766&tmod=698141052&uas=0&nvt=1&fc=1408&brdim=-7%2C0%2C-7%2C0%2C1366%2C0%2C1379%2C727%2C1514%2C702&vis=1&rsz=%7C%7Cs%7C&abl=NS&cms=2&fu=128&bc=31&bz=0.91&td=1&tdf=2&psd=W251bGwsbnVsbCxudWxsLDNd&nt=1&pgls=CAEaAzYuOA..~CAA.&ifi=6&uci=a!6&btvi=1&fsb=1&dtd=M

The Presidential Initiative for Unlocking Healthcare Value Chain (PVAC) and the National Malaria Elimination Programme (NMEP), with the support of the World Bank IMPACT, embarked on a project called “Enhancing Local Manufacturing and Supply Chain Management for Health Commodities and Supplies in Nigeria”. The aim of this project is to address these challenges through a phased approach that balances short-term and long-term objectives. The strategies for addressing these challenges will include developing and laying the groundwork for local manufacturing of malaria commodities (including ACTs, RDTs, APIs and LLINs), including enhancing production capacity, ensuring compliance with international quality standards, and fostering workforce development. At the same time, the project will focus on optimizing the pooled procurement of imported malaria commodities to improve cost-effectiveness and distribution efficiency. Over the medium to long term, these interventions will strengthen the entire health commodities value chain, create opportunities for economic growth, and support Nigeria’s self-sufficiency in critical healthcare products. This comprehensive approach seeks to improve Nigeria’s healthcare supply systems’ efficiency and resilience while unlocking new economic opportunities within the country’s health sector. The project duration is 1 year.

2. Objective

This consultancy aims to provide technical oversight to all parties working under this project to enhance the local production of Artemisinin-based Combination Therapies (ACTs) in Nigeria. This involves providing technical oversight to PVAC, NMEP, local consultants, and other identified stakeholders engaged in this workstream. This workstream includes assessing manufacturing capacity, facilitating partnerships for technology transfer, ensuring compliance with regulatory standards, and supporting policy reforms to create an enabling environment for sustainable production. The consultant/consulting firm will ensure the integration of best practices for policy and implementation and draw from previous experiences in this space to strengthen the framework (both demand and supply) for the local manufacture of quality, and affordable ACTs.

3. Scope of Work

The consultant/ firm engaged to provide this oversight function is expected to:

1. Provide technical oversight and advise all parties working in the ACT workstream on matters relating to scope, quality, and outputs through participation and reviews during the planning, implementation, and close-out phases of the ACT production capacity development workstream.
2. Support the development of recommendations required for critical policy and regulatory reforms that will address gaps in the local manufacturing of ACTs by sharing best international practices in regulation, innovative financing, international market entry, etc.
3. Facilitate the engagement of stakeholders (government agencies, partners, private sector structures, technical partners, etc.)  relevant to realizing the goals of this workstream. These stakeholders must understand the Nigerian and international regulatory and ACT manufacturing landscape.
4. Provide technical support to organize policy dialogues with key stakeholders to develop the implementation framework for priority recommendations.
5. Participate in stakeholder workshops to validate findings and co-develop a strategic roadmap for expanding Nigeria’s competitiveness and regional share for malaria product (ACT) production.
6. Provide oversight to the quality of outputs for the ACT workstream, including the compilation, assessment, and final selection of potential ACT manufacturers and recommendations for support.
7. Provide technical oversight to ensure that the appropriate support is identified and provided to the selected ACT manufacturers in the following (not-exclusive) areas:
   1. Technical support and knowledge transfer directly or through partnerships
   2. Identifying funding gaps and possible funding sources 
   3. Establish a QA system to ensure compliance with international standards
8. Meet bi-weekly with the project team to review progress and collaboratively resolve any identified issues.

4. Selection Method

The selection process will follow a Limited Consultant Qualification-Based Method (LCQBM).

Under this approach, interested consultants will submit proposals in response to the Terms of Reference (TOR) issued by PVAC. As part of the evaluation, consultants/firms must demonstrate their relevant experience and qualifications in managing similar projects. Only the most qualified consultant/ firm with the required qualification/ expertise would be considered.

5. Required Expertise

The following are the expertise required from the applying consultant / firm: 

▪ Global Health Experience: Strong background in malaria epidemiological studies, prevention and control strategies, as well as global health programs, with experience in implementing large-scale public health interventions around Artemisinin-based Combination (ACT) development in LMICs with special interest in West Africa.

https://googleads.g.doubleclick.net/pagead/ads?gdpr=0&us_privacy=1—&gpp_sid=-1&client=ca-pub-2321249943983804&output=html&h=280&adk=3292208330&adf=1381599079&pi=t.aa~a.1381849204~i.37~rp.4&w=728&abgtt=6&fwrn=4&fwrnh=100&lmt=1745427051&num_ads=1&rafmt=1&armr=3&sem=mc&pwprc=6515900736&ad_type=text_image&format=728×280&url=https%3A%2F%2Fngojobsite.com%2Finvitation-to-bid-provision-of-technical-oversight-for-the-implementation-of-workstream-on-building-local-capacity-to-produce-quality-act-at-health-systems-consult-limited-hscl%2F&fwr=0&pra=3&rh=182&rw=727&rpe=1&resp_fmts=3&wgl=1&fa=27&uach=WyJXaW5kb3dzIiwiMTUuMC4wIiwieDg2IiwiIiwiMTM1LjAuNzA0OS44NSIsbnVsbCwwLG51bGwsIjY0IixbWyJHb29nbGUgQ2hyb21lIiwiMTM1LjAuNzA0OS44NSJdLFsiTm90LUEuQnJhbmQiLCI4LjAuMC4wIl0sWyJDaHJvbWl1bSIsIjEzNS4wLjcwNDkuODUiXV0sMF0.&dt=1745426256772&bpp=3&bdt=1857&idt=3&shv=r20250421&mjsv=m202504170101&ptt=9&saldr=aa&abxe=1&cookie=ID%3Dd402398dbe8029b3%3AT%3D1730191189%3ART%3D1745426888%3AS%3DALNI_Mbqv4ZjCA2FyHoBsYRqGiGVSR4f2A&gpic=UID%3D00000f5f5123b4f7%3AT%3D1730191189%3ART%3D1745426888%3AS%3DALNI_MaUeBuU5kMVXlTiiGykJasfdDE9vw&eo_id_str=ID%3D3685604803237a2e%3AT%3D1730191189%3ART%3D1745426888%3AS%3DAA-AfjZ2X441EOy64ZtttSEJoFR_&prev_fmts=0x0%2C750x280%2C1497x702%2C728x280%2C360x280%2C360x280&nras=6&correlator=8747092532096&frm=20&pv=1&u_tz=60&u_his=1&u_h=768&u_w=1366&u_ah=720&u_aw=1366&u_cd=24&u_sd=0.9&dmc=8&adx=190&ady=2783&biw=1497&bih=702&scr_x=0&scr_y=0&eid=95358862%2C95358864%2C95354562%2C95355310%2C95357877%2C95357716&oid=2&pvsid=3942448291295766&tmod=698141052&uas=0&nvt=1&fc=1408&brdim=-7%2C0%2C-7%2C0%2C1366%2C0%2C1379%2C727%2C1514%2C702&vis=1&rsz=%7C%7Cs%7C&abl=NS&fu=128&bc=31&bz=0.91&td=1&tdf=2&psd=W251bGwsbnVsbCxudWxsLDNd&nt=1&pgls=CAEaAzYuOA..~CAA.&ifi=7&uci=a!7&btvi=4&fsb=1&dtd=M

▪ Clinical Research Expertise: In-depth knowledge, experience and skills in epidemiological and molecular biological research with special interest in the development and evaluation of affordable malaria diagnostics and ACT as well as managing large clinical trials and its associated regulatory and certification requirements.

▪ Experience in ACT Development: Expertise in the research, formulation, and manufacturing processes for ACT, including clinical trial design and implementation.

▪ Stakeholders Engagement and Coordination Capabilities: Proven ability to manage multi-sectoral projects, coordinate with governments, NGOs, INGOs, donors, research institutions and private sector partners in malaria prevention and control.

• Innovative Financing:Excellent background in innovative financing for healthcare service delivery and development especially in the management of malaria in Africa.
• Regulatory Knowledge:  Have a wide experience working with national and international regulations for ACT production approval, Good Clinical Practices (GCP) and Good Manufacturing Practices (GMP). 
• Capacity Building: Experience in training and mentoring teams in clinical research and ACT development processes.
• International Context Knowledge: Understanding of international health systems and regulatory landscapes. Familiar with the operational challenges in Africa, especially regarding healthcare needs and distribution challenges. Able to influence the local ACT manufacturing landscape along the lines of international best practices.

6. Expected Outcomes

The oversight function of this workstream is expected to support the quality of deliverables from all parties working under this workstream. These include: 

1. Evidence-based ACT-specific policy recommendations and reforms validated by stakeholders. 
2. Detailed reports of site visits and assessments.
3. A list of selected 1^st batch ACT manufacturers (at least 3) and a pipeline of recommended 2^nd batch ACT manufacturers (at least 5) for technical assistance. 
4. Detailed map of potential funding opportunities.
5. Technical assistance reports.

7. Duration of the Assignment

This assignment is expected to run for 8 months – May to December 2025

8. Submission Requirements

Interested organizations are expected to submit the following documents:

1. Technical Proposal: The technical proposal should include:

▪ A clear methodology that demonstrates expertise in managing this project.

▪ A track record and experience in implementing similar projects

▪ At least 3 references from similar projects 

• Compliance Documents: Consultant must have the permit to work in Nigeria as Nigeria’s Ministry of Interior requires. While for firms, the following documents are also required:

▪ A valid organizational registration document

▪ Up-to-date tax clearance certificates 

• Financial Proposal 

All required documents should be sent to [email protected] on or before May 2^nd, 2025. Proposals sent after this date will not be considered.Request for Consultants: Provision of Technical Oversight for the Implementation of Workstream on Building Local Capacity to Produce Quality ACT: 

Enhancing Local Manufacturing and Supply Chain Management for Health

Commodities and Supplies in Nigeria

1. Background

Nigeria faces a significant burden from both communicable and non-communicable diseases, which strains the healthcare system and hinders economic development. Despite ongoing efforts to address these challenges, the country remains heavily reliant on imports for essential health commodities. This dependency leads to high costs, supply chain vulnerabilities, and inconsistent availability of critical healthcare products. Strengthening local capacity and optimizing supply chain management is essential to improving the accessibility, affordability, and sustainability of healthcare products. This is key to advancing public health.

Market shaping strategies have proven successful in other health sectors by leveraging economies of scale, improving quality control, and enhancing distribution efficiency. Adopting this model for manufacturing and distributing essential health commodities could reduce costs, improve product consistency, and ensure more reliable supply chains. However, transitioning from an import-dependent system to one with a robust local production capacity and an efficient pooled procurement system is a complex process. It requires a comprehensive, multi-faceted approach that addresses manufacturing capabilities, quality assurance mechanisms, supply chain optimization, workforce capacity building, and supportive policy frameworks.

https://googleads.g.doubleclick.net/pagead/ads?gdpr=0&us_privacy=1—&gpp_sid=-1&client=ca-pub-2321249943983804&output=html&h=280&adk=3292208330&adf=3651786664&pi=t.aa~a.1381849204~i.13~rp.4&w=728&abgtt=6&fwrn=4&fwrnh=100&lmt=1745427050&num_ads=1&rafmt=1&armr=3&sem=mc&pwprc=6515900736&ad_type=text_image&format=728×280&url=https%3A%2F%2Fngojobsite.com%2Finvitation-to-bid-provision-of-technical-oversight-for-the-implementation-of-workstream-on-building-local-capacity-to-produce-quality-act-at-health-systems-consult-limited-hscl%2F&fwr=0&pra=3&rh=182&rw=727&rpe=1&resp_fmts=3&wgl=1&fa=27&uach=WyJXaW5kb3dzIiwiMTUuMC4wIiwieDg2IiwiIiwiMTM1LjAuNzA0OS44NSIsbnVsbCwwLG51bGwsIjY0IixbWyJHb29nbGUgQ2hyb21lIiwiMTM1LjAuNzA0OS44NSJdLFsiTm90LUEuQnJhbmQiLCI4LjAuMC4wIl0sWyJDaHJvbWl1bSIsIjEzNS4wLjcwNDkuODUiXV0sMF0.&dt=1745426256758&bpp=4&bdt=1842&idt=4&shv=r20250421&mjsv=m202504170101&ptt=9&saldr=aa&abxe=1&cookie=ID%3Dd402398dbe8029b3%3AT%3D1730191189%3ART%3D1745426888%3AS%3DALNI_Mbqv4ZjCA2FyHoBsYRqGiGVSR4f2A&gpic=UID%3D00000f5f5123b4f7%3AT%3D1730191189%3ART%3D1745426888%3AS%3DALNI_MaUeBuU5kMVXlTiiGykJasfdDE9vw&eo_id_str=ID%3D3685604803237a2e%3AT%3D1730191189%3ART%3D1745426888%3AS%3DAA-AfjZ2X441EOy64ZtttSEJoFR_&prev_fmts=0x0%2C750x280%2C1497x702&nras=3&correlator=8747092532096&frm=20&pv=1&u_tz=60&u_his=1&u_h=768&u_w=1366&u_ah=720&u_aw=1366&u_cd=24&u_sd=0.9&dmc=8&adx=190&ady=1181&biw=1497&bih=702&scr_x=0&scr_y=0&eid=95358862%2C95358864%2C95354562%2C95355310%2C95357877%2C95357716&oid=2&pvsid=3942448291295766&tmod=698141052&uas=0&nvt=1&fc=1408&brdim=-7%2C0%2C-7%2C0%2C1366%2C0%2C1379%2C727%2C1514%2C702&vis=1&rsz=%7C%7Cs%7C&abl=NS&cms=2&fu=128&bc=31&bz=0.91&td=1&tdf=2&psd=W251bGwsbnVsbCxudWxsLDNd&nt=1&pgls=CAEaAzYuOA..~CAA.&ifi=6&uci=a!6&btvi=1&fsb=1&dtd=M

The Presidential Initiative for Unlocking Healthcare Value Chain (PVAC) and the National Malaria Elimination Programme (NMEP), with the support of the World Bank IMPACT, embarked on a project called “Enhancing Local Manufacturing and Supply Chain Management for Health Commodities and Supplies in Nigeria”. The aim of this project is to address these challenges through a phased approach that balances short-term and long-term objectives. The strategies for addressing these challenges will include developing and laying the groundwork for local manufacturing of malaria commodities (including ACTs, RDTs, APIs and LLINs), including enhancing production capacity, ensuring compliance with international quality standards, and fostering workforce development. At the same time, the project will focus on optimizing the pooled procurement of imported malaria commodities to improve cost-effectiveness and distribution efficiency. Over the medium to long term, these interventions will strengthen the entire health commodities value chain, create opportunities for economic growth, and support Nigeria’s self-sufficiency in critical healthcare products. This comprehensive approach seeks to improve Nigeria’s healthcare supply systems’ efficiency and resilience while unlocking new economic opportunities within the country’s health sector. The project duration is 1 year.

2. Objective

This consultancy aims to provide technical oversight to all parties working under this project to enhance the local production of Artemisinin-based Combination Therapies (ACTs) in Nigeria. This involves providing technical oversight to PVAC, NMEP, local consultants, and other identified stakeholders engaged in this workstream. This workstream includes assessing manufacturing capacity, facilitating partnerships for technology transfer, ensuring compliance with regulatory standards, and supporting policy reforms to create an enabling environment for sustainable production. The consultant/consulting firm will ensure the integration of best practices for policy and implementation and draw from previous experiences in this space to strengthen the framework (both demand and supply) for the local manufacture of quality, and affordable ACTs.

3. Scope of Work

The consultant/ firm engaged to provide this oversight function is expected to:

1. Provide technical oversight and advise all parties working in the ACT workstream on matters relating to scope, quality, and outputs through participation and reviews during the planning, implementation, and close-out phases of the ACT production capacity development workstream.
2. Support the development of recommendations required for critical policy and regulatory reforms that will address gaps in the local manufacturing of ACTs by sharing best international practices in regulation, innovative financing, international market entry, etc.
3. Facilitate the engagement of stakeholders (government agencies, partners, private sector structures, technical partners, etc.)  relevant to realizing the goals of this workstream. These stakeholders must understand the Nigerian and international regulatory and ACT manufacturing landscape.
4. Provide technical support to organize policy dialogues with key stakeholders to develop the implementation framework for priority recommendations.
5. Participate in stakeholder workshops to validate findings and co-develop a strategic roadmap for expanding Nigeria’s competitiveness and regional share for malaria product (ACT) production.
6. Provide oversight to the quality of outputs for the ACT workstream, including the compilation, assessment, and final selection of potential ACT manufacturers and recommendations for support.
7. Provide technical oversight to ensure that the appropriate support is identified and provided to the selected ACT manufacturers in the following (not-exclusive) areas:
   1. Technical support and knowledge transfer directly or through partnerships
   2. Identifying funding gaps and possible funding sources 
   3. Establish a QA system to ensure compliance with international standards
8. Meet bi-weekly with the project team to review progress and collaboratively resolve any identified issues.

4. Selection Method

The selection process will follow a Limited Consultant Qualification-Based Method (LCQBM).

Under this approach, interested consultants will submit proposals in response to the Terms of Reference (TOR) issued by PVAC. As part of the evaluation, consultants/firms must demonstrate their relevant experience and qualifications in managing similar projects. Only the most qualified consultant/ firm with the required qualification/ expertise would be considered.

5. Required Expertise

The following are the expertise required from the applying consultant / firm: 

▪ Global Health Experience: Strong background in malaria epidemiological studies, prevention and control strategies, as well as global health programs, with experience in implementing large-scale public health interventions around Artemisinin-based Combination (ACT) development in LMICs with special interest in West Africa.

https://googleads.g.doubleclick.net/pagead/ads?gdpr=0&us_privacy=1—&gpp_sid=-1&client=ca-pub-2321249943983804&output=html&h=280&adk=3292208330&adf=1381599079&pi=t.aa~a.1381849204~i.37~rp.4&w=728&abgtt=6&fwrn=4&fwrnh=100&lmt=1745427051&num_ads=1&rafmt=1&armr=3&sem=mc&pwprc=6515900736&ad_type=text_image&format=728×280&url=https%3A%2F%2Fngojobsite.com%2Finvitation-to-bid-provision-of-technical-oversight-for-the-implementation-of-workstream-on-building-local-capacity-to-produce-quality-act-at-health-systems-consult-limited-hscl%2F&fwr=0&pra=3&rh=182&rw=727&rpe=1&resp_fmts=3&wgl=1&fa=27&uach=WyJXaW5kb3dzIiwiMTUuMC4wIiwieDg2IiwiIiwiMTM1LjAuNzA0OS44NSIsbnVsbCwwLG51bGwsIjY0IixbWyJHb29nbGUgQ2hyb21lIiwiMTM1LjAuNzA0OS44NSJdLFsiTm90LUEuQnJhbmQiLCI4LjAuMC4wIl0sWyJDaHJvbWl1bSIsIjEzNS4wLjcwNDkuODUiXV0sMF0.&dt=1745426256772&bpp=3&bdt=1857&idt=3&shv=r20250421&mjsv=m202504170101&ptt=9&saldr=aa&abxe=1&cookie=ID%3Dd402398dbe8029b3%3AT%3D1730191189%3ART%3D1745426888%3AS%3DALNI_Mbqv4ZjCA2FyHoBsYRqGiGVSR4f2A&gpic=UID%3D00000f5f5123b4f7%3AT%3D1730191189%3ART%3D1745426888%3AS%3DALNI_MaUeBuU5kMVXlTiiGykJasfdDE9vw&eo_id_str=ID%3D3685604803237a2e%3AT%3D1730191189%3ART%3D1745426888%3AS%3DAA-AfjZ2X441EOy64ZtttSEJoFR_&prev_fmts=0x0%2C750x280%2C1497x702%2C728x280%2C360x280%2C360x280&nras=6&correlator=8747092532096&frm=20&pv=1&u_tz=60&u_his=1&u_h=768&u_w=1366&u_ah=720&u_aw=1366&u_cd=24&u_sd=0.9&dmc=8&adx=190&ady=2783&biw=1497&bih=702&scr_x=0&scr_y=0&eid=95358862%2C95358864%2C95354562%2C95355310%2C95357877%2C95357716&oid=2&pvsid=3942448291295766&tmod=698141052&uas=0&nvt=1&fc=1408&brdim=-7%2C0%2C-7%2C0%2C1366%2C0%2C1379%2C727%2C1514%2C702&vis=1&rsz=%7C%7Cs%7C&abl=NS&fu=128&bc=31&bz=0.91&td=1&tdf=2&psd=W251bGwsbnVsbCxudWxsLDNd&nt=1&pgls=CAEaAzYuOA..~CAA.&ifi=7&uci=a!7&btvi=4&fsb=1&dtd=M

▪ Clinical Research Expertise: In-depth knowledge, experience and skills in epidemiological and molecular biological research with special interest in the development and evaluation of affordable malaria diagnostics and ACT as well as managing large clinical trials and its associated regulatory and certification requirements.

▪ Experience in ACT Development: Expertise in the research, formulation, and manufacturing processes for ACT, including clinical trial design and implementation.

▪ Stakeholders Engagement and Coordination Capabilities: Proven ability to manage multi-sectoral projects, coordinate with governments, NGOs, INGOs, donors, research institutions and private sector partners in malaria prevention and control.

• Innovative Financing:Excellent background in innovative financing for healthcare service delivery and development especially in the management of malaria in Africa.
• Regulatory Knowledge:  Have a wide experience working with national and international regulations for ACT production approval, Good Clinical Practices (GCP) and Good Manufacturing Practices (GMP). 
• Capacity Building: Experience in training and mentoring teams in clinical research and ACT development processes.
• International Context Knowledge: Understanding of international health systems and regulatory landscapes. Familiar with the operational challenges in Africa, especially regarding healthcare needs and distribution challenges. Able to influence the local ACT manufacturing landscape along the lines of international best practices.

6. Expected Outcomes

The oversight function of this workstream is expected to support the quality of deliverables from all parties working under this workstream. These include: 

1. Evidence-based ACT-specific policy recommendations and reforms validated by stakeholders. 
2. Detailed reports of site visits and assessments.
3. A list of selected 1^st batch ACT manufacturers (at least 3) and a pipeline of recommended 2^nd batch ACT manufacturers (at least 5) for technical assistance. 
4. Detailed map of potential funding opportunities.
5. Technical assistance reports.

7. Duration of the Assignment

This assignment is expected to run for 8 months – May to December 2025

8. Submission Requirements

Interested organizations are expected to submit the following documents:

1. Technical Proposal: The technical proposal should include:

▪ A clear methodology that demonstrates expertise in managing this project.

▪ A track record and experience in implementing similar projects

▪ At least 3 references from similar projects 

• Compliance Documents: Consultant must have the permit to work in Nigeria as Nigeria’s Ministry of Interior requires. While for firms, the following documents are also required:

▪ A valid organizational registration document

▪ Up-to-date tax clearance certificates 

• Financial Proposal 

All required documents should be sent to [email protected] on or before May 2^nd, 2025. Proposals sent after this date will not be considered.Request for Consultants: Provision of Technical Oversight for the Implementation of Workstream on Building Local Capacity to Produce Quality ACT: 

Enhancing Local Manufacturing and Supply Chain Management for Health

Commodities and Supplies in Nigeria

1. Background

Nigeria faces a significant burden from both communicable and non-communicable diseases, which strains the healthcare system and hinders economic development. Despite ongoing efforts to address these challenges, the country remains heavily reliant on imports for essential health commodities. This dependency leads to high costs, supply chain vulnerabilities, and inconsistent availability of critical healthcare products. Strengthening local capacity and optimizing supply chain management is essential to improving the accessibility, affordability, and sustainability of healthcare products. This is key to advancing public health.

Market shaping strategies have proven successful in other health sectors by leveraging economies of scale, improving quality control, and enhancing distribution efficiency. Adopting this model for manufacturing and distributing essential health commodities could reduce costs, improve product consistency, and ensure more reliable supply chains. However, transitioning from an import-dependent system to one with a robust local production capacity and an efficient pooled procurement system is a complex process. It requires a comprehensive, multi-faceted approach that addresses manufacturing capabilities, quality assurance mechanisms, supply chain optimization, workforce capacity building, and supportive policy frameworks.

https://googleads.g.doubleclick.net/pagead/ads?gdpr=0&us_privacy=1—&gpp_sid=-1&client=ca-pub-2321249943983804&output=html&h=280&adk=3292208330&adf=3651786664&pi=t.aa~a.1381849204~i.13~rp.4&w=728&abgtt=6&fwrn=4&fwrnh=100&lmt=1745427050&num_ads=1&rafmt=1&armr=3&sem=mc&pwprc=6515900736&ad_type=text_image&format=728×280&url=https%3A%2F%2Fngojobsite.com%2Finvitation-to-bid-provision-of-technical-oversight-for-the-implementation-of-workstream-on-building-local-capacity-to-produce-quality-act-at-health-systems-consult-limited-hscl%2F&fwr=0&pra=3&rh=182&rw=727&rpe=1&resp_fmts=3&wgl=1&fa=27&uach=WyJXaW5kb3dzIiwiMTUuMC4wIiwieDg2IiwiIiwiMTM1LjAuNzA0OS44NSIsbnVsbCwwLG51bGwsIjY0IixbWyJHb29nbGUgQ2hyb21lIiwiMTM1LjAuNzA0OS44NSJdLFsiTm90LUEuQnJhbmQiLCI4LjAuMC4wIl0sWyJDaHJvbWl1bSIsIjEzNS4wLjcwNDkuODUiXV0sMF0.&dt=1745426256758&bpp=4&bdt=1842&idt=4&shv=r20250421&mjsv=m202504170101&ptt=9&saldr=aa&abxe=1&cookie=ID%3Dd402398dbe8029b3%3AT%3D1730191189%3ART%3D1745426888%3AS%3DALNI_Mbqv4ZjCA2FyHoBsYRqGiGVSR4f2A&gpic=UID%3D00000f5f5123b4f7%3AT%3D1730191189%3ART%3D1745426888%3AS%3DALNI_MaUeBuU5kMVXlTiiGykJasfdDE9vw&eo_id_str=ID%3D3685604803237a2e%3AT%3D1730191189%3ART%3D1745426888%3AS%3DAA-AfjZ2X441EOy64ZtttSEJoFR_&prev_fmts=0x0%2C750x280%2C1497x702&nras=3&correlator=8747092532096&frm=20&pv=1&u_tz=60&u_his=1&u_h=768&u_w=1366&u_ah=720&u_aw=1366&u_cd=24&u_sd=0.9&dmc=8&adx=190&ady=1181&biw=1497&bih=702&scr_x=0&scr_y=0&eid=95358862%2C95358864%2C95354562%2C95355310%2C95357877%2C95357716&oid=2&pvsid=3942448291295766&tmod=698141052&uas=0&nvt=1&fc=1408&brdim=-7%2C0%2C-7%2C0%2C1366%2C0%2C1379%2C727%2C1514%2C702&vis=1&rsz=%7C%7Cs%7C&abl=NS&cms=2&fu=128&bc=31&bz=0.91&td=1&tdf=2&psd=W251bGwsbnVsbCxudWxsLDNd&nt=1&pgls=CAEaAzYuOA..~CAA.&ifi=6&uci=a!6&btvi=1&fsb=1&dtd=M

The Presidential Initiative for Unlocking Healthcare Value Chain (PVAC) and the National Malaria Elimination Programme (NMEP), with the support of the World Bank IMPACT, embarked on a project called “Enhancing Local Manufacturing and Supply Chain Management for Health Commodities and Supplies in Nigeria”. The aim of this project is to address these challenges through a phased approach that balances short-term and long-term objectives. The strategies for addressing these challenges will include developing and laying the groundwork for local manufacturing of malaria commodities (including ACTs, RDTs, APIs and LLINs), including enhancing production capacity, ensuring compliance with international quality standards, and fostering workforce development. At the same time, the project will focus on optimizing the pooled procurement of imported malaria commodities to improve cost-effectiveness and distribution efficiency. Over the medium to long term, these interventions will strengthen the entire health commodities value chain, create opportunities for economic growth, and support Nigeria’s self-sufficiency in critical healthcare products. This comprehensive approach seeks to improve Nigeria’s healthcare supply systems’ efficiency and resilience while unlocking new economic opportunities within the country’s health sector. The project duration is 1 year.

2. Objective

This consultancy aims to provide technical oversight to all parties working under this project to enhance the local production of Artemisinin-based Combination Therapies (ACTs) in Nigeria. This involves providing technical oversight to PVAC, NMEP, local consultants, and other identified stakeholders engaged in this workstream. This workstream includes assessing manufacturing capacity, facilitating partnerships for technology transfer, ensuring compliance with regulatory standards, and supporting policy reforms to create an enabling environment for sustainable production. The consultant/consulting firm will ensure the integration of best practices for policy and implementation and draw from previous experiences in this space to strengthen the framework (both demand and supply) for the local manufacture of quality, and affordable ACTs.

3. Scope of Work

The consultant/ firm engaged to provide this oversight function is expected to:

1. Provide technical oversight and advise all parties working in the ACT workstream on matters relating to scope, quality, and outputs through participation and reviews during the planning, implementation, and close-out phases of the ACT production capacity development workstream.
2. Support the development of recommendations required for critical policy and regulatory reforms that will address gaps in the local manufacturing of ACTs by sharing best international practices in regulation, innovative financing, international market entry, etc.
3. Facilitate the engagement of stakeholders (government agencies, partners, private sector structures, technical partners, etc.)  relevant to realizing the goals of this workstream. These stakeholders must understand the Nigerian and international regulatory and ACT manufacturing landscape.
4. Provide technical support to organize policy dialogues with key stakeholders to develop the implementation framework for priority recommendations.
5. Participate in stakeholder workshops to validate findings and co-develop a strategic roadmap for expanding Nigeria’s competitiveness and regional share for malaria product (ACT) production.
6. Provide oversight to the quality of outputs for the ACT workstream, including the compilation, assessment, and final selection of potential ACT manufacturers and recommendations for support.
7. Provide technical oversight to ensure that the appropriate support is identified and provided to the selected ACT manufacturers in the following (not-exclusive) areas:
   1. Technical support and knowledge transfer directly or through partnerships
   2. Identifying funding gaps and possible funding sources 
   3. Establish a QA system to ensure compliance with international standards
8. Meet bi-weekly with the project team to review progress and collaboratively resolve any identified issues.

4. Selection Method

The selection process will follow a Limited Consultant Qualification-Based Method (LCQBM).

Under this approach, interested consultants will submit proposals in response to the Terms of Reference (TOR) issued by PVAC. As part of the evaluation, consultants/firms must demonstrate their relevant experience and qualifications in managing similar projects. Only the most qualified consultant/ firm with the required qualification/ expertise would be considered.

5. Required Expertise

The following are the expertise required from the applying consultant / firm: 

▪ Global Health Experience: Strong background in malaria epidemiological studies, prevention and control strategies, as well as global health programs, with experience in implementing large-scale public health interventions around Artemisinin-based Combination (ACT) development in LMICs with special interest in West Africa.

https://googleads.g.doubleclick.net/pagead/ads?gdpr=0&us_privacy=1—&gpp_sid=-1&client=ca-pub-2321249943983804&output=html&h=280&adk=3292208330&adf=1381599079&pi=t.aa~a.1381849204~i.37~rp.4&w=728&abgtt=6&fwrn=4&fwrnh=100&lmt=1745427051&num_ads=1&rafmt=1&armr=3&sem=mc&pwprc=6515900736&ad_type=text_image&format=728×280&url=https%3A%2F%2Fngojobsite.com%2Finvitation-to-bid-provision-of-technical-oversight-for-the-implementation-of-workstream-on-building-local-capacity-to-produce-quality-act-at-health-systems-consult-limited-hscl%2F&fwr=0&pra=3&rh=182&rw=727&rpe=1&resp_fmts=3&wgl=1&fa=27&uach=WyJXaW5kb3dzIiwiMTUuMC4wIiwieDg2IiwiIiwiMTM1LjAuNzA0OS44NSIsbnVsbCwwLG51bGwsIjY0IixbWyJHb29nbGUgQ2hyb21lIiwiMTM1LjAuNzA0OS44NSJdLFsiTm90LUEuQnJhbmQiLCI4LjAuMC4wIl0sWyJDaHJvbWl1bSIsIjEzNS4wLjcwNDkuODUiXV0sMF0.&dt=1745426256772&bpp=3&bdt=1857&idt=3&shv=r20250421&mjsv=m202504170101&ptt=9&saldr=aa&abxe=1&cookie=ID%3Dd402398dbe8029b3%3AT%3D1730191189%3ART%3D1745426888%3AS%3DALNI_Mbqv4ZjCA2FyHoBsYRqGiGVSR4f2A&gpic=UID%3D00000f5f5123b4f7%3AT%3D1730191189%3ART%3D1745426888%3AS%3DALNI_MaUeBuU5kMVXlTiiGykJasfdDE9vw&eo_id_str=ID%3D3685604803237a2e%3AT%3D1730191189%3ART%3D1745426888%3AS%3DAA-AfjZ2X441EOy64ZtttSEJoFR_&prev_fmts=0x0%2C750x280%2C1497x702%2C728x280%2C360x280%2C360x280&nras=6&correlator=8747092532096&frm=20&pv=1&u_tz=60&u_his=1&u_h=768&u_w=1366&u_ah=720&u_aw=1366&u_cd=24&u_sd=0.9&dmc=8&adx=190&ady=2783&biw=1497&bih=702&scr_x=0&scr_y=0&eid=95358862%2C95358864%2C95354562%2C95355310%2C95357877%2C95357716&oid=2&pvsid=3942448291295766&tmod=698141052&uas=0&nvt=1&fc=1408&brdim=-7%2C0%2C-7%2C0%2C1366%2C0%2C1379%2C727%2C1514%2C702&vis=1&rsz=%7C%7Cs%7C&abl=NS&fu=128&bc=31&bz=0.91&td=1&tdf=2&psd=W251bGwsbnVsbCxudWxsLDNd&nt=1&pgls=CAEaAzYuOA..~CAA.&ifi=7&uci=a!7&btvi=4&fsb=1&dtd=M

▪ Clinical Research Expertise: In-depth knowledge, experience and skills in epidemiological and molecular biological research with special interest in the development and evaluation of affordable malaria diagnostics and ACT as well as managing large clinical trials and its associated regulatory and certification requirements.

▪ Experience in ACT Development: Expertise in the research, formulation, and manufacturing processes for ACT, including clinical trial design and implementation.

▪ Stakeholders Engagement and Coordination Capabilities: Proven ability to manage multi-sectoral projects, coordinate with governments, NGOs, INGOs, donors, research institutions and private sector partners in malaria prevention and control.

• Innovative Financing:Excellent background in innovative financing for healthcare service delivery and development especially in the management of malaria in Africa.
• Regulatory Knowledge:  Have a wide experience working with national and international regulations for ACT production approval, Good Clinical Practices (GCP) and Good Manufacturing Practices (GMP). 
• Capacity Building: Experience in training and mentoring teams in clinical research and ACT development processes.
• International Context Knowledge: Understanding of international health systems and regulatory landscapes. Familiar with the operational challenges in Africa, especially regarding healthcare needs and distribution challenges. Able to influence the local ACT manufacturing landscape along the lines of international best practices.

6. Expected Outcomes

The oversight function of this workstream is expected to support the quality of deliverables from all parties working under this workstream. These include: 

1. Evidence-based ACT-specific policy recommendations and reforms validated by stakeholders. 
2. Detailed reports of site visits and assessments.
3. A list of selected 1^st batch ACT manufacturers (at least 3) and a pipeline of recommended 2^nd batch ACT manufacturers (at least 5) for technical assistance. 
4. Detailed map of potential funding opportunities.
5. Technical assistance reports.

7. Duration of the Assignment

This assignment is expected to run for 8 months – May to December 2025

8. Submission Requirements

Interested organizations are expected to submit the following documents:

1. Technical Proposal: The technical proposal should include:

▪ A clear methodology that demonstrates expertise in managing this project.

▪ A track record and experience in implementing similar projects

▪ At least 3 references from similar projects 

• Compliance Documents: Consultant must have the permit to work in Nigeria as Nigeria’s Ministry of Interior requires. While for firms, the following documents are also required:

▪ A valid organizational registration document

▪ Up-to-date tax clearance certificates 

• Financial Proposal 

All required documents should be sent to [email protected] on or before May 2^nd, 2025. Proposals sent after this date will not be considered.Request for Consultants: Provision of Technical Oversight for the Implementation of Workstream on Building Local Capacity to Produce Quality ACT: 

Enhancing Local Manufacturing and Supply Chain Management for Health

Commodities and Supplies in Nigeria

1. Background

Nigeria faces a significant burden from both communicable and non-communicable diseases, which strains the healthcare system and hinders economic development. Despite ongoing efforts to address these challenges, the country remains heavily reliant on imports for essential health commodities. This dependency leads to high costs, supply chain vulnerabilities, and inconsistent availability of critical healthcare products. Strengthening local capacity and optimizing supply chain management is essential to improving the accessibility, affordability, and sustainability of healthcare products. This is key to advancing public health.

Market shaping strategies have proven successful in other health sectors by leveraging economies of scale, improving quality control, and enhancing distribution efficiency. Adopting this model for manufacturing and distributing essential health commodities could reduce costs, improve product consistency, and ensure more reliable supply chains. However, transitioning from an import-dependent system to one with a robust local production capacity and an efficient pooled procurement system is a complex process. It requires a comprehensive, multi-faceted approach that addresses manufacturing capabilities, quality assurance mechanisms, supply chain optimization, workforce capacity building, and supportive policy frameworks.

https://googleads.g.doubleclick.net/pagead/ads?gdpr=0&us_privacy=1—&gpp_sid=-1&client=ca-pub-2321249943983804&output=html&h=280&adk=3292208330&adf=3651786664&pi=t.aa~a.1381849204~i.13~rp.4&w=728&abgtt=6&fwrn=4&fwrnh=100&lmt=1745427050&num_ads=1&rafmt=1&armr=3&sem=mc&pwprc=6515900736&ad_type=text_image&format=728×280&url=https%3A%2F%2Fngojobsite.com%2Finvitation-to-bid-provision-of-technical-oversight-for-the-implementation-of-workstream-on-building-local-capacity-to-produce-quality-act-at-health-systems-consult-limited-hscl%2F&fwr=0&pra=3&rh=182&rw=727&rpe=1&resp_fmts=3&wgl=1&fa=27&uach=WyJXaW5kb3dzIiwiMTUuMC4wIiwieDg2IiwiIiwiMTM1LjAuNzA0OS44NSIsbnVsbCwwLG51bGwsIjY0IixbWyJHb29nbGUgQ2hyb21lIiwiMTM1LjAuNzA0OS44NSJdLFsiTm90LUEuQnJhbmQiLCI4LjAuMC4wIl0sWyJDaHJvbWl1bSIsIjEzNS4wLjcwNDkuODUiXV0sMF0.&dt=1745426256758&bpp=4&bdt=1842&idt=4&shv=r20250421&mjsv=m202504170101&ptt=9&saldr=aa&abxe=1&cookie=ID%3Dd402398dbe8029b3%3AT%3D1730191189%3ART%3D1745426888%3AS%3DALNI_Mbqv4ZjCA2FyHoBsYRqGiGVSR4f2A&gpic=UID%3D00000f5f5123b4f7%3AT%3D1730191189%3ART%3D1745426888%3AS%3DALNI_MaUeBuU5kMVXlTiiGykJasfdDE9vw&eo_id_str=ID%3D3685604803237a2e%3AT%3D1730191189%3ART%3D1745426888%3AS%3DAA-AfjZ2X441EOy64ZtttSEJoFR_&prev_fmts=0x0%2C750x280%2C1497x702&nras=3&correlator=8747092532096&frm=20&pv=1&u_tz=60&u_his=1&u_h=768&u_w=1366&u_ah=720&u_aw=1366&u_cd=24&u_sd=0.9&dmc=8&adx=190&ady=1181&biw=1497&bih=702&scr_x=0&scr_y=0&eid=95358862%2C95358864%2C95354562%2C95355310%2C95357877%2C95357716&oid=2&pvsid=3942448291295766&tmod=698141052&uas=0&nvt=1&fc=1408&brdim=-7%2C0%2C-7%2C0%2C1366%2C0%2C1379%2C727%2C1514%2C702&vis=1&rsz=%7C%7Cs%7C&abl=NS&cms=2&fu=128&bc=31&bz=0.91&td=1&tdf=2&psd=W251bGwsbnVsbCxudWxsLDNd&nt=1&pgls=CAEaAzYuOA..~CAA.&ifi=6&uci=a!6&btvi=1&fsb=1&dtd=M

The Presidential Initiative for Unlocking Healthcare Value Chain (PVAC) and the National Malaria Elimination Programme (NMEP), with the support of the World Bank IMPACT, embarked on a project called “Enhancing Local Manufacturing and Supply Chain Management for Health Commodities and Supplies in Nigeria”. The aim of this project is to address these challenges through a phased approach that balances short-term and long-term objectives. The strategies for addressing these challenges will include developing and laying the groundwork for local manufacturing of malaria commodities (including ACTs, RDTs, APIs and LLINs), including enhancing production capacity, ensuring compliance with international quality standards, and fostering workforce development. At the same time, the project will focus on optimizing the pooled procurement of imported malaria commodities to improve cost-effectiveness and distribution efficiency. Over the medium to long term, these interventions will strengthen the entire health commodities value chain, create opportunities for economic growth, and support Nigeria’s self-sufficiency in critical healthcare products. This comprehensive approach seeks to improve Nigeria’s healthcare supply systems’ efficiency and resilience while unlocking new economic opportunities within the country’s health sector. The project duration is 1 year.

2. Objective

This consultancy aims to provide technical oversight to all parties working under this project to enhance the local production of Artemisinin-based Combination Therapies (ACTs) in Nigeria. This involves providing technical oversight to PVAC, NMEP, local consultants, and other identified stakeholders engaged in this workstream. This workstream includes assessing manufacturing capacity, facilitating partnerships for technology transfer, ensuring compliance with regulatory standards, and supporting policy reforms to create an enabling environment for sustainable production. The consultant/consulting firm will ensure the integration of best practices for policy and implementation and draw from previous experiences in this space to strengthen the framework (both demand and supply) for the local manufacture of quality, and affordable ACTs.

3. Scope of Work

The consultant/ firm engaged to provide this oversight function is expected to:

1. Provide technical oversight and advise all parties working in the ACT workstream on matters relating to scope, quality, and outputs through participation and reviews during the planning, implementation, and close-out phases of the ACT production capacity development workstream.
2. Support the development of recommendations required for critical policy and regulatory reforms that will address gaps in the local manufacturing of ACTs by sharing best international practices in regulation, innovative financing, international market entry, etc.
3. Facilitate the engagement of stakeholders (government agencies, partners, private sector structures, technical partners, etc.)  relevant to realizing the goals of this workstream. These stakeholders must understand the Nigerian and international regulatory and ACT manufacturing landscape.
4. Provide technical support to organize policy dialogues with key stakeholders to develop the implementation framework for priority recommendations.
5. Participate in stakeholder workshops to validate findings and co-develop a strategic roadmap for expanding Nigeria’s competitiveness and regional share for malaria product (ACT) production.
6. Provide oversight to the quality of outputs for the ACT workstream, including the compilation, assessment, and final selection of potential ACT manufacturers and recommendations for support.
7. Provide technical oversight to ensure that the appropriate support is identified and provided to the selected ACT manufacturers in the following (not-exclusive) areas:
   1. Technical support and knowledge transfer directly or through partnerships
   2. Identifying funding gaps and possible funding sources 
   3. Establish a QA system to ensure compliance with international standards
8. Meet bi-weekly with the project team to review progress and collaboratively resolve any identified issues.

4. Selection Method

The selection process will follow a Limited Consultant Qualification-Based Method (LCQBM).

Under this approach, interested consultants will submit proposals in response to the Terms of Reference (TOR) issued by PVAC. As part of the evaluation, consultants/firms must demonstrate their relevant experience and qualifications in managing similar projects. Only the most qualified consultant/ firm with the required qualification/ expertise would be considered.

5. Required Expertise

The following are the expertise required from the applying consultant / firm: 

▪ Global Health Experience: Strong background in malaria epidemiological studies, prevention and control strategies, as well as global health programs, with experience in implementing large-scale public health interventions around Artemisinin-based Combination (ACT) development in LMICs with special interest in West Africa.

https://googleads.g.doubleclick.net/pagead/ads?gdpr=0&us_privacy=1—&gpp_sid=-1&client=ca-pub-2321249943983804&output=html&h=280&adk=3292208330&adf=1381599079&pi=t.aa~a.1381849204~i.37~rp.4&w=728&abgtt=6&fwrn=4&fwrnh=100&lmt=1745427051&num_ads=1&rafmt=1&armr=3&sem=mc&pwprc=6515900736&ad_type=text_image&format=728×280&url=https%3A%2F%2Fngojobsite.com%2Finvitation-to-bid-provision-of-technical-oversight-for-the-implementation-of-workstream-on-building-local-capacity-to-produce-quality-act-at-health-systems-consult-limited-hscl%2F&fwr=0&pra=3&rh=182&rw=727&rpe=1&resp_fmts=3&wgl=1&fa=27&uach=WyJXaW5kb3dzIiwiMTUuMC4wIiwieDg2IiwiIiwiMTM1LjAuNzA0OS44NSIsbnVsbCwwLG51bGwsIjY0IixbWyJHb29nbGUgQ2hyb21lIiwiMTM1LjAuNzA0OS44NSJdLFsiTm90LUEuQnJhbmQiLCI4LjAuMC4wIl0sWyJDaHJvbWl1bSIsIjEzNS4wLjcwNDkuODUiXV0sMF0.&dt=1745426256772&bpp=3&bdt=1857&idt=3&shv=r20250421&mjsv=m202504170101&ptt=9&saldr=aa&abxe=1&cookie=ID%3Dd402398dbe8029b3%3AT%3D1730191189%3ART%3D1745426888%3AS%3DALNI_Mbqv4ZjCA2FyHoBsYRqGiGVSR4f2A&gpic=UID%3D00000f5f5123b4f7%3AT%3D1730191189%3ART%3D1745426888%3AS%3DALNI_MaUeBuU5kMVXlTiiGykJasfdDE9vw&eo_id_str=ID%3D3685604803237a2e%3AT%3D1730191189%3ART%3D1745426888%3AS%3DAA-AfjZ2X441EOy64ZtttSEJoFR_&prev_fmts=0x0%2C750x280%2C1497x702%2C728x280%2C360x280%2C360x280&nras=6&correlator=8747092532096&frm=20&pv=1&u_tz=60&u_his=1&u_h=768&u_w=1366&u_ah=720&u_aw=1366&u_cd=24&u_sd=0.9&dmc=8&adx=190&ady=2783&biw=1497&bih=702&scr_x=0&scr_y=0&eid=95358862%2C95358864%2C95354562%2C95355310%2C95357877%2C95357716&oid=2&pvsid=3942448291295766&tmod=698141052&uas=0&nvt=1&fc=1408&brdim=-7%2C0%2C-7%2C0%2C1366%2C0%2C1379%2C727%2C1514%2C702&vis=1&rsz=%7C%7Cs%7C&abl=NS&fu=128&bc=31&bz=0.91&td=1&tdf=2&psd=W251bGwsbnVsbCxudWxsLDNd&nt=1&pgls=CAEaAzYuOA..~CAA.&ifi=7&uci=a!7&btvi=4&fsb=1&dtd=M

▪ Clinical Research Expertise: In-depth knowledge, experience and skills in epidemiological and molecular biological research with special interest in the development and evaluation of affordable malaria diagnostics and ACT as well as managing large clinical trials and its associated regulatory and certification requirements.

▪ Experience in ACT Development: Expertise in the research, formulation, and manufacturing processes for ACT, including clinical trial design and implementation.

▪ Stakeholders Engagement and Coordination Capabilities: Proven ability to manage multi-sectoral projects, coordinate with governments, NGOs, INGOs, donors, research institutions and private sector partners in malaria prevention and control.

• Innovative Financing:Excellent background in innovative financing for healthcare service delivery and development especially in the management of malaria in Africa.
• Regulatory Knowledge:  Have a wide experience working with national and international regulations for ACT production approval, Good Clinical Practices (GCP) and Good Manufacturing Practices (GMP). 
• Capacity Building: Experience in training and mentoring teams in clinical research and ACT development processes.
• International Context Knowledge: Understanding of international health systems and regulatory landscapes. Familiar with the operational challenges in Africa, especially regarding healthcare needs and distribution challenges. Able to influence the local ACT manufacturing landscape along the lines of international best practices.

6. Expected Outcomes

The oversight function of this workstream is expected to support the quality of deliverables from all parties working under this workstream. These include: 

1. Evidence-based ACT-specific policy recommendations and reforms validated by stakeholders. 
2. Detailed reports of site visits and assessments.
3. A list of selected 1^st batch ACT manufacturers (at least 3) and a pipeline of recommended 2^nd batch ACT manufacturers (at least 5) for technical assistance. 
4. Detailed map of potential funding opportunities.
5. Technical assistance reports.

7. Duration of the Assignment

This assignment is expected to run for 8 months – May to December 2025

8. Submission Requirements

Interested organizations are expected to submit the following documents:

1. Technical Proposal: The technical proposal should include:

▪ A clear methodology that demonstrates expertise in managing this project.

▪ A track record and experience in implementing similar projects

▪ At least 3 references from similar projects 

• Compliance Documents: Consultant must have the permit to work in Nigeria as Nigeria’s Ministry of Interior requires. While for firms, the following documents are also required:

▪ A valid organizational registration document

▪ Up-to-date tax clearance certificates 

• Financial Proposal 

All required documents should be sent to [email protected] on or before May 2^nd, 2025. Proposals sent after this date will not be considered.Request for Consultants: Provision of Technical Oversight for the Implementation of Workstream on Building Local Capacity to Produce Quality ACT: 

Enhancing Local Manufacturing and Supply Chain Management for Health

Commodities and Supplies in Nigeria

1. Background

Nigeria faces a significant burden from both communicable and non-communicable diseases, which strains the healthcare system and hinders economic development. Despite ongoing efforts to address these challenges, the country remains heavily reliant on imports for essential health commodities. This dependency leads to high costs, supply chain vulnerabilities, and inconsistent availability of critical healthcare products. Strengthening local capacity and optimizing supply chain management is essential to improving the accessibility, affordability, and sustainability of healthcare products. This is key to advancing public health.

Market shaping strategies have proven successful in other health sectors by leveraging economies of scale, improving quality control, and enhancing distribution efficiency. Adopting this model for manufacturing and distributing essential health commodities could reduce costs, improve product consistency, and ensure more reliable supply chains. However, transitioning from an import-dependent system to one with a robust local production capacity and an efficient pooled procurement system is a complex process. It requires a comprehensive, multi-faceted approach that addresses manufacturing capabilities, quality assurance mechanisms, supply chain optimization, workforce capacity building, and supportive policy frameworks.

https://googleads.g.doubleclick.net/pagead/ads?gdpr=0&us_privacy=1—&gpp_sid=-1&client=ca-pub-2321249943983804&output=html&h=280&adk=3292208330&adf=3651786664&pi=t.aa~a.1381849204~i.13~rp.4&w=728&abgtt=6&fwrn=4&fwrnh=100&lmt=1745427050&num_ads=1&rafmt=1&armr=3&sem=mc&pwprc=6515900736&ad_type=text_image&format=728×280&url=https%3A%2F%2Fngojobsite.com%2Finvitation-to-bid-provision-of-technical-oversight-for-the-implementation-of-workstream-on-building-local-capacity-to-produce-quality-act-at-health-systems-consult-limited-hscl%2F&fwr=0&pra=3&rh=182&rw=727&rpe=1&resp_fmts=3&wgl=1&fa=27&uach=WyJXaW5kb3dzIiwiMTUuMC4wIiwieDg2IiwiIiwiMTM1LjAuNzA0OS44NSIsbnVsbCwwLG51bGwsIjY0IixbWyJHb29nbGUgQ2hyb21lIiwiMTM1LjAuNzA0OS44NSJdLFsiTm90LUEuQnJhbmQiLCI4LjAuMC4wIl0sWyJDaHJvbWl1bSIsIjEzNS4wLjcwNDkuODUiXV0sMF0.&dt=1745426256758&bpp=4&bdt=1842&idt=4&shv=r20250421&mjsv=m202504170101&ptt=9&saldr=aa&abxe=1&cookie=ID%3Dd402398dbe8029b3%3AT%3D1730191189%3ART%3D1745426888%3AS%3DALNI_Mbqv4ZjCA2FyHoBsYRqGiGVSR4f2A&gpic=UID%3D00000f5f5123b4f7%3AT%3D1730191189%3ART%3D1745426888%3AS%3DALNI_MaUeBuU5kMVXlTiiGykJasfdDE9vw&eo_id_str=ID%3D3685604803237a2e%3AT%3D1730191189%3ART%3D1745426888%3AS%3DAA-AfjZ2X441EOy64ZtttSEJoFR_&prev_fmts=0x0%2C750x280%2C1497x702&nras=3&correlator=8747092532096&frm=20&pv=1&u_tz=60&u_his=1&u_h=768&u_w=1366&u_ah=720&u_aw=1366&u_cd=24&u_sd=0.9&dmc=8&adx=190&ady=1181&biw=1497&bih=702&scr_x=0&scr_y=0&eid=95358862%2C95358864%2C95354562%2C95355310%2C95357877%2C95357716&oid=2&pvsid=3942448291295766&tmod=698141052&uas=0&nvt=1&fc=1408&brdim=-7%2C0%2C-7%2C0%2C1366%2C0%2C1379%2C727%2C1514%2C702&vis=1&rsz=%7C%7Cs%7C&abl=NS&cms=2&fu=128&bc=31&bz=0.91&td=1&tdf=2&psd=W251bGwsbnVsbCxudWxsLDNd&nt=1&pgls=CAEaAzYuOA..~CAA.&ifi=6&uci=a!6&btvi=1&fsb=1&dtd=M

The Presidential Initiative for Unlocking Healthcare Value Chain (PVAC) and the National Malaria Elimination Programme (NMEP), with the support of the World Bank IMPACT, embarked on a project called “Enhancing Local Manufacturing and Supply Chain Management for Health Commodities and Supplies in Nigeria”. The aim of this project is to address these challenges through a phased approach that balances short-term and long-term objectives. The strategies for addressing these challenges will include developing and laying the groundwork for local manufacturing of malaria commodities (including ACTs, RDTs, APIs and LLINs), including enhancing production capacity, ensuring compliance with international quality standards, and fostering workforce development. At the same time, the project will focus on optimizing the pooled procurement of imported malaria commodities to improve cost-effectiveness and distribution efficiency. Over the medium to long term, these interventions will strengthen the entire health commodities value chain, create opportunities for economic growth, and support Nigeria’s self-sufficiency in critical healthcare products. This comprehensive approach seeks to improve Nigeria’s healthcare supply systems’ efficiency and resilience while unlocking new economic opportunities within the country’s health sector. The project duration is 1 year.

2. Objective

This consultancy aims to provide technical oversight to all parties working under this project to enhance the local production of Artemisinin-based Combination Therapies (ACTs) in Nigeria. This involves providing technical oversight to PVAC, NMEP, local consultants, and other identified stakeholders engaged in this workstream. This workstream includes assessing manufacturing capacity, facilitating partnerships for technology transfer, ensuring compliance with regulatory standards, and supporting policy reforms to create an enabling environment for sustainable production. The consultant/consulting firm will ensure the integration of best practices for policy and implementation and draw from previous experiences in this space to strengthen the framework (both demand and supply) for the local manufacture of quality, and affordable ACTs.

3. Scope of Work

The consultant/ firm engaged to provide this oversight function is expected to:

1. Provide technical oversight and advise all parties working in the ACT workstream on matters relating to scope, quality, and outputs through participation and reviews during the planning, implementation, and close-out phases of the ACT production capacity development workstream.
2. Support the development of recommendations required for critical policy and regulatory reforms that will address gaps in the local manufacturing of ACTs by sharing best international practices in regulation, innovative financing, international market entry, etc.
3. Facilitate the engagement of stakeholders (government agencies, partners, private sector structures, technical partners, etc.)  relevant to realizing the goals of this workstream. These stakeholders must understand the Nigerian and international regulatory and ACT manufacturing landscape.
4. Provide technical support to organize policy dialogues with key stakeholders to develop the implementation framework for priority recommendations.
5. Participate in stakeholder workshops to validate findings and co-develop a strategic roadmap for expanding Nigeria’s competitiveness and regional share for malaria product (ACT) production.
6. Provide oversight to the quality of outputs for the ACT workstream, including the compilation, assessment, and final selection of potential ACT manufacturers and recommendations for support.
7. Provide technical oversight to ensure that the appropriate support is identified and provided to the selected ACT manufacturers in the following (not-exclusive) areas:
   1. Technical support and knowledge transfer directly or through partnerships
   2. Identifying funding gaps and possible funding sources 
   3. Establish a QA system to ensure compliance with international standards
8. Meet bi-weekly with the project team to review progress and collaboratively resolve any identified issues.

4. Selection Method

The selection process will follow a Limited Consultant Qualification-Based Method (LCQBM).

Under this approach, interested consultants will submit proposals in response to the Terms of Reference (TOR) issued by PVAC. As part of the evaluation, consultants/firms must demonstrate their relevant experience and qualifications in managing similar projects. Only the most qualified consultant/ firm with the required qualification/ expertise would be considered.

5. Required Expertise

The following are the expertise required from the applying consultant / firm: 

▪ Global Health Experience: Strong background in malaria epidemiological studies, prevention and control strategies, as well as global health programs, with experience in implementing large-scale public health interventions around Artemisinin-based Combination (ACT) development in LMICs with special interest in West Africa.

https://googleads.g.doubleclick.net/pagead/ads?gdpr=0&us_privacy=1—&gpp_sid=-1&client=ca-pub-2321249943983804&output=html&h=280&adk=3292208330&adf=1381599079&pi=t.aa~a.1381849204~i.37~rp.4&w=728&abgtt=6&fwrn=4&fwrnh=100&lmt=1745427051&num_ads=1&rafmt=1&armr=3&sem=mc&pwprc=6515900736&ad_type=text_image&format=728×280&url=https%3A%2F%2Fngojobsite.com%2Finvitation-to-bid-provision-of-technical-oversight-for-the-implementation-of-workstream-on-building-local-capacity-to-produce-quality-act-at-health-systems-consult-limited-hscl%2F&fwr=0&pra=3&rh=182&rw=727&rpe=1&resp_fmts=3&wgl=1&fa=27&uach=WyJXaW5kb3dzIiwiMTUuMC4wIiwieDg2IiwiIiwiMTM1LjAuNzA0OS44NSIsbnVsbCwwLG51bGwsIjY0IixbWyJHb29nbGUgQ2hyb21lIiwiMTM1LjAuNzA0OS44NSJdLFsiTm90LUEuQnJhbmQiLCI4LjAuMC4wIl0sWyJDaHJvbWl1bSIsIjEzNS4wLjcwNDkuODUiXV0sMF0.&dt=1745426256772&bpp=3&bdt=1857&idt=3&shv=r20250421&mjsv=m202504170101&ptt=9&saldr=aa&abxe=1&cookie=ID%3Dd402398dbe8029b3%3AT%3D1730191189%3ART%3D1745426888%3AS%3DALNI_Mbqv4ZjCA2FyHoBsYRqGiGVSR4f2A&gpic=UID%3D00000f5f5123b4f7%3AT%3D1730191189%3ART%3D1745426888%3AS%3DALNI_MaUeBuU5kMVXlTiiGykJasfdDE9vw&eo_id_str=ID%3D3685604803237a2e%3AT%3D1730191189%3ART%3D1745426888%3AS%3DAA-AfjZ2X441EOy64ZtttSEJoFR_&prev_fmts=0x0%2C750x280%2C1497x702%2C728x280%2C360x280%2C360x280&nras=6&correlator=8747092532096&frm=20&pv=1&u_tz=60&u_his=1&u_h=768&u_w=1366&u_ah=720&u_aw=1366&u_cd=24&u_sd=0.9&dmc=8&adx=190&ady=2783&biw=1497&bih=702&scr_x=0&scr_y=0&eid=95358862%2C95358864%2C95354562%2C95355310%2C95357877%2C95357716&oid=2&pvsid=3942448291295766&tmod=698141052&uas=0&nvt=1&fc=1408&brdim=-7%2C0%2C-7%2C0%2C1366%2C0%2C1379%2C727%2C1514%2C702&vis=1&rsz=%7C%7Cs%7C&abl=NS&fu=128&bc=31&bz=0.91&td=1&tdf=2&psd=W251bGwsbnVsbCxudWxsLDNd&nt=1&pgls=CAEaAzYuOA..~CAA.&ifi=7&uci=a!7&btvi=4&fsb=1&dtd=M

▪ Clinical Research Expertise: In-depth knowledge, experience and skills in epidemiological and molecular biological research with special interest in the development and evaluation of affordable malaria diagnostics and ACT as well as managing large clinical trials and its associated regulatory and certification requirements.

▪ Experience in ACT Development: Expertise in the research, formulation, and manufacturing processes for ACT, including clinical trial design and implementation.

▪ Stakeholders Engagement and Coordination Capabilities: Proven ability to manage multi-sectoral projects, coordinate with governments, NGOs, INGOs, donors, research institutions and private sector partners in malaria prevention and control.

• Innovative Financing:Excellent background in innovative financing for healthcare service delivery and development especially in the management of malaria in Africa.
• Regulatory Knowledge:  Have a wide experience working with national and international regulations for ACT production approval, Good Clinical Practices (GCP) and Good Manufacturing Practices (GMP). 
• Capacity Building: Experience in training and mentoring teams in clinical research and ACT development processes.
• International Context Knowledge: Understanding of international health systems and regulatory landscapes. Familiar with the operational challenges in Africa, especially regarding healthcare needs and distribution challenges. Able to influence the local ACT manufacturing landscape along the lines of international best practices.

6. Expected Outcomes

The oversight function of this workstream is expected to support the quality of deliverables from all parties working under this workstream. These include: 

1. Evidence-based ACT-specific policy recommendations and reforms validated by stakeholders. 
2. Detailed reports of site visits and assessments.
3. A list of selected 1^st batch ACT manufacturers (at least 3) and a pipeline of recommended 2^nd batch ACT manufacturers (at least 5) for technical assistance. 
4. Detailed map of potential funding opportunities.
5. Technical assistance reports.

7. Duration of the Assignment

This assignment is expected to run for 8 months – May to December 2025

8. Submission Requirements

Interested organizations are expected to submit the following documents:

1. Technical Proposal: The technical proposal should include:

▪ A clear methodology that demonstrates expertise in managing this project.

▪ A track record and experience in implementing similar projects

▪ At least 3 references from similar projects 

• Compliance Documents: Consultant must have the permit to work in Nigeria as Nigeria’s Ministry of Interior requires. While for firms, the following documents are also required:

▪ A valid organizational registration document

▪ Up-to-date tax clearance certificates 

• Financial Proposal 

All required documents should be sent to [email protected] on or before May 2^nd, 2025. Proposals sent after this date will not be considered.Request for Consultants: Provision of Technical Oversight for the Implementation of Workstream on Building Local Capacity to Produce Quality ACT: 

Enhancing Local Manufacturing and Supply Chain Management for Health

Commodities and Supplies in Nigeria

1. Background

Nigeria faces a significant burden from both communicable and non-communicable diseases, which strains the healthcare system and hinders economic development. Despite ongoing efforts to address these challenges, the country remains heavily reliant on imports for essential health commodities. This dependency leads to high costs, supply chain vulnerabilities, and inconsistent availability of critical healthcare products. Strengthening local capacity and optimizing supply chain management is essential to improving the accessibility, affordability, and sustainability of healthcare products. This is key to advancing public health.

Market shaping strategies have proven successful in other health sectors by leveraging economies of scale, improving quality control, and enhancing distribution efficiency. Adopting this model for manufacturing and distributing essential health commodities could reduce costs, improve product consistency, and ensure more reliable supply chains. However, transitioning from an import-dependent system to one with a robust local production capacity and an efficient pooled procurement system is a complex process. It requires a comprehensive, multi-faceted approach that addresses manufacturing capabilities, quality assurance mechanisms, supply chain optimization, workforce capacity building, and supportive policy frameworks.

https://googleads.g.doubleclick.net/pagead/ads?gdpr=0&us_privacy=1—&gpp_sid=-1&client=ca-pub-2321249943983804&output=html&h=280&adk=3292208330&adf=3651786664&pi=t.aa~a.1381849204~i.13~rp.4&w=728&abgtt=6&fwrn=4&fwrnh=100&lmt=1745427050&num_ads=1&rafmt=1&armr=3&sem=mc&pwprc=6515900736&ad_type=text_image&format=728×280&url=https%3A%2F%2Fngojobsite.com%2Finvitation-to-bid-provision-of-technical-oversight-for-the-implementation-of-workstream-on-building-local-capacity-to-produce-quality-act-at-health-systems-consult-limited-hscl%2F&fwr=0&pra=3&rh=182&rw=727&rpe=1&resp_fmts=3&wgl=1&fa=27&uach=WyJXaW5kb3dzIiwiMTUuMC4wIiwieDg2IiwiIiwiMTM1LjAuNzA0OS44NSIsbnVsbCwwLG51bGwsIjY0IixbWyJHb29nbGUgQ2hyb21lIiwiMTM1LjAuNzA0OS44NSJdLFsiTm90LUEuQnJhbmQiLCI4LjAuMC4wIl0sWyJDaHJvbWl1bSIsIjEzNS4wLjcwNDkuODUiXV0sMF0.&dt=1745426256758&bpp=4&bdt=1842&idt=4&shv=r20250421&mjsv=m202504170101&ptt=9&saldr=aa&abxe=1&cookie=ID%3Dd402398dbe8029b3%3AT%3D1730191189%3ART%3D1745426888%3AS%3DALNI_Mbqv4ZjCA2FyHoBsYRqGiGVSR4f2A&gpic=UID%3D00000f5f5123b4f7%3AT%3D1730191189%3ART%3D1745426888%3AS%3DALNI_MaUeBuU5kMVXlTiiGykJasfdDE9vw&eo_id_str=ID%3D3685604803237a2e%3AT%3D1730191189%3ART%3D1745426888%3AS%3DAA-AfjZ2X441EOy64ZtttSEJoFR_&prev_fmts=0x0%2C750x280%2C1497x702&nras=3&correlator=8747092532096&frm=20&pv=1&u_tz=60&u_his=1&u_h=768&u_w=1366&u_ah=720&u_aw=1366&u_cd=24&u_sd=0.9&dmc=8&adx=190&ady=1181&biw=1497&bih=702&scr_x=0&scr_y=0&eid=95358862%2C95358864%2C95354562%2C95355310%2C95357877%2C95357716&oid=2&pvsid=3942448291295766&tmod=698141052&uas=0&nvt=1&fc=1408&brdim=-7%2C0%2C-7%2C0%2C1366%2C0%2C1379%2C727%2C1514%2C702&vis=1&rsz=%7C%7Cs%7C&abl=NS&cms=2&fu=128&bc=31&bz=0.91&td=1&tdf=2&psd=W251bGwsbnVsbCxudWxsLDNd&nt=1&pgls=CAEaAzYuOA..~CAA.&ifi=6&uci=a!6&btvi=1&fsb=1&dtd=M

The Presidential Initiative for Unlocking Healthcare Value Chain (PVAC) and the National Malaria Elimination Programme (NMEP), with the support of the World Bank IMPACT, embarked on a project called “Enhancing Local Manufacturing and Supply Chain Management for Health Commodities and Supplies in Nigeria”. The aim of this project is to address these challenges through a phased approach that balances short-term and long-term objectives. The strategies for addressing these challenges will include developing and laying the groundwork for local manufacturing of malaria commodities (including ACTs, RDTs, APIs and LLINs), including enhancing production capacity, ensuring compliance with international quality standards, and fostering workforce development. At the same time, the project will focus on optimizing the pooled procurement of imported malaria commodities to improve cost-effectiveness and distribution efficiency. Over the medium to long term, these interventions will strengthen the entire health commodities value chain, create opportunities for economic growth, and support Nigeria’s self-sufficiency in critical healthcare products. This comprehensive approach seeks to improve Nigeria’s healthcare supply systems’ efficiency and resilience while unlocking new economic opportunities within the country’s health sector. The project duration is 1 year.

2. Objective

This consultancy aims to provide technical oversight to all parties working under this project to enhance the local production of Artemisinin-based Combination Therapies (ACTs) in Nigeria. This involves providing technical oversight to PVAC, NMEP, local consultants, and other identified stakeholders engaged in this workstream. This workstream includes assessing manufacturing capacity, facilitating partnerships for technology transfer, ensuring compliance with regulatory standards, and supporting policy reforms to create an enabling environment for sustainable production. The consultant/consulting firm will ensure the integration of best practices for policy and implementation and draw from previous experiences in this space to strengthen the framework (both demand and supply) for the local manufacture of quality, and affordable ACTs.

3. Scope of Work

The consultant/ firm engaged to provide this oversight function is expected to:

1. Provide technical oversight and advise all parties working in the ACT workstream on matters relating to scope, quality, and outputs through participation and reviews during the planning, implementation, and close-out phases of the ACT production capacity development workstream.
2. Support the development of recommendations required for critical policy and regulatory reforms that will address gaps in the local manufacturing of ACTs by sharing best international practices in regulation, innovative financing, international market entry, etc.
3. Facilitate the engagement of stakeholders (government agencies, partners, private sector structures, technical partners, etc.)  relevant to realizing the goals of this workstream. These stakeholders must understand the Nigerian and international regulatory and ACT manufacturing landscape.
4. Provide technical support to organize policy dialogues with key stakeholders to develop the implementation framework for priority recommendations.
5. Participate in stakeholder workshops to validate findings and co-develop a strategic roadmap for expanding Nigeria’s competitiveness and regional share for malaria product (ACT) production.
6. Provide oversight to the quality of outputs for the ACT workstream, including the compilation, assessment, and final selection of potential ACT manufacturers and recommendations for support.
7. Provide technical oversight to ensure that the appropriate support is identified and provided to the selected ACT manufacturers in the following (not-exclusive) areas:
   1. Technical support and knowledge transfer directly or through partnerships
   2. Identifying funding gaps and possible funding sources 
   3. Establish a QA system to ensure compliance with international standards
8. Meet bi-weekly with the project team to review progress and collaboratively resolve any identified issues.

4. Selection Method

The selection process will follow a Limited Consultant Qualification-Based Method (LCQBM).

Under this approach, interested consultants will submit proposals in response to the Terms of Reference (TOR) issued by PVAC. As part of the evaluation, consultants/firms must demonstrate their relevant experience and qualifications in managing similar projects. Only the most qualified consultant/ firm with the required qualification/ expertise would be considered.

5. Required Expertise

The following are the expertise required from the applying consultant / firm: 

▪ Global Health Experience: Strong background in malaria epidemiological studies, prevention and control strategies, as well as global health programs, with experience in implementing large-scale public health interventions around Artemisinin-based Combination (ACT) development in LMICs with special interest in West Africa.

https://googleads.g.doubleclick.net/pagead/ads?gdpr=0&us_privacy=1—&gpp_sid=-1&client=ca-pub-2321249943983804&output=html&h=280&adk=3292208330&adf=1381599079&pi=t.aa~a.1381849204~i.37~rp.4&w=728&abgtt=6&fwrn=4&fwrnh=100&lmt=1745427051&num_ads=1&rafmt=1&armr=3&sem=mc&pwprc=6515900736&ad_type=text_image&format=728×280&url=https%3A%2F%2Fngojobsite.com%2Finvitation-to-bid-provision-of-technical-oversight-for-the-implementation-of-workstream-on-building-local-capacity-to-produce-quality-act-at-health-systems-consult-limited-hscl%2F&fwr=0&pra=3&rh=182&rw=727&rpe=1&resp_fmts=3&wgl=1&fa=27&uach=WyJXaW5kb3dzIiwiMTUuMC4wIiwieDg2IiwiIiwiMTM1LjAuNzA0OS44NSIsbnVsbCwwLG51bGwsIjY0IixbWyJHb29nbGUgQ2hyb21lIiwiMTM1LjAuNzA0OS44NSJdLFsiTm90LUEuQnJhbmQiLCI4LjAuMC4wIl0sWyJDaHJvbWl1bSIsIjEzNS4wLjcwNDkuODUiXV0sMF0.&dt=1745426256772&bpp=3&bdt=1857&idt=3&shv=r20250421&mjsv=m202504170101&ptt=9&saldr=aa&abxe=1&cookie=ID%3Dd402398dbe8029b3%3AT%3D1730191189%3ART%3D1745426888%3AS%3DALNI_Mbqv4ZjCA2FyHoBsYRqGiGVSR4f2A&gpic=UID%3D00000f5f5123b4f7%3AT%3D1730191189%3ART%3D1745426888%3AS%3DALNI_MaUeBuU5kMVXlTiiGykJasfdDE9vw&eo_id_str=ID%3D3685604803237a2e%3AT%3D1730191189%3ART%3D1745426888%3AS%3DAA-AfjZ2X441EOy64ZtttSEJoFR_&prev_fmts=0x0%2C750x280%2C1497x702%2C728x280%2C360x280%2C360x280&nras=6&correlator=8747092532096&frm=20&pv=1&u_tz=60&u_his=1&u_h=768&u_w=1366&u_ah=720&u_aw=1366&u_cd=24&u_sd=0.9&dmc=8&adx=190&ady=2783&biw=1497&bih=702&scr_x=0&scr_y=0&eid=95358862%2C95358864%2C95354562%2C95355310%2C95357877%2C95357716&oid=2&pvsid=3942448291295766&tmod=698141052&uas=0&nvt=1&fc=1408&brdim=-7%2C0%2C-7%2C0%2C1366%2C0%2C1379%2C727%2C1514%2C702&vis=1&rsz=%7C%7Cs%7C&abl=NS&fu=128&bc=31&bz=0.91&td=1&tdf=2&psd=W251bGwsbnVsbCxudWxsLDNd&nt=1&pgls=CAEaAzYuOA..~CAA.&ifi=7&uci=a!7&btvi=4&fsb=1&dtd=M

▪ Clinical Research Expertise: In-depth knowledge, experience and skills in epidemiological and molecular biological research with special interest in the development and evaluation of affordable malaria diagnostics and ACT as well as managing large clinical trials and its associated regulatory and certification requirements.

▪ Experience in ACT Development: Expertise in the research, formulation, and manufacturing processes for ACT, including clinical trial design and implementation.

▪ Stakeholders Engagement and Coordination Capabilities: Proven ability to manage multi-sectoral projects, coordinate with governments, NGOs, INGOs, donors, research institutions and private sector partners in malaria prevention and control.

• Innovative Financing:Excellent background in innovative financing for healthcare service delivery and development especially in the management of malaria in Africa.
• Regulatory Knowledge:  Have a wide experience working with national and international regulations for ACT production approval, Good Clinical Practices (GCP) and Good Manufacturing Practices (GMP). 
• Capacity Building: Experience in training and mentoring teams in clinical research and ACT development processes.
• International Context Knowledge: Understanding of international health systems and regulatory landscapes. Familiar with the operational challenges in Africa, especially regarding healthcare needs and distribution challenges. Able to influence the local ACT manufacturing landscape along the lines of international best practices.

6. Expected Outcomes

The oversight function of this workstream is expected to support the quality of deliverables from all parties working under this workstream. These include: 

1. Evidence-based ACT-specific policy recommendations and reforms validated by stakeholders. 
2. Detailed reports of site visits and assessments.
3. A list of selected 1^st batch ACT manufacturers (at least 3) and a pipeline of recommended 2^nd batch ACT manufacturers (at least 5) for technical assistance. 
4. Detailed map of potential funding opportunities.
5. Technical assistance reports.

7. Duration of the Assignment

This assignment is expected to run for 8 months – May to December 2025

8. Submission Requirements

Interested organizations are expected to submit the following documents:

1. Technical Proposal: The technical proposal should include:

▪ A clear methodology that demonstrates expertise in managing this project.

▪ A track record and experience in implementing similar projects

▪ At least 3 references from similar projects 

• Compliance Documents: Consultant must have the permit to work in Nigeria as Nigeria’s Ministry of Interior requires. While for firms, the following documents are also required:

▪ A valid organizational registration document

▪ Up-to-date tax clearance certificates 

• Financial Proposal 

All required documents should be sent to [email protected] on or before May 2^nd, 2025. Proposals sent after this date will not be considered.Request for Consultants: Provision of Technical Oversight for the Implementation of Workstream on Building Local Capacity to Produce Quality ACT: 

Enhancing Local Manufacturing and Supply Chain Management for Health

Commodities and Supplies in Nigeria

1. Background

Nigeria faces a significant burden from both communicable and non-communicable diseases, which strains the healthcare system and hinders economic development. Despite ongoing efforts to address these challenges, the country remains heavily reliant on imports for essential health commodities. This dependency leads to high costs, supply chain vulnerabilities, and inconsistent availability of critical healthcare products. Strengthening local capacity and optimizing supply chain management is essential to improving the accessibility, affordability, and sustainability of healthcare products. This is key to advancing public health.

Market shaping strategies have proven successful in other health sectors by leveraging economies of scale, improving quality control, and enhancing distribution efficiency. Adopting this model for manufacturing and distributing essential health commodities could reduce costs, improve product consistency, and ensure more reliable supply chains. However, transitioning from an import-dependent system to one with a robust local production capacity and an efficient pooled procurement system is a complex process. It requires a comprehensive, multi-faceted approach that addresses manufacturing capabilities, quality assurance mechanisms, supply chain optimization, workforce capacity building, and supportive policy frameworks.

https://googleads.g.doubleclick.net/pagead/ads?gdpr=0&us_privacy=1—&gpp_sid=-1&client=ca-pub-2321249943983804&output=html&h=280&adk=3292208330&adf=3651786664&pi=t.aa~a.1381849204~i.13~rp.4&w=728&abgtt=6&fwrn=4&fwrnh=100&lmt=1745427050&num_ads=1&rafmt=1&armr=3&sem=mc&pwprc=6515900736&ad_type=text_image&format=728×280&url=https%3A%2F%2Fngojobsite.com%2Finvitation-to-bid-provision-of-technical-oversight-for-the-implementation-of-workstream-on-building-local-capacity-to-produce-quality-act-at-health-systems-consult-limited-hscl%2F&fwr=0&pra=3&rh=182&rw=727&rpe=1&resp_fmts=3&wgl=1&fa=27&uach=WyJXaW5kb3dzIiwiMTUuMC4wIiwieDg2IiwiIiwiMTM1LjAuNzA0OS44NSIsbnVsbCwwLG51bGwsIjY0IixbWyJHb29nbGUgQ2hyb21lIiwiMTM1LjAuNzA0OS44NSJdLFsiTm90LUEuQnJhbmQiLCI4LjAuMC4wIl0sWyJDaHJvbWl1bSIsIjEzNS4wLjcwNDkuODUiXV0sMF0.&dt=1745426256758&bpp=4&bdt=1842&idt=4&shv=r20250421&mjsv=m202504170101&ptt=9&saldr=aa&abxe=1&cookie=ID%3Dd402398dbe8029b3%3AT%3D1730191189%3ART%3D1745426888%3AS%3DALNI_Mbqv4ZjCA2FyHoBsYRqGiGVSR4f2A&gpic=UID%3D00000f5f5123b4f7%3AT%3D1730191189%3ART%3D1745426888%3AS%3DALNI_MaUeBuU5kMVXlTiiGykJasfdDE9vw&eo_id_str=ID%3D3685604803237a2e%3AT%3D1730191189%3ART%3D1745426888%3AS%3DAA-AfjZ2X441EOy64ZtttSEJoFR_&prev_fmts=0x0%2C750x280%2C1497x702&nras=3&correlator=8747092532096&frm=20&pv=1&u_tz=60&u_his=1&u_h=768&u_w=1366&u_ah=720&u_aw=1366&u_cd=24&u_sd=0.9&dmc=8&adx=190&ady=1181&biw=1497&bih=702&scr_x=0&scr_y=0&eid=95358862%2C95358864%2C95354562%2C95355310%2C95357877%2C95357716&oid=2&pvsid=3942448291295766&tmod=698141052&uas=0&nvt=1&fc=1408&brdim=-7%2C0%2C-7%2C0%2C1366%2C0%2C1379%2C727%2C1514%2C702&vis=1&rsz=%7C%7Cs%7C&abl=NS&cms=2&fu=128&bc=31&bz=0.91&td=1&tdf=2&psd=W251bGwsbnVsbCxudWxsLDNd&nt=1&pgls=CAEaAzYuOA..~CAA.&ifi=6&uci=a!6&btvi=1&fsb=1&dtd=M

The Presidential Initiative for Unlocking Healthcare Value Chain (PVAC) and the National Malaria Elimination Programme (NMEP), with the support of the World Bank IMPACT, embarked on a project called “Enhancing Local Manufacturing and Supply Chain Management for Health Commodities and Supplies in Nigeria”. The aim of this project is to address these challenges through a phased approach that balances short-term and long-term objectives. The strategies for addressing these challenges will include developing and laying the groundwork for local manufacturing of malaria commodities (including ACTs, RDTs, APIs and LLINs), including enhancing production capacity, ensuring compliance with international quality standards, and fostering workforce development. At the same time, the project will focus on optimizing the pooled procurement of imported malaria commodities to improve cost-effectiveness and distribution efficiency. Over the medium to long term, these interventions will strengthen the entire health commodities value chain, create opportunities for economic growth, and support Nigeria’s self-sufficiency in critical healthcare products. This comprehensive approach seeks to improve Nigeria’s healthcare supply systems’ efficiency and resilience while unlocking new economic opportunities within the country’s health sector. The project duration is 1 year.

2. Objective

This consultancy aims to provide technical oversight to all parties working under this project to enhance the local production of Artemisinin-based Combination Therapies (ACTs) in Nigeria. This involves providing technical oversight to PVAC, NMEP, local consultants, and other identified stakeholders engaged in this workstream. This workstream includes assessing manufacturing capacity, facilitating partnerships for technology transfer, ensuring compliance with regulatory standards, and supporting policy reforms to create an enabling environment for sustainable production. The consultant/consulting firm will ensure the integration of best practices for policy and implementation and draw from previous experiences in this space to strengthen the framework (both demand and supply) for the local manufacture of quality, and affordable ACTs.

3. Scope of Work

The consultant/ firm engaged to provide this oversight function is expected to:

1. Provide technical oversight and advise all parties working in the ACT workstream on matters relating to scope, quality, and outputs through participation and reviews during the planning, implementation, and close-out phases of the ACT production capacity development workstream.
2. Support the development of recommendations required for critical policy and regulatory reforms that will address gaps in the local manufacturing of ACTs by sharing best international practices in regulation, innovative financing, international market entry, etc.
3. Facilitate the engagement of stakeholders (government agencies, partners, private sector structures, technical partners, etc.)  relevant to realizing the goals of this workstream. These stakeholders must understand the Nigerian and international regulatory and ACT manufacturing landscape.
4. Provide technical support to organize policy dialogues with key stakeholders to develop the implementation framework for priority recommendations.
5. Participate in stakeholder workshops to validate findings and co-develop a strategic roadmap for expanding Nigeria’s competitiveness and regional share for malaria product (ACT) production.
6. Provide oversight to the quality of outputs for the ACT workstream, including the compilation, assessment, and final selection of potential ACT manufacturers and recommendations for support.
7. Provide technical oversight to ensure that the appropriate support is identified and provided to the selected ACT manufacturers in the following (not-exclusive) areas:
   1. Technical support and knowledge transfer directly or through partnerships
   2. Identifying funding gaps and possible funding sources 
   3. Establish a QA system to ensure compliance with international standards
8. Meet bi-weekly with the project team to review progress and collaboratively resolve any identified issues.

4. Selection Method

The selection process will follow a Limited Consultant Qualification-Based Method (LCQBM).

Under this approach, interested consultants will submit proposals in response to the Terms of Reference (TOR) issued by PVAC. As part of the evaluation, consultants/firms must demonstrate their relevant experience and qualifications in managing similar projects. Only the most qualified consultant/ firm with the required qualification/ expertise would be considered.

5. Required Expertise

The following are the expertise required from the applying consultant / firm: 

▪ Global Health Experience: Strong background in malaria epidemiological studies, prevention and control strategies, as well as global health programs, with experience in implementing large-scale public health interventions around Artemisinin-based Combination (ACT) development in LMICs with special interest in West Africa.

h

▪ Clinical Research Expertise: In-depth knowledge, experience and skills in epidemiological and molecular biological research with special interest in the development and evaluation of affordable malaria diagnostics and ACT as well as managing large clinical trials and its associated regulatory and certification requirements.

▪ Experience in ACT Development: Expertise in the research, formulation, and manufacturing processes for ACT, including clinical trial design and implementation.

▪ Stakeholders Engagement and Coordination Capabilities: Proven ability to manage multi-sectoral projects, coordinate with governments, NGOs, INGOs, donors, research institutions and private sector partners in malaria prevention and control.

• Innovative Financing:Excellent background in innovative financing for healthcare service delivery and development especially in the management of malaria in Africa.
• Regulatory Knowledge:  Have a wide experience working with national and international regulations for ACT production approval, Good Clinical Practices (GCP) and Good Manufacturing Practices (GMP). 
• Capacity Building: Experience in training and mentoring teams in clinical research and ACT development processes.
• International Context Knowledge: Understanding of international health systems and regulatory landscapes. Familiar with the operational challenges in Africa, especially regarding healthcare needs and distribution challenges. Able to influence the local ACT manufacturing landscape along the lines of international best practices.

6. Expected Outcomes

The oversight function of this workstream is expected to support the quality of deliverables from all parties working under this workstream. These include: 

1. Evidence-based ACT-specific policy recommendations and reforms validated by stakeholders. 
2. Detailed reports of site visits and assessments.
3. A list of selected 1^st batch ACT manufacturers (at least 3) and a pipeline of recommended 2^nd batch ACT manufacturers (at least 5) for technical assistance. 
4. Detailed map of potential funding opportunities.
5. Technical assistance reports.

7. Duration of the Assignment

This assignment is expected to run for 8 months – May to December 2025

8. Submission Requirements

Interested organizations are expected to submit the following documents:

1. Technical Proposal: The technical proposal should include:

▪ A clear methodology that demonstrates expertise in managing this project.

▪ A track record and experience in implementing similar projects

▪ At least 3 references from similar projects 

• Compliance Documents: Consultant must have the permit to work in Nigeria as Nigeria’s Ministry of Interior requires. While for firms, the following documents are also required:

▪ A valid organizational registration document

▪ Up-to-date tax clearance certificates 

• Financial Proposal 

All required documents should be sent to [email protected] on or before May 2^nd, 2025. Proposals sent after this date will not be considered.Request for Consultants: Provision of Technical Oversight for the Implementation of Workstream on Building Local Capacity to Produce Quality ACT: 

Enhancing Local Manufacturing and Supply Chain Management for Health

Commodities and Supplies in Nigeria

1. Background

Nigeria faces a significant burden from both communicable and non-communicable diseases, which strains the healthcare system and hinders economic development. Despite ongoing efforts to address these challenges, the country remains heavily reliant on imports for essential health commodities. This dependency leads to high costs, supply chain vulnerabilities, and inconsistent availability of critical healthcare products. Strengthening local capacity and optimizing supply chain management is essential to improving the accessibility, affordability, and sustainability of healthcare products. This is key to advancing public health.

Market shaping strategies have proven successful in other health sectors by leveraging economies of scale, improving quality control, and enhancing distribution efficiency. Adopting this model for manufacturing and distributing essential health commodities could reduce costs, improve product consistency, and ensure more reliable supply chains. However, transitioning from an import-dependent system to one with a robust local production capacity and an efficient pooled procurement system is a complex process. It requires a comprehensive, multi-faceted approach that addresses manufacturing capabilities, quality assurance mechanisms, supply chain optimization, workforce capacity building, and supportive policy frameworks.

The Presidential Initiative for Unlocking Healthcare Value Chain (PVAC) and the National Malaria Elimination Programme (NMEP), with the support of the World Bank IMPACT, embarked on a project called “Enhancing Local Manufacturing and Supply Chain Management for Health Commodities and Supplies in Nigeria”. The aim of this project is to address these challenges through a phased approach that balances short-term and long-term objectives. The strategies for addressing these challenges will include developing and laying the groundwork for local manufacturing of malaria commodities (including ACTs, RDTs, APIs and LLINs), including enhancing production capacity, ensuring compliance with international quality standards, and fostering workforce development. At the same time, the project will focus on optimizing the pooled procurement of imported malaria commodities to improve cost-effectiveness and distribution efficiency. Over the medium to long term, these interventions will strengthen the entire health commodities value chain, create opportunities for economic growth, and support Nigeria’s self-sufficiency in critical healthcare products. This comprehensive approach seeks to improve Nigeria’s healthcare supply systems’ efficiency and resilience while unlocking new economic opportunities within the country’s health sector. The project duration is 1 year.

2. Objective

This consultancy aims to provide technical oversight to all parties working under this project to enhance the local production of Artemisinin-based Combination Therapies (ACTs) in Nigeria. This involves providing technical oversight to PVAC, NMEP, local consultants, and other identified stakeholders engaged in this workstream. This workstream includes assessing manufacturing capacity, facilitating partnerships for technology transfer, ensuring compliance with regulatory standards, and supporting policy reforms to create an enabling environment for sustainable production. The consultant/consulting firm will ensure the integration of best practices for policy and implementation and draw from previous experiences in this space to strengthen the framework (both demand and supply) for the local manufacture of quality, and affordable ACTs.

3. Scope of Work

The consultant/ firm engaged to provide this oversight function is expected to:

1. Provide technical oversight and advise all parties working in the ACT workstream on matters relating to scope, quality, and outputs through participation and reviews during the planning, implementation, and close-out phases of the ACT production capacity development workstream.
2. Support the development of recommendations required for critical policy and regulatory reforms that will address gaps in the local manufacturing of ACTs by sharing best international practices in regulation, innovative financing, international market entry, etc.
3. Facilitate the engagement of stakeholders (government agencies, partners, private sector structures, technical partners, etc.)  relevant to realizing the goals of this workstream. These stakeholders must understand the Nigerian and international regulatory and ACT manufacturing landscape.
4. Provide technical support to organize policy dialogues with key stakeholders to develop the implementation framework for priority recommendations.
5. Participate in stakeholder workshops to validate findings and co-develop a strategic roadmap for expanding Nigeria’s competitiveness and regional share for malaria product (ACT) production.
6. Provide oversight to the quality of outputs for the ACT workstream, including the compilation, assessment, and final selection of potential ACT manufacturers and recommendations for support.
7. Provide technical oversight to ensure that the appropriate support is identified and provided to the selected ACT manufacturers in the following (not-exclusive) areas:
   1. Technical support and knowledge transfer directly or through partnerships
   2. Identifying funding gaps and possible funding sources 
   3. Establish a QA system to ensure compliance with international standards
8. Meet bi-weekly with the project team to review progress and collaboratively resolve any identified issues.

4. Selection Method

The selection process will follow a Limited Consultant Qualification-Based Method (LCQBM).

Under this approach, interested consultants will submit proposals in response to the Terms of Reference (TOR) issued by PVAC. As part of the evaluation, consultants/firms must demonstrate their relevant experience and qualifications in managing similar projects. Only the most qualified consultant/ firm with the required qualification/ expertise would be considered.

5. Required Expertise

The following are the expertise required from the applying consultant / firm: 

▪ Global Health Experience: Strong background in malaria epidemiological studies, prevention and control strategies, as well as global health programs, with experience in implementing large-scale public health interventions around Artemisinin-based Combination (ACT) development in LMICs with special interest in West Africa.

▪ Clinical Research Expertise: In-depth knowledge, experience and skills in epidemiological and molecular biological research with special interest in the development and evaluation of affordable malaria diagnostics and ACT as well as managing large clinical trials and its associated regulatory and certification requirements.

▪ Experience in ACT Development: Expertise in the research, formulation, and manufacturing processes for ACT, including clinical trial design and implementation.

▪ Stakeholders Engagement and Coordination Capabilities: Proven ability to manage multi-sectoral projects, coordinate with governments, NGOs, INGOs, donors, research institutions and private sector partners in malaria prevention and control.

• Innovative Financing:Excellent background in innovative financing for healthcare service delivery and development especially in the management of malaria in Africa.
• Regulatory Knowledge:  Have a wide experience working with national and international regulations for ACT production approval, Good Clinical Practices (GCP) and Good Manufacturing Practices (GMP). 
• Capacity Building: Experience in training and mentoring teams in clinical research and ACT development processes.
• International Context Knowledge: Understanding of international health systems and regulatory landscapes. Familiar with the operational challenges in Africa, especially regarding healthcare needs and distribution challenges. Able to influence the local ACT manufacturing landscape along the lines of international best practices.

6. Expected Outcomes

The oversight function of this workstream is expected to support the quality of deliverables from all parties working under this workstream. These include: 

1. Evidence-based ACT-specific policy recommendations and reforms validated by stakeholders. 
2. Detailed reports of site visits and assessments.
3. A list of selected 1^st batch ACT manufacturers (at least 3) and a pipeline of recommended 2^nd batch ACT manufacturers (at least 5) for technical assistance. 
4. Detailed map of potential funding opportunities.
5. Technical assistance reports.

7. Duration of the Assignment

This assignment is expected to run for 8 months – May to December 2025

8. Submission Requirements

Interested organizations are expected to submit the following documents:

1. Technical Proposal: The technical proposal should include:

▪ A clear methodology that demonstrates expertise in managing this project.

▪ A track record and experience in implementing similar projects

▪ At least 3 references from similar projects 

• Compliance Documents: Consultant must have the permit to work in Nigeria as Nigeria’s Ministry of Interior requires. While for firms, the following documents are also required:

▪ A valid organizational registration document

▪ Up-to-date tax clearance certificates 

• Financial Proposal 

All required documents should be sent to [email protected] on or before May 2^nd, 2025. Proposals sent after this date will not be considered.Request for Consultants: Provision of Technical Oversight for the Implementation of Workstream on Building Local Capacity to Produce Quality ACT: 

Enhancing Local Manufacturing and Supply Chain Management for Health

Commodities and Supplies in Nigeria

1. Background

Nigeria faces a significant burden from both communicable and non-communicable diseases, which strains the healthcare system and hinders economic development. Despite ongoing efforts to address these challenges, the country remains heavily reliant on imports for essential health commodities. This dependency leads to high costs, supply chain vulnerabilities, and inconsistent availability of critical healthcare products. Strengthening local capacity and optimizing supply chain management is essential to improving the accessibility, affordability, and sustainability of healthcare products. This is key to advancing public health.

Market shaping strategies have proven successful in other health sectors by leveraging economies of scale, improving quality control, and enhancing distribution efficiency. Adopting this model for manufacturing and distributing essential health commodities could reduce costs, improve product consistency, and ensure more reliable supply chains. However, transitioning from an import-dependent system to one with a robust local production capacity and an efficient pooled procurement system is a complex process. It requires a comprehensive, multi-faceted approach that addresses manufacturing capabilities, quality assurance mechanisms, supply chain optimization, workforce capacity building, and supportive policy frameworks.

https://googleads.g.doubleclick.net/pagead/ads?gdpr=0&us_privacy=1—&gpp_sid=-1&client=ca-pub-2321249943983804&output=html&h=280&adk=3292208330&adf=3651786664&pi=t.aa~a.1381849204~i.13~rp.4&w=728&abgtt=6&fwrn=4&fwrnh=100&lmt=1745427050&num_ads=1&rafmt=1&armr=3&sem=mc&pwprc=6515900736&ad_type=text_image&format=728×280&url=https%3A%2F%2Fngojobsite.com%2Finvitation-to-bid-provision-of-technical-oversight-for-the-implementation-of-workstream-on-building-local-capacity-to-produce-quality-act-at-health-systems-consult-limited-hscl%2F&fwr=0&pra=3&rh=182&rw=727&rpe=1&resp_fmts=3&wgl=1&fa=27&uach=WyJXaW5kb3dzIiwiMTUuMC4wIiwieDg2IiwiIiwiMTM1LjAuNzA0OS44NSIsbnVsbCwwLG51bGwsIjY0IixbWyJHb29nbGUgQ2hyb21lIiwiMTM1LjAuNzA0OS44NSJdLFsiTm90LUEuQnJhbmQiLCI4LjAuMC4wIl0sWyJDaHJvbWl1bSIsIjEzNS4wLjcwNDkuODUiXV0sMF0.&dt=1745426256758&bpp=4&bdt=1842&idt=4&shv=r20250421&mjsv=m202504170101&ptt=9&saldr=aa&abxe=1&cookie=ID%3Dd402398dbe8029b3%3AT%3D1730191189%3ART%3D1745426888%3AS%3DALNI_Mbqv4ZjCA2FyHoBsYRqGiGVSR4f2A&gpic=UID%3D00000f5f5123b4f7%3AT%3D1730191189%3ART%3D1745426888%3AS%3DALNI_MaUeBuU5kMVXlTiiGykJasfdDE9vw&eo_id_str=ID%3D3685604803237a2e%3AT%3D1730191189%3ART%3D1745426888%3AS%3DAA-AfjZ2X441EOy64ZtttSEJoFR_&prev_fmts=0x0%2C750x280%2C1497x702&nras=3&correlator=8747092532096&frm=20&pv=1&u_tz=60&u_his=1&u_h=768&u_w=1366&u_ah=720&u_aw=1366&u_cd=24&u_sd=0.9&dmc=8&adx=190&ady=1181&biw=1497&bih=702&scr_x=0&scr_y=0&eid=95358862%2C95358864%2C95354562%2C95355310%2C95357877%2C95357716&oid=2&pvsid=3942448291295766&tmod=698141052&uas=0&nvt=1&fc=1408&brdim=-7%2C0%2C-7%2C0%2C1366%2C0%2C1379%2C727%2C1514%2C702&vis=1&rsz=%7C%7Cs%7C&abl=NS&cms=2&fu=128&bc=31&bz=0.91&td=1&tdf=2&psd=W251bGwsbnVsbCxudWxsLDNd&nt=1&pgls=CAEaAzYuOA..~CAA.&ifi=6&uci=a!6&btvi=1&fsb=1&dtd=M

The Presidential Initiative for Unlocking Healthcare Value Chain (PVAC) and the National Malaria Elimination Programme (NMEP), with the support of the World Bank IMPACT, embarked on a project called “Enhancing Local Manufacturing and Supply Chain Management for Health Commodities and Supplies in Nigeria”. The aim of this project is to address these challenges through a phased approach that balances short-term and long-term objectives. The strategies for addressing these challenges will include developing and laying the groundwork for local manufacturing of malaria commodities (including ACTs, RDTs, APIs and LLINs), including enhancing production capacity, ensuring compliance with international quality standards, and fostering workforce development. At the same time, the project will focus on optimizing the pooled procurement of imported malaria commodities to improve cost-effectiveness and distribution efficiency. Over the medium to long term, these interventions will strengthen the entire health commodities value chain, create opportunities for economic growth, and support Nigeria’s self-sufficiency in critical healthcare products. This comprehensive approach seeks to improve Nigeria’s healthcare supply systems’ efficiency and resilience while unlocking new economic opportunities within the country’s health sector. The project duration is 1 year.

2. Objective

This consultancy aims to provide technical oversight to all parties working under this project to enhance the local production of Artemisinin-based Combination Therapies (ACTs) in Nigeria. This involves providing technical oversight to PVAC, NMEP, local consultants, and other identified stakeholders engaged in this workstream. This workstream includes assessing manufacturing capacity, facilitating partnerships for technology transfer, ensuring compliance with regulatory standards, and supporting policy reforms to create an enabling environment for sustainable production. The consultant/consulting firm will ensure the integration of best practices for policy and implementation and draw from previous experiences in this space to strengthen the framework (both demand and supply) for the local manufacture of quality, and affordable ACTs.

3. Scope of Work

The consultant/ firm engaged to provide this oversight function is expected to:

1. Provide technical oversight and advise all parties working in the ACT workstream on matters relating to scope, quality, and outputs through participation and reviews during the planning, implementation, and close-out phases of the ACT production capacity development workstream.
2. Support the development of recommendations required for critical policy and regulatory reforms that will address gaps in the local manufacturing of ACTs by sharing best international practices in regulation, innovative financing, international market entry, etc.
3. Facilitate the engagement of stakeholders (government agencies, partners, private sector structures, technical partners, etc.)  relevant to realizing the goals of this workstream. These stakeholders must understand the Nigerian and international regulatory and ACT manufacturing landscape.
4. Provide technical support to organize policy dialogues with key stakeholders to develop the implementation framework for priority recommendations.
5. Participate in stakeholder workshops to validate findings and co-develop a strategic roadmap for expanding Nigeria’s competitiveness and regional share for malaria product (ACT) production.
6. Provide oversight to the quality of outputs for the ACT workstream, including the compilation, assessment, and final selection of potential ACT manufacturers and recommendations for support.
7. Provide technical oversight to ensure that the appropriate support is identified and provided to the selected ACT manufacturers in the following (not-exclusive) areas:
   1. Technical support and knowledge transfer directly or through partnerships
   2. Identifying funding gaps and possible funding sources 
   3. Establish a QA system to ensure compliance with international standards
8. Meet bi-weekly with the project team to review progress and collaboratively resolve any identified issues.

4. Selection Method

The selection process will follow a Limited Consultant Qualification-Based Method (LCQBM).

Under this approach, interested consultants will submit proposals in response to the Terms of Reference (TOR) issued by PVAC. As part of the evaluation, consultants/firms must demonstrate their relevant experience and qualifications in managing similar projects. Only the most qualified consultant/ firm with the required qualification/ expertise would be considered.

5. Required Expertise

The following are the expertise required from the applying consultant / firm: 

▪ Global Health Experience: Strong background in malaria epidemiological studies, prevention and control strategies, as well as global health programs, with experience in implementing large-scale public health interventions around Artemisinin-based Combination (ACT) development in LMICs with special interest in West Africa.

▪ Clinical Research Expertise: In-depth knowledge, experience and skills in epidemiological and molecular biological research with special interest in the development and evaluation of affordable malaria diagnostics and ACT as well as managing large clinical trials and its associated regulatory and certification requirements.

▪ Experience in ACT Development: Expertise in the research, formulation, and manufacturing processes for ACT, including clinical trial design and implementation.

▪ Stakeholders Engagement and Coordination Capabilities: Proven ability to manage multi-sectoral projects, coordinate with governments, NGOs, INGOs, donors, research institutions and private sector partners in malaria prevention and control.

• Innovative Financing:Excellent background in innovative financing for healthcare service delivery and development especially in the management of malaria in Africa.
• Regulatory Knowledge:  Have a wide experience working with national and international regulations for ACT production approval, Good Clinical Practices (GCP) and Good Manufacturing Practices (GMP). 
• Capacity Building: Experience in training and mentoring teams in clinical research and ACT development processes.
• International Context Knowledge: Understanding of international health systems and regulatory landscapes. Familiar with the operational challenges in Africa, especially regarding healthcare needs and distribution challenges. Able to influence the local ACT manufacturing landscape along the lines of international best practices.

6. Expected Outcomes

The oversight function of this workstream is expected to support the quality of deliverables from all parties working under this workstream. These include: 

1. Evidence-based ACT-specific policy recommendations and reforms validated by stakeholders. 
2. Detailed reports of site visits and assessments.
3. A list of selected 1^st batch ACT manufacturers (at least 3) and a pipeline of recommended 2^nd batch ACT manufacturers (at least 5) for technical assistance. 
4. Detailed map of potential funding opportunities.
5. Technical assistance reports.

7. Duration of the Assignment

This assignment is expected to run for 8 months – May to December 2025

8. Submission Requirements

Interested organizations are expected to submit the following documents:

1. Technical Proposal: The technical proposal should include:

▪ A clear methodology that demonstrates expertise in managing this project.

▪ A track record and experience in implementing similar projects

▪ At least 3 references from similar projects 

• Compliance Documents: Consultant must have the permit to work in Nigeria as Nigeria’s Ministry of Interior requires. While for firms, the following documents are also required:

▪ A valid organizational registration document

▪ Up-to-date tax clearance certificates 

• Financial Proposal 

All required documents should be sent to [email protected] on or before May 2^nd, 2025. Proposals sent after this date will not be considered.Request for Consultants: Provision of Technical Oversight for the Implementation of Workstream on Building Local Capacity to Produce Quality ACT: 

Enhancing Local Manufacturing and Supply Chain Management for Health

Commodities and Supplies in Nigeria

1. Background

Nigeria faces a significant burden from both communicable and non-communicable diseases, which strains the healthcare system and hinders economic development. Despite ongoing efforts to address these challenges, the country remains heavily reliant on imports for essential health commodities. This dependency leads to high costs, supply chain vulnerabilities, and inconsistent availability of critical healthcare products. Strengthening local capacity and optimizing supply chain management is essential to improving the accessibility, affordability, and sustainability of healthcare products. This is key to advancing public health.

Market shaping strategies have proven successful in other health sectors by leveraging economies of scale, improving quality control, and enhancing distribution efficiency. Adopting this model for manufacturing and distributing essential health commodities could reduce costs, improve product consistency, and ensure more reliable supply chains. However, transitioning from an import-dependent system to one with a robust local production capacity and an efficient pooled procurement system is a complex process. It requires a comprehensive, multi-faceted approach that addresses manufacturing capabilities, quality assurance mechanisms, supply chain optimization, workforce capacity building, and supportive policy frameworks.

The Presidential Initiative for Unlocking Healthcare Value Chain (PVAC) and the National Malaria Elimination Programme (NMEP), with the support of the World Bank IMPACT, embarked on a project called “Enhancing Local Manufacturing and Supply Chain Management for Health Commodities and Supplies in Nigeria”. The aim of this project is to address these challenges through a phased approach that balances short-term and long-term objectives. The strategies for addressing these challenges will include developing and laying the groundwork for local manufacturing of malaria commodities (including ACTs, RDTs, APIs and LLINs), including enhancing production capacity, ensuring compliance with international quality standards, and fostering workforce development. At the same time, the project will focus on optimizing the pooled procurement of imported malaria commodities to improve cost-effectiveness and distribution efficiency. Over the medium to long term, these interventions will strengthen the entire health commodities value chain, create opportunities for economic growth, and support Nigeria’s self-sufficiency in critical healthcare products. This comprehensive approach seeks to improve Nigeria’s healthcare supply systems’ efficiency and resilience while unlocking new economic opportunities within the country’s health sector. The project duration is 1 year.

2. Objective

This consultancy aims to provide technical oversight to all parties working under this project to enhance the local production of Artemisinin-based Combination Therapies (ACTs) in Nigeria. This involves providing technical oversight to PVAC, NMEP, local consultants, and other identified stakeholders engaged in this workstream. This workstream includes assessing manufacturing capacity, facilitating partnerships for technology transfer, ensuring compliance with regulatory standards, and supporting policy reforms to create an enabling environment for sustainable production. The consultant/consulting firm will ensure the integration of best practices for policy and implementation and draw from previous experiences in this space to strengthen the framework (both demand and supply) for the local manufacture of quality, and affordable ACTs.

3. Scope of Work

The consultant/ firm engaged to provide this oversight function is expected to:

1. Provide technical oversight and advise all parties working in the ACT workstream on matters relating to scope, quality, and outputs through participation and reviews during the planning, implementation, and close-out phases of the ACT production capacity development workstream.
2. Support the development of recommendations required for critical policy and regulatory reforms that will address gaps in the local manufacturing of ACTs by sharing best international practices in regulation, innovative financing, international market entry, etc.
3. Facilitate the engagement of stakeholders (government agencies, partners, private sector structures, technical partners, etc.)  relevant to realizing the goals of this workstream. These stakeholders must understand the Nigerian and international regulatory and ACT manufacturing landscape.
4. Provide technical support to organize policy dialogues with key stakeholders to develop the implementation framework for priority recommendations.
5. Participate in stakeholder workshops to validate findings and co-develop a strategic roadmap for expanding Nigeria’s competitiveness and regional share for malaria product (ACT) production.
6. Provide oversight to the quality of outputs for the ACT workstream, including the compilation, assessment, and final selection of potential ACT manufacturers and recommendations for support.
7. Provide technical oversight to ensure that the appropriate support is identified and provided to the selected ACT manufacturers in the following (not-exclusive) areas:
   1. Technical support and knowledge transfer directly or through partnerships
   2. Identifying funding gaps and possible funding sources 
   3. Establish a QA system to ensure compliance with international standards
8. Meet bi-weekly with the project team to review progress and collaboratively resolve any identified issues.

4. Selection Method

The selection process will follow a Limited Consultant Qualification-Based Method (LCQBM).

Under this approach, interested consultants will submit proposals in response to the Terms of Reference (TOR) issued by PVAC. As part of the evaluation, consultants/firms must demonstrate their relevant experience and qualifications in managing similar projects. Only the most qualified consultant/ firm with the required qualification/ expertise would be considered.

5. Required Expertise

The following are the expertise required from the applying consultant / firm: 

▪ Global Health Experience: Strong background in malaria epidemiological studies, prevention and control strategies, as well as global health programs, with experience in implementing large-scale public health interventions around Artemisinin-based Combination (ACT) development in LMICs with special interest in West Africa.

▪ Clinical Research Expertise: In-depth knowledge, experience and skills in epidemiological and molecular biological research with special interest in the development and evaluation of affordable malaria diagnostics and ACT as well as managing large clinical trials and its associated regulatory and certification requirements.

▪ Experience in ACT Development: Expertise in the research, formulation, and manufacturing processes for ACT, including clinical trial design and implementation.

▪ Stakeholders Engagement and Coordination Capabilities: Proven ability to manage multi-sectoral projects, coordinate with governments, NGOs, INGOs, donors, research institutions and private sector partners in malaria prevention and control.

• Innovative Financing:Excellent background in innovative financing for healthcare service delivery and development especially in the management of malaria in Africa.
• Regulatory Knowledge:  Have a wide experience working with national and international regulations for ACT production approval, Good Clinical Practices (GCP) and Good Manufacturing Practices (GMP). 
• Capacity Building: Experience in training and mentoring teams in clinical research and ACT development processes.
• International Context Knowledge: Understanding of international health systems and regulatory landscapes. Familiar with the operational challenges in Africa, especially regarding healthcare needs and distribution challenges. Able to influence the local ACT manufacturing landscape along the lines of international best practices.

6. Expected Outcomes

The oversight function of this workstream is expected to support the quality of deliverables from all parties working under this workstream. These include: 

1. Evidence-based ACT-specific policy recommendations and reforms validated by stakeholders. 
2. Detailed reports of site visits and assessments.
3. A list of selected 1^st batch ACT manufacturers (at least 3) and a pipeline of recommended 2^nd batch ACT manufacturers (at least 5) for technical assistance. 
4. Detailed map of potential funding opportunities.
5. Technical assistance reports.

7. Duration of the Assignment

This assignment is expected to run for 8 months – May to December 2025

8. Submission Requirements

Interested organizations are expected to submit the following documents:

1. Technical Proposal: The technical proposal should include:

▪ A clear methodology that demonstrates expertise in managing this project.

▪ A track record and experience in implementing similar projects

▪ At least 3 references from similar projects 

• Compliance Documents: Consultant must have the permit to work in Nigeria as Nigeria’s Ministry of Interior requires. While for firms, the following documents are also required:

▪ A valid organizational registration document

▪ Up-to-date tax clearance certificates 

• Financial Proposal 

All required documents should be sent to [email protected] on or before May 2^nd, 2025. Proposals sent after this date will not be considered.Request for Consultants: Provision of Technical Oversight for the Implementation of Workstream on Building Local Capacity to Produce Quality ACT: 

Enhancing Local Manufacturing and Supply Chain Management for Health

Commodities and Supplies in Nigeria

1. Background

Nigeria faces a significant burden from both communicable and non-communicable diseases, which strains the healthcare system and hinders economic development. Despite ongoing efforts to address these challenges, the country remains heavily reliant on imports for essential health commodities. This dependency leads to high costs, supply chain vulnerabilities, and inconsistent availability of critical healthcare products. Strengthening local capacity and optimizing supply chain management is essential to improving the accessibility, affordability, and sustainability of healthcare products. This is key to advancing public health.

Market shaping strategies have proven successful in other health sectors by leveraging economies of scale, improving quality control, and enhancing distribution efficiency. Adopting this model for manufacturing and distributing essential health commodities could reduce costs, improve product consistency, and ensure more reliable supply chains. However, transitioning from an import-dependent system to one with a robust local production capacity and an efficient pooled procurement system is a complex process. It requires a comprehensive, multi-faceted approach that addresses manufacturing capabilities, quality assurance mechanisms, supply chain optimization, workforce capacity building, and supportive policy frameworks.

The Presidential Initiative for Unlocking Healthcare Value Chain (PVAC) and the National Malaria Elimination Programme (NMEP), with the support of the World Bank IMPACT, embarked on a project called “Enhancing Local Manufacturing and Supply Chain Management for Health Commodities and Supplies in Nigeria”. The aim of this project is to address these challenges through a phased approach that balances short-term and long-term objectives. The strategies for addressing these challenges will include developing and laying the groundwork for local manufacturing of malaria commodities (including ACTs, RDTs, APIs and LLINs), including enhancing production capacity, ensuring compliance with international quality standards, and fostering workforce development. At the same time, the project will focus on optimizing the pooled procurement of imported malaria commodities to improve cost-effectiveness and distribution efficiency. Over the medium to long term, these interventions will strengthen the entire health commodities value chain, create opportunities for economic growth, and support Nigeria’s self-sufficiency in critical healthcare products. This comprehensive approach seeks to improve Nigeria’s healthcare supply systems’ efficiency and resilience while unlocking new economic opportunities within the country’s health sector. The project duration is 1 year.

2. Objective

This consultancy aims to provide technical oversight to all parties working under this project to enhance the local production of Artemisinin-based Combination Therapies (ACTs) in Nigeria. This involves providing technical oversight to PVAC, NMEP, local consultants, and other identified stakeholders engaged in this workstream. This workstream includes assessing manufacturing capacity, facilitating partnerships for technology transfer, ensuring compliance with regulatory standards, and supporting policy reforms to create an enabling environment for sustainable production. The consultant/consulting firm will ensure the integration of best practices for policy and implementation and draw from previous experiences in this space to strengthen the framework (both demand and supply) for the local manufacture of quality, and affordable ACTs.

3. Scope of Work

The consultant/ firm engaged to provide this oversight function is expected to:

1. Provide technical oversight and advise all parties working in the ACT workstream on matters relating to scope, quality, and outputs through participation and reviews during the planning, implementation, and close-out phases of the ACT production capacity development workstream.
2. Support the development of recommendations required for critical policy and regulatory reforms that will address gaps in the local manufacturing of ACTs by sharing best international practices in regulation, innovative financing, international market entry, etc.
3. Facilitate the engagement of stakeholders (government agencies, partners, private sector structures, technical partners, etc.)  relevant to realizing the goals of this workstream. These stakeholders must understand the Nigerian and international regulatory and ACT manufacturing landscape.
4. Provide technical support to organize policy dialogues with key stakeholders to develop the implementation framework for priority recommendations.
5. Participate in stakeholder workshops to validate findings and co-develop a strategic roadmap for expanding Nigeria’s competitiveness and regional share for malaria product (ACT) production.
6. Provide oversight to the quality of outputs for the ACT workstream, including the compilation, assessment, and final selection of potential ACT manufacturers and recommendations for support.
7. Provide technical oversight to ensure that the appropriate support is identified and provided to the selected ACT manufacturers in the following (not-exclusive) areas:
   1. Technical support and knowledge transfer directly or through partnerships
   2. Identifying funding gaps and possible funding sources 
   3. Establish a QA system to ensure compliance with international standards
8. Meet bi-weekly with the project team to review progress and collaboratively resolve any identified issues.

4. Selection Method

The selection process will follow a Limited Consultant Qualification-Based Method (LCQBM).

Under this approach, interested consultants will submit proposals in response to the Terms of Reference (TOR) issued by PVAC. As part of the evaluation, consultants/firms must demonstrate their relevant experience and qualifications in managing similar projects. Only the most qualified consultant/ firm with the required qualification/ expertise would be considered.

5. Required Expertise

The following are the expertise required from the applying consultant / firm: 

▪ Global Health Experience: Strong background in malaria epidemiological studies, prevention and control strategies, as well as global health programs, with experience in implementing large-scale public health interventions around Artemisinin-based Combination (ACT) development in LMICs with special interest in West Africa.

▪ Clinical Research Expertise: In-depth knowledge, experience and skills in epidemiological and molecular biological research with special interest in the development and evaluation of affordable malaria diagnostics and ACT as well as managing large clinical trials and its associated regulatory and certification requirements.

▪ Experience in ACT Development: Expertise in the research, formulation, and manufacturing processes for ACT, including clinical trial design and implementation.

▪ Stakeholders Engagement and Coordination Capabilities: Proven ability to manage multi-sectoral projects, coordinate with governments, NGOs, INGOs, donors, research institutions and private sector partners in malaria prevention and control.

• Innovative Financing:Excellent background in innovative financing for healthcare service delivery and development especially in the management of malaria in Africa.
• Regulatory Knowledge:  Have a wide experience working with national and international regulations for ACT production approval, Good Clinical Practices (GCP) and Good Manufacturing Practices (GMP). 
• Capacity Building: Experience in training and mentoring teams in clinical research and ACT development processes.
• International Context Knowledge: Understanding of international health systems and regulatory landscapes. Familiar with the operational challenges in Africa, especially regarding healthcare needs and distribution challenges. Able to influence the local ACT manufacturing landscape along the lines of international best practices.

6. Expected Outcomes

The oversight function of this workstream is expected to support the quality of deliverables from all parties working under this workstream. These include: 

1. Evidence-based ACT-specific policy recommendations and reforms validated by stakeholders. 
2. Detailed reports of site visits and assessments.
3. A list of selected 1^st batch ACT manufacturers (at least 3) and a pipeline of recommended 2^nd batch ACT manufacturers (at least 5) for technical assistance. 
4. Detailed map of potential funding opportunities.
5. Technical assistance reports.

7. Duration of the Assignment

This assignment is expected to run for 8 months – May to December 2025

8. Submission Requirements

Interested organizations are expected to submit the following documents:

1. Technical Proposal: The technical proposal should include:

▪ A clear methodology that demonstrates expertise in managing this project.

▪ A track record and experience in implementing similar projects

▪ At least 3 references from similar projects 

• Compliance Documents: Consultant must have the permit to work in Nigeria as Nigeria’s Ministry of Interior requires. While for firms, the following documents are also required:

▪ A valid organizational registration document

▪ Up-to-date tax clearance certificates 

• Financial Proposal 

All required documents should be sent to [email protected] on or before May 2^nd, 2025. Proposals sent after this date will not be considered.Request for Consultants: Provision of Technical Oversight for the Implementation of Workstream on Building Local Capacity to Produce Quality ACT: 

Enhancing Local Manufacturing and Supply Chain Management for Health

Commodities and Supplies in Nigeria

1. Background

Nigeria faces a significant burden from both communicable and non-communicable diseases, which strains the healthcare system and hinders economic development. Despite ongoing efforts to address these challenges, the country remains heavily reliant on imports for essential health commodities. This dependency leads to high costs, supply chain vulnerabilities, and inconsistent availability of critical healthcare products. Strengthening local capacity and optimizing supply chain management is essential to improving the accessibility, affordability, and sustainability of healthcare products. This is key to advancing public health.

Market shaping strategies have proven successful in other health sectors by leveraging economies of scale, improving quality control, and enhancing distribution efficiency. Adopting this model for manufacturing and distributing essential health commodities could reduce costs, improve product consistency, and ensure more reliable supply chains. However, transitioning from an import-dependent system to one with a robust local production capacity and an efficient pooled procurement system is a complex process. It requires a comprehensive, multi-faceted approach that addresses manufacturing capabilities, quality assurance mechanisms, supply chain optimization, workforce capacity building, and supportive policy frameworks.

The Presidential Initiative for Unlocking Healthcare Value Chain (PVAC) and the National Malaria Elimination Programme (NMEP), with the support of the World Bank IMPACT, embarked on a project called “Enhancing Local Manufacturing and Supply Chain Management for Health Commodities and Supplies in Nigeria”. The aim of this project is to address these challenges through a phased approach that balances short-term and long-term objectives. The strategies for addressing these challenges will include developing and laying the groundwork for local manufacturing of malaria commodities (including ACTs, RDTs, APIs and LLINs), including enhancing production capacity, ensuring compliance with international quality standards, and fostering workforce development. At the same time, the project will focus on optimizing the pooled procurement of imported malaria commodities to improve cost-effectiveness and distribution efficiency. Over the medium to long term, these interventions will strengthen the entire health commodities value chain, create opportunities for economic growth, and support Nigeria’s self-sufficiency in critical healthcare products. This comprehensive approach seeks to improve Nigeria’s healthcare supply systems’ efficiency and resilience while unlocking new economic opportunities within the country’s health sector. The project duration is 1 year.

2. Objective

This consultancy aims to provide technical oversight to all parties working under this project to enhance the local production of Artemisinin-based Combination Therapies (ACTs) in Nigeria. This involves providing technical oversight to PVAC, NMEP, local consultants, and other identified stakeholders engaged in this workstream. This workstream includes assessing manufacturing capacity, facilitating partnerships for technology transfer, ensuring compliance with regulatory standards, and supporting policy reforms to create an enabling environment for sustainable production. The consultant/consulting firm will ensure the integration of best practices for policy and implementation and draw from previous experiences in this space to strengthen the framework (both demand and supply) for the local manufacture of quality, and affordable ACTs.

3. Scope of Work

The consultant/ firm engaged to provide this oversight function is expected to:

1. Provide technical oversight and advise all parties working in the ACT workstream on matters relating to scope, quality, and outputs through participation and reviews during the planning, implementation, and close-out phases of the ACT production capacity development workstream.
2. Support the development of recommendations required for critical policy and regulatory reforms that will address gaps in the local manufacturing of ACTs by sharing best international practices in regulation, innovative financing, international market entry, etc.
3. Facilitate the engagement of stakeholders (government agencies, partners, private sector structures, technical partners, etc.)  relevant to realizing the goals of this workstream. These stakeholders must understand the Nigerian and international regulatory and ACT manufacturing landscape.
4. Provide technical support to organize policy dialogues with key stakeholders to develop the implementation framework for priority recommendations.
5. Participate in stakeholder workshops to validate findings and co-develop a strategic roadmap for expanding Nigeria’s competitiveness and regional share for malaria product (ACT) production.
6. Provide oversight to the quality of outputs for the ACT workstream, including the compilation, assessment, and final selection of potential ACT manufacturers and recommendations for support.
7. Provide technical oversight to ensure that the appropriate support is identified and provided to the selected ACT manufacturers in the following (not-exclusive) areas:
   1. Technical support and knowledge transfer directly or through partnerships
   2. Identifying funding gaps and possible funding sources 
   3. Establish a QA system to ensure compliance with international standards
8. Meet bi-weekly with the project team to review progress and collaboratively resolve any identified issues.

4. Selection Method

The selection process will follow a Limited Consultant Qualification-Based Method (LCQBM).

Under this approach, interested consultants will submit proposals in response to the Terms of Reference (TOR) issued by PVAC. As part of the evaluation, consultants/firms must demonstrate their relevant experience and qualifications in managing similar projects. Only the most qualified consultant/ firm with the required qualification/ expertise would be considered.

5. Required Expertise

The following are the expertise required from the applying consultant / firm: 

▪ Global Health Experience: Strong background in malaria epidemiological studies, prevention and control strategies, as well as global health programs, with experience in implementing large-scale public health interventions around Artemisinin-based Combination (ACT) development in LMICs with special interest in West Africa.

https://googleads.g.doubleclick.net/pagead/ads?gdpr=0&us_privacy=1—&gpp_sid=-1&client=ca-pub-2321249943983804&output=html&h=280&adk=3292208330&adf=1381599079&pi=t.aa~a.1381849204~i.37~rp.4&w=728&abgtt=6&fwrn=4&fwrnh=100&lmt=1745427051&num_ads=1&rafmt=1&armr=3&sem=mc&pwprc=6515900736&ad_type=text_image&format=728×280&url=https%3A%2F%2Fngojobsite.com%2Finvitation-to-bid-provision-of-technical-oversight-for-the-implementation-of-workstream-on-building-local-capacity-to-produce-quality-act-at-health-systems-consult-limited-hscl%2F&fwr=0&pra=3&rh=182&rw=727&rpe=1&resp_fmts=3&wgl=1&fa=27&uach=WyJXaW5kb3dzIiwiMTUuMC4wIiwieDg2IiwiIiwiMTM1LjAuNzA0OS44NSIsbnVsbCwwLG51bGwsIjY0IixbWyJHb29nbGUgQ2hyb21lIiwiMTM1LjAuNzA0OS44NSJdLFsiTm90LUEuQnJhbmQiLCI4LjAuMC4wIl0sWyJDaHJvbWl1bSIsIjEzNS4wLjcwNDkuODUiXV0sMF0.&dt=1745426256772&bpp=3&bdt=1857&idt=3&shv=r20250421&mjsv=m202504170101&ptt=9&saldr=aa&abxe=1&cookie=ID%3Dd402398dbe8029b3%3AT%3D1730191189%3ART%3D1745426888%3AS%3DALNI_Mbqv4ZjCA2FyHoBsYRqGiGVSR4f2A&gpic=UID%3D00000f5f5123b4f7%3AT%3D1730191189%3ART%3D1745426888%3AS%3DALNI_MaUeBuU5kMVXlTiiGykJasfdDE9vw&eo_id_str=ID%3D3685604803237a2e%3AT%3D1730191189%3ART%3D1745426888%3AS%3DAA-AfjZ2X441EOy64ZtttSEJoFR_&prev_fmts=0x0%2C750x280%2C1497x702%2C728x280%2C360x280%2C360x280&nras=6&correlator=8747092532096&frm=20&pv=1&u_tz=60&u_his=1&u_h=768&u_w=1366&u_ah=720&u_aw=1366&u_cd=24&u_sd=0.9&dmc=8&adx=190&ady=2783&biw=1497&bih=702&scr_x=0&scr_y=0&eid=95358862%2C95358864%2C95354562%2C95355310%2C95357877%2C95357716&oid=2&pvsid=3942448291295766&tmod=698141052&uas=0&nvt=1&fc=1408&brdim=-7%2C0%2C-7%2C0%2C1366%2C0%2C1379%2C727%2C1514%2C702&vis=1&rsz=%7C%7Cs%7C&abl=NS&fu=128&bc=31&bz=0.91&td=1&tdf=2&psd=W251bGwsbnVsbCxudWxsLDNd&nt=1&pgls=CAEaAzYuOA..~CAA.&ifi=7&uci=a!7&btvi=4&fsb=1&dtd=M

▪ Clinical Research Expertise: In-depth knowledge, experience and skills in epidemiological and molecular biological research with special interest in the development and evaluation of affordable malaria diagnostics and ACT as well as managing large clinical trials and its associated regulatory and certification requirements.

▪ Experience in ACT Development: Expertise in the research, formulation, and manufacturing processes for ACT, including clinical trial design and implementation.

▪ Stakeholders Engagement and Coordination Capabilities: Proven ability to manage multi-sectoral projects, coordinate with governments, NGOs, INGOs, donors, research institutions and private sector partners in malaria prevention and control.

• Innovative Financing:Excellent background in innovative financing for healthcare service delivery and development especially in the management of malaria in Africa.
• Regulatory Knowledge:  Have a wide experience working with national and international regulations for ACT production approval, Good Clinical Practices (GCP) and Good Manufacturing Practices (GMP). 
• Capacity Building: Experience in training and mentoring teams in clinical research and ACT development processes.
• International Context Knowledge: Understanding of international health systems and regulatory landscapes. Familiar with the operational challenges in Africa, especially regarding healthcare needs and distribution challenges. Able to influence the local ACT manufacturing landscape along the lines of international best practices.

6. Expected Outcomes

The oversight function of this workstream is expected to support the quality of deliverables from all parties working under this workstream. These include: 

1. Evidence-based ACT-specific policy recommendations and reforms validated by stakeholders. 
2. Detailed reports of site visits and assessments.
3. A list of selected 1^st batch ACT manufacturers (at least 3) and a pipeline of recommended 2^nd batch ACT manufacturers (at least 5) for technical assistance. 
4. Detailed map of potential funding opportunities.
5. Technical assistance reports.

7. Duration of the Assignment

This assignment is expected to run for 8 months – May to December 2025

8. Submission Requirements

Interested organizations are expected to submit the following documents:

1. Technical Proposal: The technical proposal should include:

▪ A clear methodology that demonstrates expertise in managing this project.

▪ A track record and experience in implementing similar projects

▪ At least 3 references from similar projects 

• Compliance Documents: Consultant must have the permit to work in Nigeria as Nigeria’s Ministry of Interior requires. While for firms, the following documents are also required:

▪ A valid organizational registration document

▪ Up-to-date tax clearance certificates 

• Financial Proposal 

All required documents should be sent to [email protected] on or before May 2^nd, 2025. Proposals sent after this date will not be considered.Request for Consultants: Provision of Technical Oversight for the Implementation of Workstream on Building Local Capacity to Produce Quality ACT: 

Enhancing Local Manufacturing and Supply Chain Management for Health

Commodities and Supplies in Nigeria

1. Background

Nigeria faces a significant burden from both communicable and non-communicable diseases, which strains the healthcare system and hinders economic development. Despite ongoing efforts to address these challenges, the country remains heavily reliant on imports for essential health commodities. This dependency leads to high costs, supply chain vulnerabilities, and inconsistent availability of critical healthcare products. Strengthening local capacity and optimizing supply chain management is essential to improving the accessibility, affordability, and sustainability of healthcare products. This is key to advancing public health.

Market shaping strategies have proven successful in other health sectors by leveraging economies of scale, improving quality control, and enhancing distribution efficiency. Adopting this model for manufacturing and distributing essential health commodities could reduce costs, improve product consistency, and ensure more reliable supply chains. However, transitioning from an import-dependent system to one with a robust local production capacity and an efficient pooled procurement system is a complex process. It requires a comprehensive, multi-faceted approach that addresses manufacturing capabilities, quality assurance mechanisms, supply chain optimization, workforce capacity building, and supportive policy frameworks.

https://googleads.g.doubleclick.net/pagead/ads?gdpr=0&us_privacy=1—&gpp_sid=-1&client=ca-pub-2321249943983804&output=html&h=280&adk=3292208330&adf=3651786664&pi=t.aa~a.1381849204~i.13~rp.4&w=728&abgtt=6&fwrn=4&fwrnh=100&lmt=1745427050&num_ads=1&rafmt=1&armr=3&sem=mc&pwprc=6515900736&ad_type=text_image&format=728×280&url=https%3A%2F%2Fngojobsite.com%2Finvitation-to-bid-provision-of-technical-oversight-for-the-implementation-of-workstream-on-building-local-capacity-to-produce-quality-act-at-health-systems-consult-limited-hscl%2F&fwr=0&pra=3&rh=182&rw=727&rpe=1&resp_fmts=3&wgl=1&fa=27&uach=WyJXaW5kb3dzIiwiMTUuMC4wIiwieDg2IiwiIiwiMTM1LjAuNzA0OS44NSIsbnVsbCwwLG51bGwsIjY0IixbWyJHb29nbGUgQ2hyb21lIiwiMTM1LjAuNzA0OS44NSJdLFsiTm90LUEuQnJhbmQiLCI4LjAuMC4wIl0sWyJDaHJvbWl1bSIsIjEzNS4wLjcwNDkuODUiXV0sMF0.&dt=1745426256758&bpp=4&bdt=1842&idt=4&shv=r20250421&mjsv=m202504170101&ptt=9&saldr=aa&abxe=1&cookie=ID%3Dd402398dbe8029b3%3AT%3D1730191189%3ART%3D1745426888%3AS%3DALNI_Mbqv4ZjCA2FyHoBsYRqGiGVSR4f2A&gpic=UID%3D00000f5f5123b4f7%3AT%3D1730191189%3ART%3D1745426888%3AS%3DALNI_MaUeBuU5kMVXlTiiGykJasfdDE9vw&eo_id_str=ID%3D3685604803237a2e%3AT%3D1730191189%3ART%3D1745426888%3AS%3DAA-AfjZ2X441EOy64ZtttSEJoFR_&prev_fmts=0x0%2C750x280%2C1497x702&nras=3&correlator=8747092532096&frm=20&pv=1&u_tz=60&u_his=1&u_h=768&u_w=1366&u_ah=720&u_aw=1366&u_cd=24&u_sd=0.9&dmc=8&adx=190&ady=1181&biw=1497&bih=702&scr_x=0&scr_y=0&eid=95358862%2C95358864%2C95354562%2C95355310%2C95357877%2C95357716&oid=2&pvsid=3942448291295766&tmod=698141052&uas=0&nvt=1&fc=1408&brdim=-7%2C0%2C-7%2C0%2C1366%2C0%2C1379%2C727%2C1514%2C702&vis=1&rsz=%7C%7Cs%7C&abl=NS&cms=2&fu=128&bc=31&bz=0.91&td=1&tdf=2&psd=W251bGwsbnVsbCxudWxsLDNd&nt=1&pgls=CAEaAzYuOA..~CAA.&ifi=6&uci=a!6&btvi=1&fsb=1&dtd=M

The Presidential Initiative for Unlocking Healthcare Value Chain (PVAC) and the National Malaria Elimination Programme (NMEP), with the support of the World Bank IMPACT, embarked on a project called “Enhancing Local Manufacturing and Supply Chain Management for Health Commodities and Supplies in Nigeria”. The aim of this project is to address these challenges through a phased approach that balances short-term and long-term objectives. The strategies for addressing these challenges will include developing and laying the groundwork for local manufacturing of malaria commodities (including ACTs, RDTs, APIs and LLINs), including enhancing production capacity, ensuring compliance with international quality standards, and fostering workforce development. At the same time, the project will focus on optimizing the pooled procurement of imported malaria commodities to improve cost-effectiveness and distribution efficiency. Over the medium to long term, these interventions will strengthen the entire health commodities value chain, create opportunities for economic growth, and support Nigeria’s self-sufficiency in critical healthcare products. This comprehensive approach seeks to improve Nigeria’s healthcare supply systems’ efficiency and resilience while unlocking new economic opportunities within the country’s health sector. The project duration is 1 year.

2. Objective

This consultancy aims to provide technical oversight to all parties working under this project to enhance the local production of Artemisinin-based Combination Therapies (ACTs) in Nigeria. This involves providing technical oversight to PVAC, NMEP, local consultants, and other identified stakeholders engaged in this workstream. This workstream includes assessing manufacturing capacity, facilitating partnerships for technology transfer, ensuring compliance with regulatory standards, and supporting policy reforms to create an enabling environment for sustainable production. The consultant/consulting firm will ensure the integration of best practices for policy and implementation and draw from previous experiences in this space to strengthen the framework (both demand and supply) for the local manufacture of quality, and affordable ACTs.

3. Scope of Work

The consultant/ firm engaged to provide this oversight function is expected to:

1. Provide technical oversight and advise all parties working in the ACT workstream on matters relating to scope, quality, and outputs through participation and reviews during the planning, implementation, and close-out phases of the ACT production capacity development workstream.
2. Support the development of recommendations required for critical policy and regulatory reforms that will address gaps in the local manufacturing of ACTs by sharing best international practices in regulation, innovative financing, international market entry, etc.
3. Facilitate the engagement of stakeholders (government agencies, partners, private sector structures, technical partners, etc.)  relevant to realizing the goals of this workstream. These stakeholders must understand the Nigerian and international regulatory and ACT manufacturing landscape.
4. Provide technical support to organize policy dialogues with key stakeholders to develop the implementation framework for priority recommendations.
5. Participate in stakeholder workshops to validate findings and co-develop a strategic roadmap for expanding Nigeria’s competitiveness and regional share for malaria product (ACT) production.
6. Provide oversight to the quality of outputs for the ACT workstream, including the compilation, assessment, and final selection of potential ACT manufacturers and recommendations for support.
7. Provide technical oversight to ensure that the appropriate support is identified and provided to the selected ACT manufacturers in the following (not-exclusive) areas:
   1. Technical support and knowledge transfer directly or through partnerships
   2. Identifying funding gaps and possible funding sources 
   3. Establish a QA system to ensure compliance with international standards
8. Meet bi-weekly with the project team to review progress and collaboratively resolve any identified issues.

4. Selection Method

The selection process will follow a Limited Consultant Qualification-Based Method (LCQBM).

Under this approach, interested consultants will submit proposals in response to the Terms of Reference (TOR) issued by PVAC. As part of the evaluation, consultants/firms must demonstrate their relevant experience and qualifications in managing similar projects. Only the most qualified consultant/ firm with the required qualification/ expertise would be considered.

5. Required Expertise

The following are the expertise required from the applying consultant / firm: 

▪ Global Health Experience: Strong background in malaria epidemiological studies, prevention and control strategies, as well as global health programs, with experience in implementing large-scale public health interventions around Artemisinin-based Combination (ACT) development in LMICs with special interest in West Africa.

https://googleads.g.doubleclick.net/pagead/ads?gdpr=0&us_privacy=1—&gpp_sid=-1&client=ca-pub-2321249943983804&output=html&h=280&adk=3292208330&adf=1381599079&pi=t.aa~a.1381849204~i.37~rp.4&w=728&abgtt=6&fwrn=4&fwrnh=100&lmt=1745427051&num_ads=1&rafmt=1&armr=3&sem=mc&pwprc=6515900736&ad_type=text_image&format=728×280&url=https%3A%2F%2Fngojobsite.com%2Finvitation-to-bid-provision-of-technical-oversight-for-the-implementation-of-workstream-on-building-local-capacity-to-produce-quality-act-at-health-systems-consult-limited-hscl%2F&fwr=0&pra=3&rh=182&rw=727&rpe=1&resp_fmts=3&wgl=1&fa=27&uach=WyJXaW5kb3dzIiwiMTUuMC4wIiwieDg2IiwiIiwiMTM1LjAuNzA0OS44NSIsbnVsbCwwLG51bGwsIjY0IixbWyJHb29nbGUgQ2hyb21lIiwiMTM1LjAuNzA0OS44NSJdLFsiTm90LUEuQnJhbmQiLCI4LjAuMC4wIl0sWyJDaHJvbWl1bSIsIjEzNS4wLjcwNDkuODUiXV0sMF0.&dt=1745426256772&bpp=3&bdt=1857&idt=3&shv=r20250421&mjsv=m202504170101&ptt=9&saldr=aa&abxe=1&cookie=ID%3Dd402398dbe8029b3%3AT%3D1730191189%3ART%3D1745426888%3AS%3DALNI_Mbqv4ZjCA2FyHoBsYRqGiGVSR4f2A&gpic=UID%3D00000f5f5123b4f7%3AT%3D1730191189%3ART%3D1745426888%3AS%3DALNI_MaUeBuU5kMVXlTiiGykJasfdDE9vw&eo_id_str=ID%3D3685604803237a2e%3AT%3D1730191189%3ART%3D1745426888%3AS%3DAA-AfjZ2X441EOy64ZtttSEJoFR_&prev_fmts=0x0%2C750x280%2C1497x702%2C728x280%2C360x280%2C360x280&nras=6&correlator=8747092532096&frm=20&pv=1&u_tz=60&u_his=1&u_h=768&u_w=1366&u_ah=720&u_aw=1366&u_cd=24&u_sd=0.9&dmc=8&adx=190&ady=2783&biw=1497&bih=702&scr_x=0&scr_y=0&eid=95358862%2C95358864%2C95354562%2C95355310%2C95357877%2C95357716&oid=2&pvsid=3942448291295766&tmod=698141052&uas=0&nvt=1&fc=1408&brdim=-7%2C0%2C-7%2C0%2C1366%2C0%2C1379%2C727%2C1514%2C702&vis=1&rsz=%7C%7Cs%7C&abl=NS&fu=128&bc=31&bz=0.91&td=1&tdf=2&psd=W251bGwsbnVsbCxudWxsLDNd&nt=1&pgls=CAEaAzYuOA..~CAA.&ifi=7&uci=a!7&btvi=4&fsb=1&dtd=M

▪ Clinical Research Expertise: In-depth knowledge, experience and skills in epidemiological and molecular biological research with special interest in the development and evaluation of affordable malaria diagnostics and ACT as well as managing large clinical trials and its associated regulatory and certification requirements.

▪ Experience in ACT Development: Expertise in the research, formulation, and manufacturing processes for ACT, including clinical trial design and implementation.

▪ Stakeholders Engagement and Coordination Capabilities: Proven ability to manage multi-sectoral projects, coordinate with governments, NGOs, INGOs, donors, research institutions and private sector partners in malaria prevention and control.

• Innovative Financing:Excellent background in innovative financing for healthcare service delivery and development especially in the management of malaria in Africa.
• Regulatory Knowledge:  Have a wide experience working with national and international regulations for ACT production approval, Good Clinical Practices (GCP) and Good Manufacturing Practices (GMP). 
• Capacity Building: Experience in training and mentoring teams in clinical research and ACT development processes.
• International Context Knowledge: Understanding of international health systems and regulatory landscapes. Familiar with the operational challenges in Africa, especially regarding healthcare needs and distribution challenges. Able to influence the local ACT manufacturing landscape along the lines of international best practices.

6. Expected Outcomes

The oversight function of this workstream is expected to support the quality of deliverables from all parties working under this workstream. These include: 

1. Evidence-based ACT-specific policy recommendations and reforms validated by stakeholders. 
2. Detailed reports of site visits and assessments.
3. A list of selected 1^st batch ACT manufacturers (at least 3) and a pipeline of recommended 2^nd batch ACT manufacturers (at least 5) for technical assistance. 
4. Detailed map of potential funding opportunities.
5. Technical assistance reports.

7. Duration of the Assignment

This assignment is expected to run for 8 months – May to December 2025

8. Submission Requirements

Interested organizations are expected to submit the following documents:

1. Technical Proposal: The technical proposal should include:

▪ A clear methodology that demonstrates expertise in managing this project.

▪ A track record and experience in implementing similar projects

▪ At least 3 references from similar projects 

• Compliance Documents: Consultant must have the permit to work in Nigeria as Nigeria’s Ministry of Interior requires. While for firms, the following documents are also required:

▪ A valid organizational registration document

▪ Up-to-date tax clearance certificates 

• Financial Proposal 

All required documents should be sent to [email protected] on or before May 2^nd, 2025. Proposals sent after this date will not be considered.Request for Consultants: Provision of Technical Oversight for the Implementation of Workstream on Building Local Capacity to Produce Quality ACT: 

Enhancing Local Manufacturing and Supply Chain Management for Health

Commodities and Supplies in Nigeria

1. Background

Nigeria faces a significant burden from both communicable and non-communicable diseases, which strains the healthcare system and hinders economic development. Despite ongoing efforts to address these challenges, the country remains heavily reliant on imports for essential health commodities. This dependency leads to high costs, supply chain vulnerabilities, and inconsistent availability of critical healthcare products. Strengthening local capacity and optimizing supply chain management is essential to improving the accessibility, affordability, and sustainability of healthcare products. This is key to advancing public health.

Market shaping strategies have proven successful in other health sectors by leveraging economies of scale, improving quality control, and enhancing distribution efficiency. Adopting this model for manufacturing and distributing essential health commodities could reduce costs, improve product consistency, and ensure more reliable supply chains. However, transitioning from an import-dependent system to one with a robust local production capacity and an efficient pooled procurement system is a complex process. It requires a comprehensive, multi-faceted approach that addresses manufacturing capabilities, quality assurance mechanisms, supply chain optimization, workforce capacity building, and supportive policy frameworks.

The Presidential Initiative for Unlocking Healthcare Value Chain (PVAC) and the National Malaria Elimination Programme (NMEP), with the support of the World Bank IMPACT, embarked on a project called “Enhancing Local Manufacturing and Supply Chain Management for Health Commodities and Supplies in Nigeria”. The aim of this project is to address these challenges through a phased approach that balances short-term and long-term objectives. The strategies for addressing these challenges will include developing and laying the groundwork for local manufacturing of malaria commodities (including ACTs, RDTs, APIs and LLINs), including enhancing production capacity, ensuring compliance with international quality standards, and fostering workforce development. At the same time, the project will focus on optimizing the pooled procurement of imported malaria commodities to improve cost-effectiveness and distribution efficiency. Over the medium to long term, these interventions will strengthen the entire health commodities value chain, create opportunities for economic growth, and support Nigeria’s self-sufficiency in critical healthcare products. This comprehensive approach seeks to improve Nigeria’s healthcare supply systems’ efficiency and resilience while unlocking new economic opportunities within the country’s health sector. The project duration is 1 year.

2. Objective

This consultancy aims to provide technical oversight to all parties working under this project to enhance the local production of Artemisinin-based Combination Therapies (ACTs) in Nigeria. This involves providing technical oversight to PVAC, NMEP, local consultants, and other identified stakeholders engaged in this workstream. This workstream includes assessing manufacturing capacity, facilitating partnerships for technology transfer, ensuring compliance with regulatory standards, and supporting policy reforms to create an enabling environment for sustainable production. The consultant/consulting firm will ensure the integration of best practices for policy and implementation and draw from previous experiences in this space to strengthen the framework (both demand and supply) for the local manufacture of quality, and affordable ACTs.

3. Scope of Work

The consultant/ firm engaged to provide this oversight function is expected to:

1. Provide technical oversight and advise all parties working in the ACT workstream on matters relating to scope, quality, and outputs through participation and reviews during the planning, implementation, and close-out phases of the ACT production capacity development workstream.
2. Support the development of recommendations required for critical policy and regulatory reforms that will address gaps in the local manufacturing of ACTs by sharing best international practices in regulation, innovative financing, international market entry, etc.
3. Facilitate the engagement of stakeholders (government agencies, partners, private sector structures, technical partners, etc.)  relevant to realizing the goals of this workstream. These stakeholders must understand the Nigerian and international regulatory and ACT manufacturing landscape.
4. Provide technical support to organize policy dialogues with key stakeholders to develop the implementation framework for priority recommendations.
5. Participate in stakeholder workshops to validate findings and co-develop a strategic roadmap for expanding Nigeria’s competitiveness and regional share for malaria product (ACT) production.
6. Provide oversight to the quality of outputs for the ACT workstream, including the compilation, assessment, and final selection of potential ACT manufacturers and recommendations for support.
7. Provide technical oversight to ensure that the appropriate support is identified and provided to the selected ACT manufacturers in the following (not-exclusive) areas:
   1. Technical support and knowledge transfer directly or through partnerships
   2. Identifying funding gaps and possible funding sources 
   3. Establish a QA system to ensure compliance with international standards
8. Meet bi-weekly with the project team to review progress and collaboratively resolve any identified issues.

4. Selection Method

The selection process will follow a Limited Consultant Qualification-Based Method (LCQBM).

Under this approach, interested consultants will submit proposals in response to the Terms of Reference (TOR) issued by PVAC. As part of the evaluation, consultants/firms must demonstrate their relevant experience and qualifications in managing similar projects. Only the most qualified consultant/ firm with the required qualification/ expertise would be considered.

5. Required Expertise

The following are the expertise required from the applying consultant / firm: 

▪ Global Health Experience: Strong background in malaria epidemiological studies, prevention and control strategies, as well as global health programs, with experience in implementing large-scale public health interventions around Artemisinin-based Combination (ACT) development in LMICs with special interest in West Africa.

https://googleads.g.doubleclick.net/pagead/ads?gdpr=0&us_privacy=1—&gpp_sid=-1&client=ca-pub-2321249943983804&output=html&h=280&adk=3292208330&adf=1381599079&pi=t.aa~a.1381849204~i.37~rp.4&w=728&abgtt=6&fwrn=4&fwrnh=100&lmt=1745427051&num_ads=1&rafmt=1&armr=3&sem=mc&pwprc=6515900736&ad_type=text_image&format=728×280&url=https%3A%2F%2Fngojobsite.com%2Finvitation-to-bid-provision-of-technical-oversight-for-the-implementation-of-workstream-on-building-local-capacity-to-produce-quality-act-at-health-systems-consult-limited-hscl%2F&fwr=0&pra=3&rh=182&rw=727&rpe=1&resp_fmts=3&wgl=1&fa=27&uach=WyJXaW5kb3dzIiwiMTUuMC4wIiwieDg2IiwiIiwiMTM1LjAuNzA0OS44NSIsbnVsbCwwLG51bGwsIjY0IixbWyJHb29nbGUgQ2hyb21lIiwiMTM1LjAuNzA0OS44NSJdLFsiTm90LUEuQnJhbmQiLCI4LjAuMC4wIl0sWyJDaHJvbWl1bSIsIjEzNS4wLjcwNDkuODUiXV0sMF0.&dt=1745426256772&bpp=3&bdt=1857&idt=3&shv=r20250421&mjsv=m202504170101&ptt=9&saldr=aa&abxe=1&cookie=ID%3Dd402398dbe8029b3%3AT%3D1730191189%3ART%3D1745426888%3AS%3DALNI_Mbqv4ZjCA2FyHoBsYRqGiGVSR4f2A&gpic=UID%3D00000f5f5123b4f7%3AT%3D1730191189%3ART%3D1745426888%3AS%3DALNI_MaUeBuU5kMVXlTiiGykJasfdDE9vw&eo_id_str=ID%3D3685604803237a2e%3AT%3D1730191189%3ART%3D1745426888%3AS%3DAA-AfjZ2X441EOy64ZtttSEJoFR_&prev_fmts=0x0%2C750x280%2C1497x702%2C728x280%2C360x280%2C360x280&nras=6&correlator=8747092532096&frm=20&pv=1&u_tz=60&u_his=1&u_h=768&u_w=1366&u_ah=720&u_aw=1366&u_cd=24&u_sd=0.9&dmc=8&adx=190&ady=2783&biw=1497&bih=702&scr_x=0&scr_y=0&eid=95358862%2C95358864%2C95354562%2C95355310%2C95357877%2C95357716&oid=2&pvsid=3942448291295766&tmod=698141052&uas=0&nvt=1&fc=1408&brdim=-7%2C0%2C-7%2C0%2C1366%2C0%2C1379%2C727%2C1514%2C702&vis=1&rsz=%7C%7Cs%7C&abl=NS&fu=128&bc=31&bz=0.91&td=1&tdf=2&psd=W251bGwsbnVsbCxudWxsLDNd&nt=1&pgls=CAEaAzYuOA..~CAA.&ifi=7&uci=a!7&btvi=4&fsb=1&dtd=M

▪ Clinical Research Expertise: In-depth knowledge, experience and skills in epidemiological and molecular biological research with special interest in the development and evaluation of affordable malaria diagnostics and ACT as well as managing large clinical trials and its associated regulatory and certification requirements.

▪ Experience in ACT Development: Expertise in the research, formulation, and manufacturing processes for ACT, including clinical trial design and implementation.

▪ Stakeholders Engagement and Coordination Capabilities: Proven ability to manage multi-sectoral projects, coordinate with governments, NGOs, INGOs, donors, research institutions and private sector partners in malaria prevention and control.

• Innovative Financing:Excellent background in innovative financing for healthcare service delivery and development especially in the management of malaria in Africa.
• Regulatory Knowledge:  Have a wide experience working with national and international regulations for ACT production approval, Good Clinical Practices (GCP) and Good Manufacturing Practices (GMP). 
• Capacity Building: Experience in training and mentoring teams in clinical research and ACT development processes.
• International Context Knowledge: Understanding of international health systems and regulatory landscapes. Familiar with the operational challenges in Africa, especially regarding healthcare needs and distribution challenges. Able to influence the local ACT manufacturing landscape along the lines of international best practices.

6. Expected Outcomes

The oversight function of this workstream is expected to support the quality of deliverables from all parties working under this workstream. These include: 

1. Evidence-based ACT-specific policy recommendations and reforms validated by stakeholders. 
2. Detailed reports of site visits and assessments.
3. A list of selected 1^st batch ACT manufacturers (at least 3) and a pipeline of recommended 2^nd batch ACT manufacturers (at least 5) for technical assistance. 
4. Detailed map of potential funding opportunities.
5. Technical assistance reports.

7. Duration of the Assignment

This assignment is expected to run for 8 months – May to December 2025

8. Submission Requirements

Interested organizations are expected to submit the following documents:

1. Technical Proposal: The technical proposal should include:

▪ A clear methodology that demonstrates expertise in managing this project.

▪ A track record and experience in implementing similar projects

▪ At least 3 references from similar projects 

• Compliance Documents: Consultant must have the permit to work in Nigeria as Nigeria’s Ministry of Interior requires. While for firms, the following documents are also required:

▪ A valid organizational registration document

▪ Up-to-date tax clearance certificates 

• Financial Proposal 

All required documents should be sent to [email protected] on or before May 2^nd, 2025. Proposals sent after this date will not be considered.Request for Consultants: Provision of Technical Oversight for the Implementation of Workstream on Building Local Capacity to Produce Quality ACT: 

Enhancing Local Manufacturing and Supply Chain Management for Health

Commodities and Supplies in Nigeria

1. Background

Nigeria faces a significant burden from both communicable and non-communicable diseases, which strains the healthcare system and hinders economic development. Despite ongoing efforts to address these challenges, the country remains heavily reliant on imports for essential health commodities. This dependency leads to high costs, supply chain vulnerabilities, and inconsistent availability of critical healthcare products. Strengthening local capacity and optimizing supply chain management is essential to improving the accessibility, affordability, and sustainability of healthcare products. This is key to advancing public health.

Market shaping strategies have proven successful in other health sectors by leveraging economies of scale, improving quality control, and enhancing distribution efficiency. Adopting this model for manufacturing and distributing essential health commodities could reduce costs, improve product consistency, and ensure more reliable supply chains. However, transitioning from an import-dependent system to one with a robust local production capacity and an efficient pooled procurement system is a complex process. It requires a comprehensive, multi-faceted approach that addresses manufacturing capabilities, quality assurance mechanisms, supply chain optimization, workforce capacity building, and supportive policy frameworks.

https://googleads.g.doubleclick.net/pagead/ads?gdpr=0&us_privacy=1—&gpp_sid=-1&client=ca-pub-2321249943983804&output=html&h=280&adk=3292208330&adf=3651786664&pi=t.aa~a.1381849204~i.13~rp.4&w=728&abgtt=6&fwrn=4&fwrnh=100&lmt=1745427050&num_ads=1&rafmt=1&armr=3&sem=mc&pwprc=6515900736&ad_type=text_image&format=728×280&url=https%3A%2F%2Fngojobsite.com%2Finvitation-to-bid-provision-of-technical-oversight-for-the-implementation-of-workstream-on-building-local-capacity-to-produce-quality-act-at-health-systems-consult-limited-hscl%2F&fwr=0&pra=3&rh=182&rw=727&rpe=1&resp_fmts=3&wgl=1&fa=27&uach=WyJXaW5kb3dzIiwiMTUuMC4wIiwieDg2IiwiIiwiMTM1LjAuNzA0OS44NSIsbnVsbCwwLG51bGwsIjY0IixbWyJHb29nbGUgQ2hyb21lIiwiMTM1LjAuNzA0OS44NSJdLFsiTm90LUEuQnJhbmQiLCI4LjAuMC4wIl0sWyJDaHJvbWl1bSIsIjEzNS4wLjcwNDkuODUiXV0sMF0.&dt=1745426256758&bpp=4&bdt=1842&idt=4&shv=r20250421&mjsv=m202504170101&ptt=9&saldr=aa&abxe=1&cookie=ID%3Dd402398dbe8029b3%3AT%3D1730191189%3ART%3D1745426888%3AS%3DALNI_Mbqv4ZjCA2FyHoBsYRqGiGVSR4f2A&gpic=UID%3D00000f5f5123b4f7%3AT%3D1730191189%3ART%3D1745426888%3AS%3DALNI_MaUeBuU5kMVXlTiiGykJasfdDE9vw&eo_id_str=ID%3D3685604803237a2e%3AT%3D1730191189%3ART%3D1745426888%3AS%3DAA-AfjZ2X441EOy64ZtttSEJoFR_&prev_fmts=0x0%2C750x280%2C1497x702&nras=3&correlator=8747092532096&frm=20&pv=1&u_tz=60&u_his=1&u_h=768&u_w=1366&u_ah=720&u_aw=1366&u_cd=24&u_sd=0.9&dmc=8&adx=190&ady=1181&biw=1497&bih=702&scr_x=0&scr_y=0&eid=95358862%2C95358864%2C95354562%2C95355310%2C95357877%2C95357716&oid=2&pvsid=3942448291295766&tmod=698141052&uas=0&nvt=1&fc=1408&brdim=-7%2C0%2C-7%2C0%2C1366%2C0%2C1379%2C727%2C1514%2C702&vis=1&rsz=%7C%7Cs%7C&abl=NS&cms=2&fu=128&bc=31&bz=0.91&td=1&tdf=2&psd=W251bGwsbnVsbCxudWxsLDNd&nt=1&pgls=CAEaAzYuOA..~CAA.&ifi=6&uci=a!6&btvi=1&fsb=1&dtd=M

The Presidential Initiative for Unlocking Healthcare Value Chain (PVAC) and the National Malaria Elimination Programme (NMEP), with the support of the World Bank IMPACT, embarked on a project called “Enhancing Local Manufacturing and Supply Chain Management for Health Commodities and Supplies in Nigeria”. The aim of this project is to address these challenges through a phased approach that balances short-term and long-term objectives. The strategies for addressing these challenges will include developing and laying the groundwork for local manufacturing of malaria commodities (including ACTs, RDTs, APIs and LLINs), including enhancing production capacity, ensuring compliance with international quality standards, and fostering workforce development. At the same time, the project will focus on optimizing the pooled procurement of imported malaria commodities to improve cost-effectiveness and distribution efficiency. Over the medium to long term, these interventions will strengthen the entire health commodities value chain, create opportunities for economic growth, and support Nigeria’s self-sufficiency in critical healthcare products. This comprehensive approach seeks to improve Nigeria’s healthcare supply systems’ efficiency and resilience while unlocking new economic opportunities within the country’s health sector. The project duration is 1 year.

2. Objective

This consultancy aims to provide technical oversight to all parties working under this project to enhance the local production of Artemisinin-based Combination Therapies (ACTs) in Nigeria. This involves providing technical oversight to PVAC, NMEP, local consultants, and other identified stakeholders engaged in this workstream. This workstream includes assessing manufacturing capacity, facilitating partnerships for technology transfer, ensuring compliance with regulatory standards, and supporting policy reforms to create an enabling environment for sustainable production. The consultant/consulting firm will ensure the integration of best practices for policy and implementation and draw from previous experiences in this space to strengthen the framework (both demand and supply) for the local manufacture of quality, and affordable ACTs.

3. Scope of Work

The consultant/ firm engaged to provide this oversight function is expected to:

1. Provide technical oversight and advise all parties working in the ACT workstream on matters relating to scope, quality, and outputs through participation and reviews during the planning, implementation, and close-out phases of the ACT production capacity development workstream.
2. Support the development of recommendations required for critical policy and regulatory reforms that will address gaps in the local manufacturing of ACTs by sharing best international practices in regulation, innovative financing, international market entry, etc.
3. Facilitate the engagement of stakeholders (government agencies, partners, private sector structures, technical partners, etc.)  relevant to realizing the goals of this workstream. These stakeholders must understand the Nigerian and international regulatory and ACT manufacturing landscape.
4. Provide technical support to organize policy dialogues with key stakeholders to develop the implementation framework for priority recommendations.
5. Participate in stakeholder workshops to validate findings and co-develop a strategic roadmap for expanding Nigeria’s competitiveness and regional share for malaria product (ACT) production.
6. Provide oversight to the quality of outputs for the ACT workstream, including the compilation, assessment, and final selection of potential ACT manufacturers and recommendations for support.
7. Provide technical oversight to ensure that the appropriate support is identified and provided to the selected ACT manufacturers in the following (not-exclusive) areas:
   1. Technical support and knowledge transfer directly or through partnerships
   2. Identifying funding gaps and possible funding sources 
   3. Establish a QA system to ensure compliance with international standards
8. Meet bi-weekly with the project team to review progress and collaboratively resolve any identified issues.

4. Selection Method

The selection process will follow a Limited Consultant Qualification-Based Method (LCQBM).

Under this approach, interested consultants will submit proposals in response to the Terms of Reference (TOR) issued by PVAC. As part of the evaluation, consultants/firms must demonstrate their relevant experience and qualifications in managing similar projects. Only the most qualified consultant/ firm with the required qualification/ expertise would be considered.

5. Required Expertise

The following are the expertise required from the applying consultant / firm: 

▪ Global Health Experience: Strong background in malaria epidemiological studies, prevention and control strategies, as well as global health programs, with experience in implementing large-scale public health interventions around Artemisinin-based Combination (ACT) development in LMICs with special interest in West Africa.

https://googleads.g.doubleclick.net/pagead/ads?gdpr=0&us_privacy=1—&gpp_sid=-1&client=ca-pub-2321249943983804&output=html&h=280&adk=3292208330&adf=1381599079&pi=t.aa~a.1381849204~i.37~rp.4&w=728&abgtt=6&fwrn=4&fwrnh=100&lmt=1745427051&num_ads=1&rafmt=1&armr=3&sem=mc&pwprc=6515900736&ad_type=text_image&format=728×280&url=https%3A%2F%2Fngojobsite.com%2Finvitation-to-bid-provision-of-technical-oversight-for-the-implementation-of-workstream-on-building-local-capacity-to-produce-quality-act-at-health-systems-consult-limited-hscl%2F&fwr=0&pra=3&rh=182&rw=727&rpe=1&resp_fmts=3&wgl=1&fa=27&uach=WyJXaW5kb3dzIiwiMTUuMC4wIiwieDg2IiwiIiwiMTM1LjAuNzA0OS44NSIsbnVsbCwwLG51bGwsIjY0IixbWyJHb29nbGUgQ2hyb21lIiwiMTM1LjAuNzA0OS44NSJdLFsiTm90LUEuQnJhbmQiLCI4LjAuMC4wIl0sWyJDaHJvbWl1bSIsIjEzNS4wLjcwNDkuODUiXV0sMF0.&dt=1745426256772&bpp=3&bdt=1857&idt=3&shv=r20250421&mjsv=m202504170101&ptt=9&saldr=aa&abxe=1&cookie=ID%3Dd402398dbe8029b3%3AT%3D1730191189%3ART%3D1745426888%3AS%3DALNI_Mbqv4ZjCA2FyHoBsYRqGiGVSR4f2A&gpic=UID%3D00000f5f5123b4f7%3AT%3D1730191189%3ART%3D1745426888%3AS%3DALNI_MaUeBuU5kMVXlTiiGykJasfdDE9vw&eo_id_str=ID%3D3685604803237a2e%3AT%3D1730191189%3ART%3D1745426888%3AS%3DAA-AfjZ2X441EOy64ZtttSEJoFR_&prev_fmts=0x0%2C750x280%2C1497x702%2C728x280%2C360x280%2C360x280&nras=6&correlator=8747092532096&frm=20&pv=1&u_tz=60&u_his=1&u_h=768&u_w=1366&u_ah=720&u_aw=1366&u_cd=24&u_sd=0.9&dmc=8&adx=190&ady=2783&biw=1497&bih=702&scr_x=0&scr_y=0&eid=95358862%2C95358864%2C95354562%2C95355310%2C95357877%2C95357716&oid=2&pvsid=3942448291295766&tmod=698141052&uas=0&nvt=1&fc=1408&brdim=-7%2C0%2C-7%2C0%2C1366%2C0%2C1379%2C727%2C1514%2C702&vis=1&rsz=%7C%7Cs%7C&abl=NS&fu=128&bc=31&bz=0.91&td=1&tdf=2&psd=W251bGwsbnVsbCxudWxsLDNd&nt=1&pgls=CAEaAzYuOA..~CAA.&ifi=7&uci=a!7&btvi=4&fsb=1&dtd=M

▪ Clinical Research Expertise: In-depth knowledge, experience and skills in epidemiological and molecular biological research with special interest in the development and evaluation of affordable malaria diagnostics and ACT as well as managing large clinical trials and its associated regulatory and certification requirements.

▪ Experience in ACT Development: Expertise in the research, formulation, and manufacturing processes for ACT, including clinical trial design and implementation.

▪ Stakeholders Engagement and Coordination Capabilities: Proven ability to manage multi-sectoral projects, coordinate with governments, NGOs, INGOs, donors, research institutions and private sector partners in malaria prevention and control.

• Innovative Financing:Excellent background in innovative financing for healthcare service delivery and development especially in the management of malaria in Africa.
• Regulatory Knowledge:  Have a wide experience working with national and international regulations for ACT production approval, Good Clinical Practices (GCP) and Good Manufacturing Practices (GMP). 
• Capacity Building: Experience in training and mentoring teams in clinical research and ACT development processes.
• International Context Knowledge: Understanding of international health systems and regulatory landscapes. Familiar with the operational challenges in Africa, especially regarding healthcare needs and distribution challenges. Able to influence the local ACT manufacturing landscape along the lines of international best practices.

6. Expected Outcomes

The oversight function of this workstream is expected to support the quality of deliverables from all parties working under this workstream. These include: 

1. Evidence-based ACT-specific policy recommendations and reforms validated by stakeholders. 
2. Detailed reports of site visits and assessments.
3. A list of selected 1^st batch ACT manufacturers (at least 3) and a pipeline of recommended 2^nd batch ACT manufacturers (at least 5) for technical assistance. 
4. Detailed map of potential funding opportunities.
5. Technical assistance reports.

7. Duration of the Assignment

This assignment is expected to run for 8 months – May to December 2025

8. Submission Requirements

Interested organizations are expected to submit the following documents:

1. Technical Proposal: The technical proposal should include:

▪ A clear methodology that demonstrates expertise in managing this project.

▪ A track record and experience in implementing similar projects

▪ At least 3 references from similar projects 

• Compliance Documents: Consultant must have the permit to work in Nigeria as Nigeria’s Ministry of Interior requires. While for firms, the following documents are also required:

▪ A valid organizational registration document

▪ Up-to-date tax clearance certificates 

• Financial Proposal 

All required documents should be sent to [email protected] on or before May 2^nd, 2025. Proposals sent after this date will not be considered.Request for Consultants: Provision of Technical Oversight for the Implementation of Workstream on Building Local Capacity to Produce Quality ACT: 

Enhancing Local Manufacturing and Supply Chain Management for Health

Commodities and Supplies in Nigeria

1. Background

Nigeria faces a significant burden from both communicable and non-communicable diseases, which strains the healthcare system and hinders economic development. Despite ongoing efforts to address these challenges, the country remains heavily reliant on imports for essential health commodities. This dependency leads to high costs, supply chain vulnerabilities, and inconsistent availability of critical healthcare products. Strengthening local capacity and optimizing supply chain management is essential to improving the accessibility, affordability, and sustainability of healthcare products. This is key to advancing public health.

Market shaping strategies have proven successful in other health sectors by leveraging economies of scale, improving quality control, and enhancing distribution efficiency. Adopting this model for manufacturing and distributing essential health commodities could reduce costs, improve product consistency, and ensure more reliable supply chains. However, transitioning from an import-dependent system to one with a robust local production capacity and an efficient pooled procurement system is a complex process. It requires a comprehensive, multi-faceted approach that addresses manufacturing capabilities, quality assurance mechanisms, supply chain optimization, workforce capacity building, and supportive policy frameworks.

https://googleads.g.doubleclick.net/pagead/ads?gdpr=0&us_privacy=1—&gpp_sid=-1&client=ca-pub-2321249943983804&output=html&h=280&adk=3292208330&adf=3651786664&pi=t.aa~a.1381849204~i.13~rp.4&w=728&abgtt=6&fwrn=4&fwrnh=100&lmt=1745427050&num_ads=1&rafmt=1&armr=3&sem=mc&pwprc=6515900736&ad_type=text_image&format=728×280&url=https%3A%2F%2Fngojobsite.com%2Finvitation-to-bid-provision-of-technical-oversight-for-the-implementation-of-workstream-on-building-local-capacity-to-produce-quality-act-at-health-systems-consult-limited-hscl%2F&fwr=0&pra=3&rh=182&rw=727&rpe=1&resp_fmts=3&wgl=1&fa=27&uach=WyJXaW5kb3dzIiwiMTUuMC4wIiwieDg2IiwiIiwiMTM1LjAuNzA0OS44NSIsbnVsbCwwLG51bGwsIjY0IixbWyJHb29nbGUgQ2hyb21lIiwiMTM1LjAuNzA0OS44NSJdLFsiTm90LUEuQnJhbmQiLCI4LjAuMC4wIl0sWyJDaHJvbWl1bSIsIjEzNS4wLjcwNDkuODUiXV0sMF0.&dt=1745426256758&bpp=4&bdt=1842&idt=4&shv=r20250421&mjsv=m202504170101&ptt=9&saldr=aa&abxe=1&cookie=ID%3Dd402398dbe8029b3%3AT%3D1730191189%3ART%3D1745426888%3AS%3DALNI_Mbqv4ZjCA2FyHoBsYRqGiGVSR4f2A&gpic=UID%3D00000f5f5123b4f7%3AT%3D1730191189%3ART%3D1745426888%3AS%3DALNI_MaUeBuU5kMVXlTiiGykJasfdDE9vw&eo_id_str=ID%3D3685604803237a2e%3AT%3D1730191189%3ART%3D1745426888%3AS%3DAA-AfjZ2X441EOy64ZtttSEJoFR_&prev_fmts=0x0%2C750x280%2C1497x702&nras=3&correlator=8747092532096&frm=20&pv=1&u_tz=60&u_his=1&u_h=768&u_w=1366&u_ah=720&u_aw=1366&u_cd=24&u_sd=0.9&dmc=8&adx=190&ady=1181&biw=1497&bih=702&scr_x=0&scr_y=0&eid=95358862%2C95358864%2C95354562%2C95355310%2C95357877%2C95357716&oid=2&pvsid=3942448291295766&tmod=698141052&uas=0&nvt=1&fc=1408&brdim=-7%2C0%2C-7%2C0%2C1366%2C0%2C1379%2C727%2C1514%2C702&vis=1&rsz=%7C%7Cs%7C&abl=NS&cms=2&fu=128&bc=31&bz=0.91&td=1&tdf=2&psd=W251bGwsbnVsbCxudWxsLDNd&nt=1&pgls=CAEaAzYuOA..~CAA.&ifi=6&uci=a!6&btvi=1&fsb=1&dtd=M

The Presidential Initiative for Unlocking Healthcare Value Chain (PVAC) and the National Malaria Elimination Programme (NMEP), with the support of the World Bank IMPACT, embarked on a project called “Enhancing Local Manufacturing and Supply Chain Management for Health Commodities and Supplies in Nigeria”. The aim of this project is to address these challenges through a phased approach that balances short-term and long-term objectives. The strategies for addressing these challenges will include developing and laying the groundwork for local manufacturing of malaria commodities (including ACTs, RDTs, APIs and LLINs), including enhancing production capacity, ensuring compliance with international quality standards, and fostering workforce development. At the same time, the project will focus on optimizing the pooled procurement of imported malaria commodities to improve cost-effectiveness and distribution efficiency. Over the medium to long term, these interventions will strengthen the entire health commodities value chain, create opportunities for economic growth, and support Nigeria’s self-sufficiency in critical healthcare products. This comprehensive approach seeks to improve Nigeria’s healthcare supply systems’ efficiency and resilience while unlocking new economic opportunities within the country’s health sector. The project duration is 1 year.

2. Objective

This consultancy aims to provide technical oversight to all parties working under this project to enhance the local production of Artemisinin-based Combination Therapies (ACTs) in Nigeria. This involves providing technical oversight to PVAC, NMEP, local consultants, and other identified stakeholders engaged in this workstream. This workstream includes assessing manufacturing capacity, facilitating partnerships for technology transfer, ensuring compliance with regulatory standards, and supporting policy reforms to create an enabling environment for sustainable production. The consultant/consulting firm will ensure the integration of best practices for policy and implementation and draw from previous experiences in this space to strengthen the framework (both demand and supply) for the local manufacture of quality, and affordable ACTs.

3. Scope of Work

The consultant/ firm engaged to provide this oversight function is expected to:

1. Provide technical oversight and advise all parties working in the ACT workstream on matters relating to scope, quality, and outputs through participation and reviews during the planning, implementation, and close-out phases of the ACT production capacity development workstream.
2. Support the development of recommendations required for critical policy and regulatory reforms that will address gaps in the local manufacturing of ACTs by sharing best international practices in regulation, innovative financing, international market entry, etc.
3. Facilitate the engagement of stakeholders (government agencies, partners, private sector structures, technical partners, etc.)  relevant to realizing the goals of this workstream. These stakeholders must understand the Nigerian and international regulatory and ACT manufacturing landscape.
4. Provide technical support to organize policy dialogues with key stakeholders to develop the implementation framework for priority recommendations.
5. Participate in stakeholder workshops to validate findings and co-develop a strategic roadmap for expanding Nigeria’s competitiveness and regional share for malaria product (ACT) production.
6. Provide oversight to the quality of outputs for the ACT workstream, including the compilation, assessment, and final selection of potential ACT manufacturers and recommendations for support.
7. Provide technical oversight to ensure that the appropriate support is identified and provided to the selected ACT manufacturers in the following (not-exclusive) areas:
   1. Technical support and knowledge transfer directly or through partnerships
   2. Identifying funding gaps and possible funding sources 
   3. Establish a QA system to ensure compliance with international standards
8. Meet bi-weekly with the project team to review progress and collaboratively resolve any identified issues.

4. Selection Method

The selection process will follow a Limited Consultant Qualification-Based Method (LCQBM).

Under this approach, interested consultants will submit proposals in response to the Terms of Reference (TOR) issued by PVAC. As part of the evaluation, consultants/firms must demonstrate their relevant experience and qualifications in managing similar projects. Only the most qualified consultant/ firm with the required qualification/ expertise would be considered.

5. Required Expertise

The following are the expertise required from the applying consultant / firm: 

▪ Global Health Experience: Strong background in malaria epidemiological studies, prevention and control strategies, as well as global health programs, with experience in implementing large-scale public health interventions around Artemisinin-based Combination (ACT) development in LMICs with special interest in West Africa.

▪ Clinical Research Expertise: In-depth knowledge, experience and skills in epidemiological and molecular biological research with special interest in the development and evaluation of affordable malaria diagnostics and ACT as well as managing large clinical trials and its associated regulatory and certification requirements.

▪ Experience in ACT Development: Expertise in the research, formulation, and manufacturing processes for ACT, including clinical trial design and implementation.

▪ Stakeholders Engagement and Coordination Capabilities: Proven ability to manage multi-sectoral projects, coordinate with governments, NGOs, INGOs, donors, research institutions and private sector partners in malaria prevention and control.

• Innovative Financing:Excellent background in innovative financing for healthcare service delivery and development especially in the management of malaria in Africa.
• Regulatory Knowledge:  Have a wide experience working with national and international regulations for ACT production approval, Good Clinical Practices (GCP) and Good Manufacturing Practices (GMP). 
• Capacity Building: Experience in training and mentoring teams in clinical research and ACT development processes.
• International Context Knowledge: Understanding of international health systems and regulatory landscapes. Familiar with the operational challenges in Africa, especially regarding healthcare needs and distribution challenges. Able to influence the local ACT manufacturing landscape along the lines of international best practices.

6. Expected Outcomes

The oversight function of this workstream is expected to support the quality of deliverables from all parties working under this workstream. These include: 

1. Evidence-based ACT-specific policy recommendations and reforms validated by stakeholders. 
2. Detailed reports of site visits and assessments.
3. A list of selected 1^st batch ACT manufacturers (at least 3) and a pipeline of recommended 2^nd batch ACT manufacturers (at least 5) for technical assistance. 
4. Detailed map of potential funding opportunities.
5. Technical assistance reports.

7. Duration of the Assignment

This assignment is expected to run for 8 months – May to December 2025

8. Submission Requirements

Interested organizations are expected to submit the following documents:

1. Technical Proposal: The technical proposal should include:

▪ A clear methodology that demonstrates expertise in managing this project.

▪ A track record and experience in implementing similar projects

▪ At least 3 references from similar projects 

• Compliance Documents: Consultant must have the permit to work in Nigeria as Nigeria’s Ministry of Interior requires. While for firms, the following documents are also required:

▪ A valid organizational registration document

▪ Up-to-date tax clearance certificates 

• Financial Proposal 

All required documents should be sent to [email protected] on or before May 2^nd, 2025. Proposals sent after this date will not be considered.Request for Consultants: Provision of Technical Oversight for the Implementation of Workstream on Building Local Capacity to Produce Quality ACT: 

Enhancing Local Manufacturing and Supply Chain Management for Health

Commodities and Supplies in Nigeria

1. Background

Nigeria faces a significant burden from both communicable and non-communicable diseases, which strains the healthcare system and hinders economic development. Despite ongoing efforts to address these challenges, the country remains heavily reliant on imports for essential health commodities. This dependency leads to high costs, supply chain vulnerabilities, and inconsistent availability of critical healthcare products. Strengthening local capacity and optimizing supply chain management is essential to improving the accessibility, affordability, and sustainability of healthcare products. This is key to advancing public health.

Market shaping strategies have proven successful in other health sectors by leveraging economies of scale, improving quality control, and enhancing distribution efficiency. Adopting this model for manufacturing and distributing essential health commodities could reduce costs, improve product consistency, and ensure more reliable supply chains. However, transitioning from an import-dependent system to one with a robust local production capacity and an efficient pooled procurement system is a complex process. It requires a comprehensive, multi-faceted approach that addresses manufacturing capabilities, quality assurance mechanisms, supply chain optimization, workforce capacity building, and supportive policy frameworks.

The Presidential Initiative for Unlocking Healthcare Value Chain (PVAC) and the National Malaria Elimination Programme (NMEP), with the support of the World Bank IMPACT, embarked on a project called “Enhancing Local Manufacturing and Supply Chain Management for Health Commodities and Supplies in Nigeria”. The aim of this project is to address these challenges through a phased approach that balances short-term and long-term objectives. The strategies for addressing these challenges will include developing and laying the groundwork for local manufacturing of malaria commodities (including ACTs, RDTs, APIs and LLINs), including enhancing production capacity, ensuring compliance with international quality standards, and fostering workforce development. At the same time, the project will focus on optimizing the pooled procurement of imported malaria commodities to improve cost-effectiveness and distribution efficiency. Over the medium to long term, these interventions will strengthen the entire health commodities value chain, create opportunities for economic growth, and support Nigeria’s self-sufficiency in critical healthcare products. This comprehensive approach seeks to improve Nigeria’s healthcare supply systems’ efficiency and resilience while unlocking new economic opportunities within the country’s health sector. The project duration is 1 year.

2. Objective

This consultancy aims to provide technical oversight to all parties working under this project to enhance the local production of Artemisinin-based Combination Therapies (ACTs) in Nigeria. This involves providing technical oversight to PVAC, NMEP, local consultants, and other identified stakeholders engaged in this workstream. This workstream includes assessing manufacturing capacity, facilitating partnerships for technology transfer, ensuring compliance with regulatory standards, and supporting policy reforms to create an enabling environment for sustainable production. The consultant/consulting firm will ensure the integration of best practices for policy and implementation and draw from previous experiences in this space to strengthen the framework (both demand and supply) for the local manufacture of quality, and affordable ACTs.

3. Scope of Work

The consultant/ firm engaged to provide this oversight function is expected to:

1. Provide technical oversight and advise all parties working in the ACT workstream on matters relating to scope, quality, and outputs through participation and reviews during the planning, implementation, and close-out phases of the ACT production capacity development workstream.
2. Support the development of recommendations required for critical policy and regulatory reforms that will address gaps in the local manufacturing of ACTs by sharing best international practices in regulation, innovative financing, international market entry, etc.
3. Facilitate the engagement of stakeholders (government agencies, partners, private sector structures, technical partners, etc.)  relevant to realizing the goals of this workstream. These stakeholders must understand the Nigerian and international regulatory and ACT manufacturing landscape.
4. Provide technical support to organize policy dialogues with key stakeholders to develop the implementation framework for priority recommendations.
5. Participate in stakeholder workshops to validate findings and co-develop a strategic roadmap for expanding Nigeria’s competitiveness and regional share for malaria product (ACT) production.
6. Provide oversight to the quality of outputs for the ACT workstream, including the compilation, assessment, and final selection of potential ACT manufacturers and recommendations for support.
7. Provide technical oversight to ensure that the appropriate support is identified and provided to the selected ACT manufacturers in the following (not-exclusive) areas:
   1. Technical support and knowledge transfer directly or through partnerships
   2. Identifying funding gaps and possible funding sources 
   3. Establish a QA system to ensure compliance with international standards
8. Meet bi-weekly with the project team to review progress and collaboratively resolve any identified issues.

4. Selection Method

The selection process will follow a Limited Consultant Qualification-Based Method (LCQBM).

Under this approach, interested consultants will submit proposals in response to the Terms of Reference (TOR) issued by PVAC. As part of the evaluation, consultants/firms must demonstrate their relevant experience and qualifications in managing similar projects. Only the most qualified consultant/ firm with the required qualification/ expertise would be considered.

5. Required Expertise

The following are the expertise required from the applying consultant / firm: 

▪ Global Health Experience: Strong background in malaria epidemiological studies, prevention and control strategies, as well as global health programs, with experience in implementing large-scale public health interventions around Artemisinin-based Combination (ACT) development in LMICs with special interest in West Africa.

▪ Clinical Research Expertise: In-depth knowledge, experience and skills in epidemiological and molecular biological research with special interest in the development and evaluation of affordable malaria diagnostics and ACT as well as managing large clinical trials and its associated regulatory and certification requirements.

▪ Experience in ACT Development: Expertise in the research, formulation, and manufacturing processes for ACT, including clinical trial design and implementation.

▪ Stakeholders Engagement and Coordination Capabilities: Proven ability to manage multi-sectoral projects, coordinate with governments, NGOs, INGOs, donors, research institutions and private sector partners in malaria prevention and control.

• Innovative Financing:Excellent background in innovative financing for healthcare service delivery and development especially in the management of malaria in Africa.
• Regulatory Knowledge:  Have a wide experience working with national and international regulations for ACT production approval, Good Clinical Practices (GCP) and Good Manufacturing Practices (GMP). 
• Capacity Building: Experience in training and mentoring teams in clinical research and ACT development processes.
• International Context Knowledge: Understanding of international health systems and regulatory landscapes. Familiar with the operational challenges in Africa, especially regarding healthcare needs and distribution challenges. Able to influence the local ACT manufacturing landscape along the lines of international best practices.

6. Expected Outcomes

The oversight function of this workstream is expected to support the quality of deliverables from all parties working under this workstream. These include: 

1. Evidence-based ACT-specific policy recommendations and reforms validated by stakeholders. 
2. Detailed reports of site visits and assessments.
3. A list of selected 1^st batch ACT manufacturers (at least 3) and a pipeline of recommended 2^nd batch ACT manufacturers (at least 5) for technical assistance. 
4. Detailed map of potential funding opportunities.
5. Technical assistance reports.

7. Duration of the Assignment

This assignment is expected to run for 8 months – May to December 2025

8. Submission Requirements

Interested organizations are expected to submit the following documents:

1. Technical Proposal: The technical proposal should include:

▪ A clear methodology that demonstrates expertise in managing this project.

▪ A track record and experience in implementing similar projects

▪ At least 3 references from similar projects 

• Compliance Documents: Consultant must have the permit to work in Nigeria as Nigeria’s Ministry of Interior requires. While for firms, the following documents are also required:

▪ A valid organizational registration document

▪ Up-to-date tax clearance certificates 

• Financial Proposal 

All required documents should be sent to [email protected] on or before May 2^nd, 2025. Proposals sent after this date will not be considered.Request for Consultants: Provision of Technical Oversight for the Implementation of Workstream on Building Local Capacity to Produce Quality ACT: 

Enhancing Local Manufacturing and Supply Chain Management for Health

Commodities and Supplies in Nigeria

1. Background

Nigeria faces a significant burden from both communicable and non-communicable diseases, which strains the healthcare system and hinders economic development. Despite ongoing efforts to address these challenges, the country remains heavily reliant on imports for essential health commodities. This dependency leads to high costs, supply chain vulnerabilities, and inconsistent availability of critical healthcare products. Strengthening local capacity and optimizing supply chain management is essential to improving the accessibility, affordability, and sustainability of healthcare products. This is key to advancing public health.

Market shaping strategies have proven successful in other health sectors by leveraging economies of scale, improving quality control, and enhancing distribution efficiency. Adopting this model for manufacturing and distributing essential health commodities could reduce costs, improve product consistency, and ensure more reliable supply chains. However, transitioning from an import-dependent system to one with a robust local production capacity and an efficient pooled procurement system is a complex process. It requires a comprehensive, multi-faceted approach that addresses manufacturing capabilities, quality assurance mechanisms, supply chain optimization, workforce capacity building, and supportive policy frameworks.

The Presidential Initiative for Unlocking Healthcare Value Chain (PVAC) and the National Malaria Elimination Programme (NMEP), with the support of the World Bank IMPACT, embarked on a project called “Enhancing Local Manufacturing and Supply Chain Management for Health Commodities and Supplies in Nigeria”. The aim of this project is to address these challenges through a phased approach that balances short-term and long-term objectives. The strategies for addressing these challenges will include developing and laying the groundwork for local manufacturing of malaria commodities (including ACTs, RDTs, APIs and LLINs), including enhancing production capacity, ensuring compliance with international quality standards, and fostering workforce development. At the same time, the project will focus on optimizing the pooled procurement of imported malaria commodities to improve cost-effectiveness and distribution efficiency. Over the medium to long term, these interventions will strengthen the entire health commodities value chain, create opportunities for economic growth, and support Nigeria’s self-sufficiency in critical healthcare products. This comprehensive approach seeks to improve Nigeria’s healthcare supply systems’ efficiency and resilience while unlocking new economic opportunities within the country’s health sector. The project duration is 1 year.

2. Objective

This consultancy aims to provide technical oversight to all parties working under this project to enhance the local production of Artemisinin-based Combination Therapies (ACTs) in Nigeria. This involves providing technical oversight to PVAC, NMEP, local consultants, and other identified stakeholders engaged in this workstream. This workstream includes assessing manufacturing capacity, facilitating partnerships for technology transfer, ensuring compliance with regulatory standards, and supporting policy reforms to create an enabling environment for sustainable production. The consultant/consulting firm will ensure the integration of best practices for policy and implementation and draw from previous experiences in this space to strengthen the framework (both demand and supply) for the local manufacture of quality, and affordable ACTs.

3. Scope of Work

The consultant/ firm engaged to provide this oversight function is expected to:

1. Provide technical oversight and advise all parties working in the ACT workstream on matters relating to scope, quality, and outputs through participation and reviews during the planning, implementation, and close-out phases of the ACT production capacity development workstream.
2. Support the development of recommendations required for critical policy and regulatory reforms that will address gaps in the local manufacturing of ACTs by sharing best international practices in regulation, innovative financing, international market entry, etc.
3. Facilitate the engagement of stakeholders (government agencies, partners, private sector structures, technical partners, etc.)  relevant to realizing the goals of this workstream. These stakeholders must understand the Nigerian and international regulatory and ACT manufacturing landscape.
4. Provide technical support to organize policy dialogues with key stakeholders to develop the implementation framework for priority recommendations.
5. Participate in stakeholder workshops to validate findings and co-develop a strategic roadmap for expanding Nigeria’s competitiveness and regional share for malaria product (ACT) production.
6. Provide oversight to the quality of outputs for the ACT workstream, including the compilation, assessment, and final selection of potential ACT manufacturers and recommendations for support.
7. Provide technical oversight to ensure that the appropriate support is identified and provided to the selected ACT manufacturers in the following (not-exclusive) areas:
   1. Technical support and knowledge transfer directly or through partnerships
   2. Identifying funding gaps and possible funding sources 
   3. Establish a QA system to ensure compliance with international standards
8. Meet bi-weekly with the project team to review progress and collaboratively resolve any identified issues.

4. Selection Method

The selection process will follow a Limited Consultant Qualification-Based Method (LCQBM).

Under this approach, interested consultants will submit proposals in response to the Terms of Reference (TOR) issued by PVAC. As part of the evaluation, consultants/firms must demonstrate their relevant experience and qualifications in managing similar projects. Only the most qualified consultant/ firm with the required qualification/ expertise would be considered.

5. Required Expertise

The following are the expertise required from the applying consultant / firm: 

▪ Global Health Experience: Strong background in malaria epidemiological studies, prevention and control strategies, as well as global health programs, with experience in implementing large-scale public health interventions around Artemisinin-based Combination (ACT) development in LMICs with special interest in West Africa.

▪ Clinical Research Expertise: In-depth knowledge, experience and skills in epidemiological and molecular biological research with special interest in the development and evaluation of affordable malaria diagnostics and ACT as well as managing large clinical trials and its associated regulatory and certification requirements.

▪ Experience in ACT Development: Expertise in the research, formulation, and manufacturing processes for ACT, including clinical trial design and implementation.

▪ Stakeholders Engagement and Coordination Capabilities: Proven ability to manage multi-sectoral projects, coordinate with governments, NGOs, INGOs, donors, research institutions and private sector partners in malaria prevention and control.

• Innovative Financing:Excellent background in innovative financing for healthcare service delivery and development especially in the management of malaria in Africa.
• Regulatory Knowledge:  Have a wide experience working with national and international regulations for ACT production approval, Good Clinical Practices (GCP) and Good Manufacturing Practices (GMP). 
• Capacity Building: Experience in training and mentoring teams in clinical research and ACT development processes.
• International Context Knowledge: Understanding of international health systems and regulatory landscapes. Familiar with the operational challenges in Africa, especially regarding healthcare needs and distribution challenges. Able to influence the local ACT manufacturing landscape along the lines of international best practices.

6. Expected Outcomes

The oversight function of this workstream is expected to support the quality of deliverables from all parties working under this workstream. These include: 

1. Evidence-based ACT-specific policy recommendations and reforms validated by stakeholders. 
2. Detailed reports of site visits and assessments.
3. A list of selected 1^st batch ACT manufacturers (at least 3) and a pipeline of recommended 2^nd batch ACT manufacturers (at least 5) for technical assistance. 
4. Detailed map of potential funding opportunities.
5. Technical assistance reports.

7. Duration of the Assignment

This assignment is expected to run for 8 months – May to December 2025

8. Submission Requirements

Interested organizations are expected to submit the following documents:

1. Technical Proposal: The technical proposal should include:

▪ A clear methodology that demonstrates expertise in managing this project.

▪ A track record and experience in implementing similar projects

▪ At least 3 references from similar projects 

• Compliance Documents: Consultant must have the permit to work in Nigeria as Nigeria’s Ministry of Interior requires. While for firms, the following documents are also required:

▪ A valid organizational registration document

▪ Up-to-date tax clearance certificates 

• Financial Proposal 

All required documents should be sent to [email protected] on or before May 2^nd, 2025. Proposals sent after this date will not be considered.Request for Consultants: Provision of Technical Oversight for the Implementation of Workstream on Building Local Capacity to Produce Quality ACT: 

Enhancing Local Manufacturing and Supply Chain Management for Health

Commodities and Supplies in Nigeria

1. Background

Nigeria faces a significant burden from both communicable and non-communicable diseases, which strains the healthcare system and hinders economic development. Despite ongoing efforts to address these challenges, the country remains heavily reliant on imports for essential health commodities. This dependency leads to high costs, supply chain vulnerabilities, and inconsistent availability of critical healthcare products. Strengthening local capacity and optimizing supply chain management is essential to improving the accessibility, affordability, and sustainability of healthcare products. This is key to advancing public health.

Market shaping strategies have proven successful in other health sectors by leveraging economies of scale, improving quality control, and enhancing distribution efficiency. Adopting this model for manufacturing and distributing essential health commodities could reduce costs, improve product consistency, and ensure more reliable supply chains. However, transitioning from an import-dependent system to one with a robust local production capacity and an efficient pooled procurement system is a complex process. It requires a comprehensive, multi-faceted approach that addresses manufacturing capabilities, quality assurance mechanisms, supply chain optimization, workforce capacity building, and supportive policy frameworks.

https://googleads.g.doubleclick.net/pagead/ads?gdpr=0&us_privacy=1—&gpp_sid=-1&client=ca-pub-2321249943983804&output=html&h=280&adk=3292208330&adf=3651786664&pi=t.aa~a.1381849204~i.13~rp.4&w=728&abgtt=6&fwrn=4&fwrnh=100&lmt=1745427050&num_ads=1&rafmt=1&armr=3&sem=mc&pwprc=6515900736&ad_type=text_image&format=728×280&url=https%3A%2F%2Fngojobsite.com%2Finvitation-to-bid-provision-of-technical-oversight-for-the-implementation-of-workstream-on-building-local-capacity-to-produce-quality-act-at-health-systems-consult-limited-hscl%2F&fwr=0&pra=3&rh=182&rw=727&rpe=1&resp_fmts=3&wgl=1&fa=27&uach=WyJXaW5kb3dzIiwiMTUuMC4wIiwieDg2IiwiIiwiMTM1LjAuNzA0OS44NSIsbnVsbCwwLG51bGwsIjY0IixbWyJHb29nbGUgQ2hyb21lIiwiMTM1LjAuNzA0OS44NSJdLFsiTm90LUEuQnJhbmQiLCI4LjAuMC4wIl0sWyJDaHJvbWl1bSIsIjEzNS4wLjcwNDkuODUiXV0sMF0.&dt=1745426256758&bpp=4&bdt=1842&idt=4&shv=r20250421&mjsv=m202504170101&ptt=9&saldr=aa&abxe=1&cookie=ID%3Dd402398dbe8029b3%3AT%3D1730191189%3ART%3D1745426888%3AS%3DALNI_Mbqv4ZjCA2FyHoBsYRqGiGVSR4f2A&gpic=UID%3D00000f5f5123b4f7%3AT%3D1730191189%3ART%3D1745426888%3AS%3DALNI_MaUeBuU5kMVXlTiiGykJasfdDE9vw&eo_id_str=ID%3D3685604803237a2e%3AT%3D1730191189%3ART%3D1745426888%3AS%3DAA-AfjZ2X441EOy64ZtttSEJoFR_&prev_fmts=0x0%2C750x280%2C1497x702&nras=3&correlator=8747092532096&frm=20&pv=1&u_tz=60&u_his=1&u_h=768&u_w=1366&u_ah=720&u_aw=1366&u_cd=24&u_sd=0.9&dmc=8&adx=190&ady=1181&biw=1497&bih=702&scr_x=0&scr_y=0&eid=95358862%2C95358864%2C95354562%2C95355310%2C95357877%2C95357716&oid=2&pvsid=3942448291295766&tmod=698141052&uas=0&nvt=1&fc=1408&brdim=-7%2C0%2C-7%2C0%2C1366%2C0%2C1379%2C727%2C1514%2C702&vis=1&rsz=%7C%7Cs%7C&abl=NS&cms=2&fu=128&bc=31&bz=0.91&td=1&tdf=2&psd=W251bGwsbnVsbCxudWxsLDNd&nt=1&pgls=CAEaAzYuOA..~CAA.&ifi=6&uci=a!6&btvi=1&fsb=1&dtd=M

The Presidential Initiative for Unlocking Healthcare Value Chain (PVAC) and the National Malaria Elimination Programme (NMEP), with the support of the World Bank IMPACT, embarked on a project called “Enhancing Local Manufacturing and Supply Chain Management for Health Commodities and Supplies in Nigeria”. The aim of this project is to address these challenges through a phased approach that balances short-term and long-term objectives. The strategies for addressing these challenges will include developing and laying the groundwork for local manufacturing of malaria commodities (including ACTs, RDTs, APIs and LLINs), including enhancing production capacity, ensuring compliance with international quality standards, and fostering workforce development. At the same time, the project will focus on optimizing the pooled procurement of imported malaria commodities to improve cost-effectiveness and distribution efficiency. Over the medium to long term, these interventions will strengthen the entire health commodities value chain, create opportunities for economic growth, and support Nigeria’s self-sufficiency in critical healthcare products. This comprehensive approach seeks to improve Nigeria’s healthcare supply systems’ efficiency and resilience while unlocking new economic opportunities within the country’s health sector. The project duration is 1 year.

2. Objective

This consultancy aims to provide technical oversight to all parties working under this project to enhance the local production of Artemisinin-based Combination Therapies (ACTs) in Nigeria. This involves providing technical oversight to PVAC, NMEP, local consultants, and other identified stakeholders engaged in this workstream. This workstream includes assessing manufacturing capacity, facilitating partnerships for technology transfer, ensuring compliance with regulatory standards, and supporting policy reforms to create an enabling environment for sustainable production. The consultant/consulting firm will ensure the integration of best practices for policy and implementation and draw from previous experiences in this space to strengthen the framework (both demand and supply) for the local manufacture of quality, and affordable ACTs.

3. Scope of Work

The consultant/ firm engaged to provide this oversight function is expected to:

1. Provide technical oversight and advise all parties working in the ACT workstream on matters relating to scope, quality, and outputs through participation and reviews during the planning, implementation, and close-out phases of the ACT production capacity development workstream.
2. Support the development of recommendations required for critical policy and regulatory reforms that will address gaps in the local manufacturing of ACTs by sharing best international practices in regulation, innovative financing, international market entry, etc.
3. Facilitate the engagement of stakeholders (government agencies, partners, private sector structures, technical partners, etc.)  relevant to realizing the goals of this workstream. These stakeholders must understand the Nigerian and international regulatory and ACT manufacturing landscape.
4. Provide technical support to organize policy dialogues with key stakeholders to develop the implementation framework for priority recommendations.
5. Participate in stakeholder workshops to validate findings and co-develop a strategic roadmap for expanding Nigeria’s competitiveness and regional share for malaria product (ACT) production.
6. Provide oversight to the quality of outputs for the ACT workstream, including the compilation, assessment, and final selection of potential ACT manufacturers and recommendations for support.
7. Provide technical oversight to ensure that the appropriate support is identified and provided to the selected ACT manufacturers in the following (not-exclusive) areas:
   1. Technical support and knowledge transfer directly or through partnerships
   2. Identifying funding gaps and possible funding sources 
   3. Establish a QA system to ensure compliance with international standards
8. Meet bi-weekly with the project team to review progress and collaboratively resolve any identified issues.

4. Selection Method

The selection process will follow a Limited Consultant Qualification-Based Method (LCQBM).

Under this approach, interested consultants will submit proposals in response to the Terms of Reference (TOR) issued by PVAC. As part of the evaluation, consultants/firms must demonstrate their relevant experience and qualifications in managing similar projects. Only the most qualified consultant/ firm with the required qualification/ expertise would be considered.

5. Required Expertise

The following are the expertise required from the applying consultant / firm: 

▪ Global Health Experience: Strong background in malaria epidemiological studies, prevention and control strategies, as well as global health programs, with experience in implementing large-scale public health interventions around Artemisinin-based Combination (ACT) development in LMICs with special interest in West Africa.

▪ Clinical Research Expertise: In-depth knowledge, experience and skills in epidemiological and molecular biological research with special interest in the development and evaluation of affordable malaria diagnostics and ACT as well as managing large clinical trials and its associated regulatory and certification requirements.

▪ Experience in ACT Development: Expertise in the research, formulation, and manufacturing processes for ACT, including clinical trial design and implementation.

▪ Stakeholders Engagement and Coordination Capabilities: Proven ability to manage multi-sectoral projects, coordinate with governments, NGOs, INGOs, donors, research institutions and private sector partners in malaria prevention and control.

• Innovative Financing:Excellent background in innovative financing for healthcare service delivery and development especially in the management of malaria in Africa.
• Regulatory Knowledge:  Have a wide experience working with national and international regulations for ACT production approval, Good Clinical Practices (GCP) and Good Manufacturing Practices (GMP). 
• Capacity Building: Experience in training and mentoring teams in clinical research and ACT development processes.
• International Context Knowledge: Understanding of international health systems and regulatory landscapes. Familiar with the operational challenges in Africa, especially regarding healthcare needs and distribution challenges. Able to influence the local ACT manufacturing landscape along the lines of international best practices.

6. Expected Outcomes

The oversight function of this workstream is expected to support the quality of deliverables from all parties working under this workstream. These include: 

1. Evidence-based ACT-specific policy recommendations and reforms validated by stakeholders. 
2. Detailed reports of site visits and assessments.
3. A list of selected 1^st batch ACT manufacturers (at least 3) and a pipeline of recommended 2^nd batch ACT manufacturers (at least 5) for technical assistance. 
4. Detailed map of potential funding opportunities.
5. Technical assistance reports.

7. Duration of the Assignment

This assignment is expected to run for 8 months – May to December 2025

8. Submission Requirements

Interested organizations are expected to submit the following documents:

1. Technical Proposal: The technical proposal should include:

▪ A clear methodology that demonstrates expertise in managing this project.

▪ A track record and experience in implementing similar projects

▪ At least 3 references from similar projects 

• Compliance Documents: Consultant must have the permit to work in Nigeria as Nigeria’s Ministry of Interior requires. While for firms, the following documents are also required:

▪ A valid organizational registration document

▪ Up-to-date tax clearance certificates 

• Financial Proposal 

All required documents should be sent to [email protected] on or before May 2^nd, 2025. Proposals sent after this date will not be considered.Request for Consultants: Provision of Technical Oversight for the Implementation of Workstream on Building Local Capacity to Produce Quality ACT: 

Enhancing Local Manufacturing and Supply Chain Management for Health

Commodities and Supplies in Nigeria

1. Background

Nigeria faces a significant burden from both communicable and non-communicable diseases, which strains the healthcare system and hinders economic development. Despite ongoing efforts to address these challenges, the country remains heavily reliant on imports for essential health commodities. This dependency leads to high costs, supply chain vulnerabilities, and inconsistent availability of critical healthcare products. Strengthening local capacity and optimizing supply chain management is essential to improving the accessibility, affordability, and sustainability of healthcare products. This is key to advancing public health.

Market shaping strategies have proven successful in other health sectors by leveraging economies of scale, improving quality control, and enhancing distribution efficiency. Adopting this model for manufacturing and distributing essential health commodities could reduce costs, improve product consistency, and ensure more reliable supply chains. However, transitioning from an import-dependent system to one with a robust local production capacity and an efficient pooled procurement system is a complex process. It requires a comprehensive, multi-faceted approach that addresses manufacturing capabilities, quality assurance mechanisms, supply chain optimization, workforce capacity building, and supportive policy frameworks.

The Presidential Initiative for Unlocking Healthcare Value Chain (PVAC) and the National Malaria Elimination Programme (NMEP), with the support of the World Bank IMPACT, embarked on a project called “Enhancing Local Manufacturing and Supply Chain Management for Health Commodities and Supplies in Nigeria”. The aim of this project is to address these challenges through a phased approach that balances short-term and long-term objectives. The strategies for addressing these challenges will include developing and laying the groundwork for local manufacturing of malaria commodities (including ACTs, RDTs, APIs and LLINs), including enhancing production capacity, ensuring compliance with international quality standards, and fostering workforce development. At the same time, the project will focus on optimizing the pooled procurement of imported malaria commodities to improve cost-effectiveness and distribution efficiency. Over the medium to long term, these interventions will strengthen the entire health commodities value chain, create opportunities for economic growth, and support Nigeria’s self-sufficiency in critical healthcare products. This comprehensive approach seeks to improve Nigeria’s healthcare supply systems’ efficiency and resilience while unlocking new economic opportunities within the country’s health sector. The project duration is 1 year.

2. Objective

This consultancy aims to provide technical oversight to all parties working under this project to enhance the local production of Artemisinin-based Combination Therapies (ACTs) in Nigeria. This involves providing technical oversight to PVAC, NMEP, local consultants, and other identified stakeholders engaged in this workstream. This workstream includes assessing manufacturing capacity, facilitating partnerships for technology transfer, ensuring compliance with regulatory standards, and supporting policy reforms to create an enabling environment for sustainable production. The consultant/consulting firm will ensure the integration of best practices for policy and implementation and draw from previous experiences in this space to strengthen the framework (both demand and supply) for the local manufacture of quality, and affordable ACTs.

3. Scope of Work

The consultant/ firm engaged to provide this oversight function is expected to:

1. Provide technical oversight and advise all parties working in the ACT workstream on matters relating to scope, quality, and outputs through participation and reviews during the planning, implementation, and close-out phases of the ACT production capacity development workstream.
2. Support the development of recommendations required for critical policy and regulatory reforms that will address gaps in the local manufacturing of ACTs by sharing best international practices in regulation, innovative financing, international market entry, etc.
3. Facilitate the engagement of stakeholders (government agencies, partners, private sector structures, technical partners, etc.)  relevant to realizing the goals of this workstream. These stakeholders must understand the Nigerian and international regulatory and ACT manufacturing landscape.
4. Provide technical support to organize policy dialogues with key stakeholders to develop the implementation framework for priority recommendations.
5. Participate in stakeholder workshops to validate findings and co-develop a strategic roadmap for expanding Nigeria’s competitiveness and regional share for malaria product (ACT) production.
6. Provide oversight to the quality of outputs for the ACT workstream, including the compilation, assessment, and final selection of potential ACT manufacturers and recommendations for support.
7. Provide technical oversight to ensure that the appropriate support is identified and provided to the selected ACT manufacturers in the following (not-exclusive) areas:
   1. Technical support and knowledge transfer directly or through partnerships
   2. Identifying funding gaps and possible funding sources 
   3. Establish a QA system to ensure compliance with international standards
8. Meet bi-weekly with the project team to review progress and collaboratively resolve any identified issues.

4. Selection Method

The selection process will follow a Limited Consultant Qualification-Based Method (LCQBM).

Under this approach, interested consultants will submit proposals in response to the Terms of Reference (TOR) issued by PVAC. As part of the evaluation, consultants/firms must demonstrate their relevant experience and qualifications in managing similar projects. Only the most qualified consultant/ firm with the required qualification/ expertise would be considered.

5. Required Expertise

The following are the expertise required from the applying consultant / firm: 

▪ Global Health Experience: Strong background in malaria epidemiological studies, prevention and control strategies, as well as global health programs, with experience in implementing large-scale public health interventions around Artemisinin-based Combination (ACT) development in LMICs with special interest in West Africa.

https://googleads.g.doubleclick.net/pagead/ads?gdpr=0&us_privacy=1—&gpp_sid=-1&client=ca-pub-2321249943983804&output=html&h=280&adk=3292208330&adf=1381599079&pi=t.aa~a.1381849204~i.37~rp.4&w=728&abgtt=6&fwrn=4&fwrnh=100&lmt=1745427051&num_ads=1&rafmt=1&armr=3&sem=mc&pwprc=6515900736&ad_type=text_image&format=728×280&url=https%3A%2F%2Fngojobsite.com%2Finvitation-to-bid-provision-of-technical-oversight-for-the-implementation-of-workstream-on-building-local-capacity-to-produce-quality-act-at-health-systems-consult-limited-hscl%2F&fwr=0&pra=3&rh=182&rw=727&rpe=1&resp_fmts=3&wgl=1&fa=27&uach=WyJXaW5kb3dzIiwiMTUuMC4wIiwieDg2IiwiIiwiMTM1LjAuNzA0OS44NSIsbnVsbCwwLG51bGwsIjY0IixbWyJHb29nbGUgQ2hyb21lIiwiMTM1LjAuNzA0OS44NSJdLFsiTm90LUEuQnJhbmQiLCI4LjAuMC4wIl0sWyJDaHJvbWl1bSIsIjEzNS4wLjcwNDkuODUiXV0sMF0.&dt=1745426256772&bpp=3&bdt=1857&idt=3&shv=r20250421&mjsv=m202504170101&ptt=9&saldr=aa&abxe=1&cookie=ID%3Dd402398dbe8029b3%3AT%3D1730191189%3ART%3D1745426888%3AS%3DALNI_Mbqv4ZjCA2FyHoBsYRqGiGVSR4f2A&gpic=UID%3D00000f5f5123b4f7%3AT%3D1730191189%3ART%3D1745426888%3AS%3DALNI_MaUeBuU5kMVXlTiiGykJasfdDE9vw&eo_id_str=ID%3D3685604803237a2e%3AT%3D1730191189%3ART%3D1745426888%3AS%3DAA-AfjZ2X441EOy64ZtttSEJoFR_&prev_fmts=0x0%2C750x280%2C1497x702%2C728x280%2C360x280%2C360x280&nras=6&correlator=8747092532096&frm=20&pv=1&u_tz=60&u_his=1&u_h=768&u_w=1366&u_ah=720&u_aw=1366&u_cd=24&u_sd=0.9&dmc=8&adx=190&ady=2783&biw=1497&bih=702&scr_x=0&scr_y=0&eid=95358862%2C95358864%2C95354562%2C95355310%2C95357877%2C95357716&oid=2&pvsid=3942448291295766&tmod=698141052&uas=0&nvt=1&fc=1408&brdim=-7%2C0%2C-7%2C0%2C1366%2C0%2C1379%2C727%2C1514%2C702&vis=1&rsz=%7C%7Cs%7C&abl=NS&fu=128&bc=31&bz=0.91&td=1&tdf=2&psd=W251bGwsbnVsbCxudWxsLDNd&nt=1&pgls=CAEaAzYuOA..~CAA.&ifi=7&uci=a!7&btvi=4&fsb=1&dtd=M

▪ Clinical Research Expertise: In-depth knowledge, experience and skills in epidemiological and molecular biological research with special interest in the development and evaluation of affordable malaria diagnostics and ACT as well as managing large clinical trials and its associated regulatory and certification requirements.

▪ Experience in ACT Development: Expertise in the research, formulation, and manufacturing processes for ACT, including clinical trial design and implementation.

▪ Stakeholders Engagement and Coordination Capabilities: Proven ability to manage multi-sectoral projects, coordinate with governments, NGOs, INGOs, donors, research institutions and private sector partners in malaria prevention and control.

• Innovative Financing:Excellent background in innovative financing for healthcare service delivery and development especially in the management of malaria in Africa.
• Regulatory Knowledge:  Have a wide experience working with national and international regulations for ACT production approval, Good Clinical Practices (GCP) and Good Manufacturing Practices (GMP). 
• Capacity Building: Experience in training and mentoring teams in clinical research and ACT development processes.
• International Context Knowledge: Understanding of international health systems and regulatory landscapes. Familiar with the operational challenges in Africa, especially regarding healthcare needs and distribution challenges. Able to influence the local ACT manufacturing landscape along the lines of international best practices.

6. Expected Outcomes

The oversight function of this workstream is expected to support the quality of deliverables from all parties working under this workstream. These include: 

1. Evidence-based ACT-specific policy recommendations and reforms validated by stakeholders. 
2. Detailed reports of site visits and assessments.
3. A list of selected 1^st batch ACT manufacturers (at least 3) and a pipeline of recommended 2^nd batch ACT manufacturers (at least 5) for technical assistance. 
4. Detailed map of potential funding opportunities.
5. Technical assistance reports.

7. Duration of the Assignment

This assignment is expected to run for 8 months – May to December 2025

8. Submission Requirements

Interested organizations are expected to submit the following documents:

1. Technical Proposal: The technical proposal should include:

▪ A clear methodology that demonstrates expertise in managing this project.

▪ A track record and experience in implementing similar projects

▪ At least 3 references from similar projects 

• Compliance Documents: Consultant must have the permit to work in Nigeria as Nigeria’s Ministry of Interior requires. While for firms, the following documents are also required:

▪ A valid organizational registration document

▪ Up-to-date tax clearance certificates 

• Financial Proposal 

All required documents should be sent to [email protected] on or before May 2^nd, 2025. Proposals sent after this date will not be considered.

The Center for Clinical Care and Clinical Research is an indigenous, non-profit organization that promotes best practices in health care delivery, medical training and research using locally adapted models of health systems strengthening. CCCRN built a vast network of health and allied professional staff, partners and collaborators.

We require qualified candidates to fill the under-listed position for a 5-year USAID award known as Transforming Health and Resilience for Individuals Through Vibrant Empowerment (THRIVE) South Project, implemented in the five states of Akwa Ibom, Bayelsa, Cross River, Edo and Lagos:

Job Title: Strategic Information Officer

Location: Edo / Lagos
Position Type: Full Time
Reports To: Senior Technical Advisor, Strategic Information (STASI)

Job Responsibilities

• S/he will provide an overall support to the implementation of M&E activities at the Project office, State Ministries of Women Affairs (SMW), State Action Committee on AIDS (SACA), and other OVC stakeholders in Edo State.
• S/he should collaborate with his/her counterparts at THRIVE South in-country headquarters to ensure that all M&E tools and management information systems (MIS) are availability and up to date for routine program monitoring activities in the state.  
• The Officer, Strategic Information (SI) will ensure that data entry into national, PEPFAR and project MIS – National OVC management information system (NOMIS), District Health Information System (DHIS), Data for Accountability and Impact (DATIM) and other MIS; are always up to date.
• He will collaborate with the MEAL teams of the project and the CSOs to ensure that accurate and high-quality program data are collected and entered into the MIS platforms in a timely manner, reports generated along with the narratives, to provide information for OVC programming and management decision making. 
• Also, s/he will support the training of CSO staff, promote program learning and sharing among staff, partners and stakeholders and encourage data utilization at all levels.

Specific Responsibilities

• Ensure CSOs understand the information needs of project stakeholders and donors and adhere to system requirements
• Work closely with the CSO M&E officers to ensure they understand the data requirements and data-gathering and report formats.  
• Support CSO M&E staff in their work with the Community Case Workers (CCWs or equivalent) to ensure that enough training is done for CCWs and volunteers, that the correct forms are used and that accurate reports are submitted on a timely basis.
• In collaboration with the THRIVE South MEAL team build capacity of CSO M&E staff in the understanding of OVC MER indicators and custom indicators and how they are measured.
• Ensure that CSOs enter accurate and high-quality data and reports on the MIS platforms on a timely basis or as may be needed.
• Work with contract M&E firm in the implementation of data quality assessments (DQAs), Site Improvement and Monitoring System (SIMS) implementation.  
• Ensure that CSOs participate in the DQAs, understand the recommendations for remedial action, and comply with those recommendations
• Collaborate with the Database Manager in the analysis and report of CSO’s data using the MIS required platforms on weekly, monthly, quarterly, semi-annual and annual basis to USAID and other stakeholders, as may be required.
• Identifies and responds to key stakeholders’ information needs in MEAL activities, using a range of appropriate communication methods.
• Undertake any MEAL responsibilities that may be assigned to him from time to time by his supervisor of the management team.

Qualifications and Skills

• Bachelor’s degree in social science with emphasis in rural development, public health, statistics or a development related field.
• Demonstrated skills in M&E design with previous experience in application of quantitative and qualitative research methodologies.
• At least three years of professional experience implementing/managing M&E for programs related to Health, HIV and OVC, agriculture or food and nutrition security programming, of which at least one year with NGOs.
• Experience in designing computer databases in Excel, Access, SQL and NoSQL, or in other database packages, and computer literacy in MS Office – Excel, Power Point and Word.
• Demonstrated ability to work effectively with government and civil society partners and communities as well as transfer knowledge to diverse audiences through workshops, training and meetings using participatory methods and adult learning principles.
• Proven leadership and inter-personal skills for effective teamwork; as well as the ability to work independently on a frequent basis, taking initiative, managing a variety of activities concurrently, and delivering outputs on schedule.
• Demonstrated ability to support partners working at a distance to achieve results against program objectives/targets.

Application Closing Date
8th May, 2025.

How to Apply
Interested and qualified candidates should:
Click here to apply online